










The handle http://hdl.handle.net/1887/20277  holds various files of this Leiden University 
dissertation. 
 
Author: Hogewoning, Arjan 





The printing of this thesis was financially supported by
African Tiger Holding LTD. Accra, Ghana
The Koornzaayer Foundation, The Netherlands
ISBN: 978-94-6191-497-2
Cover: In Zicht Grafisch Ontwerp
Layout: In Zicht Grafisch Ontwerp
Print: Ipskamp Drukkers BV, Enschede 
© Arjan Hogewoning, 2012 
All rights reserved. No part of this thesis may be reproduced or printed in any form or by any means, electronically, 
mechanically, including photocopy, recording or any information storage and retrieval system without written 




 ter verkrijging van 
de graad van Doctor aan de Universiteit Leiden,
op gezag van Rector Magnificus prof.mr. P.F. van der Heijden,
volgens besluit van het College voor Promoties







Voor Door, Pieter, Anne en Benjamin
Photograph of Dr. Albert Schweitzer, by Maria Austria 
and given to the author by Pieter M.Mentzel
“It was in front of three iles situated on the river Ogooué near the village of Igendja,  
80 km downstream of Lambaréné, that I got the vision, one day in September 1915,  




 Prof. dr. W. Bergman 
    Prof. dr. M. Yazdanbakhsh
 
Co-promotor
 Dr. A.P.M. Lavrijsen
Overige leden
 Prof. dr. M.H. Vermeer 
   Dr. L.G. Visser 
   Prof. dr. H.J.C. de Vries (AMC, Amsterdam)
Contents
Chapter 1 General introduction 9
Chapter 2 Skin diseases among schoolchildren in Ghana, Gabon and Rwanda 21
Chapter 3  Prevalence of symptomatic tinea capitis and associated causative 41 
organisms in the Greater Accra Region, Ghana
Chapter 4  Prevalence and causative fungal species of tinea capitis among  53 
schoolchildren in Gabon
Chapter 5  Point and period prevalences of eczema in rural and urban  65 
schoolchildren in Ghana, Gabon and Rwanda
Chapter 6  Allergic characteristics of urban schoolchildren with atopic eczema  81 
in Ghana
Chapter 7  Prevalence and risk factors of inflammatory acne vulgaris in rural  97 
and urban Ghanaian schoolchildren
Chapter 8  Skin diseases and conditions among children in sub-Sahara Africa 113 
A Practical Guide for Healthcare workers
Chapter 9  General Discussion 195
 Summary and concluding remarks 205
Chapter 10  Nederlandse Samenvatting 211
 List of Publications 215
 Curriculum Vitae 217
 Dankwoord | Acknowledgements 219
Children are the most vulnerable citizens in any society  
and the greatest of our treasures.
Nelson Mandela






Skin diseases in developing countries are present in large numbers, especially among 
children and deserve our sincere and full attention.1-6  They are accounting for a high 
percentage of visits to hospitals and primary healthcare centers and create a serious 
impact on health care services.7-9 In a review of prevalence studies in children by the 
WHO, the prevalence of skin diseases were ranging from 21% to 87%.10 These high 
figures warrant the study of morbidity, causative factors and economic costs.1;11 Skin 
diseases are often considered less important in health priority programs compared with 
diseases that cause high mortality like tuberculosis, HIV/AIDS, meningitis or hepatitis.2 
Compared with other diseases, skin diseases have a lower mortality rate but can affect 
the wellbeing, quality of life and health conditions of children who already form a 
vulnerable group.2 
Using a comparative assessment of disability-adjusted life years (DALY’s) the World 
Health Organization’s 2004 report on the global burden of diseases showed a total 
amount of 376.525.000 DALY’s in Africa which was at least two times higher than in any 
other region in the world. For skin diseases  in Africa there was a total of 902.000 DALY’s 
(0.2% of the total burden) which was similar to that caused by several psychiatric 
disorders.12 
Most of the prevalence data in Africa come from hospital or dispensary-based records 
and therefore are less reliable when estimating the prevalence on a national scale. Pop-
ulation-based prevalence figures are needed for reliable planning of national health 
and prevention programs. Only a few population-based studies on this subject are 
available.5;9;13;14 Most of these studies have been conducted on schoolchildren. In most 
recent prevalence studies, conducted in sub-Sahara Africa the majority of the skin 
diseases found among schoolchildren are dominated by infections like tinea capitis and 
pyoderma.5;10;13-20 This is a pattern found in most countries with poor socio economic 
circumstances. We performed several studies to gain more insight in the prevalence of 
tinea capitis and the causative organisms, to determine the burden of this infectious 
disease in communities and to identify possible strategies for prevention and treatment.
In industrialized countries the highest burden of skin diseases is formed by inflammatory 
diseases like acne vulgaris and eczema but recent studies from Africa reported also an 
increase in prevalence.21;22 Therefore, we performed several studies focusing on “western” 
skin diseases and the impact of socio-economic developments on the prevalence by 
comparing rural versus urban schools.   
The prevalence of classical tropical diseases like leprosy or filarial lymph edema is low 
although the socio economical impact can be enormous.10;23-29
This thesis focuses on three skin diseases in particular, namely, tinea capitis, eczema and 
acne, which diseases are discussed in some more detail below.
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The rising prevalence of eczema might be related to improved sanitation and reduction 
in childhood infections, the so called hygiene hypothesis.53-58 Also helminthic infections 
have shown to induce hypo responsiveness and are negatively associated with atopy 
and allergy.57;59-62 Other risk factors for the development of eczema are changes in 
lifestyle because of a higher socio-economic status, reduced crowding at home, 
changes in food consumption. Also the growing urbanization in Africa has been 
associated with an increased risk of eczema.10;43;63;64
Prevalence and risk factors of acne vulgaris in Africa
Acne vulgaris is a common skin condition in children and adolescents between the age 
of 10 and 18 years which is much more frequently seen in the industrialized world 
compared with developing countries.21;22;65;66 Community-based studies, studying acne 
vulgaris in Africa are scarce. Most studies are hospital based and don’t give a correct 
figure about the prevalence.67 In industrialized countries this condition affects between 
31% and 95% of the adolescent population while in Africa percentages of 2.8% and 8.9% 
are reported.14;68;69 
With the changing socio-economic situation in developing countries, especially 
westernization in urban areas, it is believed that the prevalence of acne vulgaris in 
developing countries will increase to the level of industrialized countries.67;70 
Aim and structure of the thesis
The aims of the thesis were:
1)  To measure the point-prevalence of different skin diseases (with special attention for 
childhood eczema, acne and tinea capitis) among schoolchildren in both rural and 
urban schools and in three different African countries (Gabon, Ghana and Rwanda). 
Between 2004 and 2007 cross-sectional studies with 4839 schoolchildren
were conducted in Ghana, Gabon and Rwanda in urban and rural schools with different 
social economic levels (low, middle, high). All children were included in the study and 
were investigated by a dermatologist or a team of dermatologists.
2)   To determine causative agents for tinea capitis in Ghana and Gabon.
In June 2004, 463 school children from 2 rural and 2 urban schools in the Greater Accra 
Region were fully examined by a team of dermatologists. The same happened in 
January 2005 in the region of Lambaréné, Gabon when 454 children in one rural and 
one urban school were examined. When there were clinical signs of fungal infection on 
The most common skin diseases among children in Africa are described in Chapter 8. 
In this chapter several skin diseases among preschool children and some typical 
tropical diseases are presented. With this chapter (and a website to match: www.african-
skindiseases.org) the author hopes to offer an easy access to basic information and 
pictures for healthcare workers in Africa.
The prevalence and causative organisms of tinea capitis in Africa
Tinea capitis is endemic among schoolchildren in tropical Africa.30 Factors like over -
crowding, malnutrition and climatic conditions such as heat and humidity can lead to 
an increase in fungal infections in tropical and semi-tropical countries.31 
The prevalence of tinea capitis is higher among schoolchildren in rural areas due to the 
lack of anti-fungal treatments, poor hygienic conditions, and school and household 
overcrowding.32;33 
Superficial infections of the scalp are caused by Trichophyton and Microsporum species. 
Those causing an endotrix infection are frequently seen in Africa. The most important 
causative agents are Trichophyton soudanense, Trichophyton tonsurans, Trichophyton 
violaceum and yaoundei. The species that cause an ectotrix infection are Microsporum 
audouinii, Microsporum canis and gypseum. Microsporum audouinii is frequently seen 
in Africa while canis is seen more often in European countries.34;35
Which species is causing tinea capitis is highly dependent on geography, time and 
social status. During the past 60 years the predominant etiologic agent of tinea capitis 
in the USA has changed from M. audouinii to T.tonsurans most probably due to the 
sensitivity of M. audouinii to griseofulvin treatment and the import of T. tonsurans by 
immigrants. During the late 19th and 20th centuries, M.audouini and M.canis were the 
most frequent etiologic agents in Western and Mediterranean Europe while Trichophyton 
schoenleinii was often seen in Eastern Europe.34;36;37 In Africa the most frequently seen 
agents were Trichophyton soudanense, violaceum and tonsurans and Microsporum 
audouini. These agents are all anthropophilic and are spread rapidly in circumstances of 
overcrowding.18;38-42
The prevalence and characteristics of eczema among schoolchildren  
in Africa
Higher prevalences of eczema are found in developed countries like Northern Europe, 
North America, Japan and Australia compared with African countries. Recent studies 
however show a sharp increase in African countries, especially amongst infants.5;14;21;43-49 
Most of these studies are hospital based and therefore less reliable than community 
based studies. The questionnaire based period-prevalences are higher than the point-
prevalences as measured by physical examination, which can be explained by the 
chronic relapsing character of eczema.50-54
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Chapter 1 provides a short introduction and defines the aims of this study.
Chapter 2 presents prevalence estimates of most skin diseases diagnosed in our studies 
among schoolchildren in three different countries, Gabon, Ghana and Rwanda
Chapter 3 presents the point-prevalence of tinea capitis among schoolchildren in the 
greater Accra region in Ghana including the most important causative fungal species. 
Chapter 4 presents, like the study in Ghana, the point-prevalence of tinea capitis 
among schoolchildren in Gabon and the result of the determination of the fungal 
species and summarizes the results of the most recently published studies on tinea 
capitis in Africa.
Chapter 5 focuses on the point-prevalence and period-prevalence of eczema among 
schoolchildren in the three mentioned countries. The point-prevalence obtained by 
physical examination by one or more dermatologists are compared with the period-
prevalence obtained by questionnaires based on ISAAC (The International Study of 
Asthma and Allergies in Childhood).
Chapter 6 determines allergic characteristics and identifies possible risk factors for 
eczema among schoolchildren in an urbanized area in Ghana.
Chapter 7 presents the prevalence of acne vulgaris among Ghanaian schoolchildren. 
The difference between the prevalence rates among rural and urban schoolchildren is 
presented as well as possible risk factors like a higher body mass index. 
Chapter 8  This chapter is aimed as a practical guide for medical healthcare workers in 
Africa and describes  the etiology, clinical signs and treatment of the most prevalent 
skin diseases among children in Africa and also describes some typical tropical skin 
diseases and some diseases among preschool children. This chapter can be accessed on 
internet via www.africanskindiseases.org.
Chapter 9 summarizes our results and discusses our findings in a broader perspective. 
The findings presented in this thesis are discussed and summarized in the Summary.
the scalp (scaling, hair loss, black dots, pustules and scars), samples were taken for 
analysis and transported at room temperature to the Mycology Laboratory of the 
Department of Dermatology of the Leiden University Medical Centre in Leiden, The 
Netherlands.
3) To study (socio-economic and environmental) risk factors for eczema.
 
A matched case-control study was performed to identify risk factors in childhood 
eczema. Between February and December 2005, 86 schoolchildren with
moderate to severe eczema were selected at the dermatological
outpatient clinics of three hospitals in Accra, Ghana by a dermatologist.
For each included child with eczema, one to three controls were selected from the 
same school and class. All children completed a questionnaire and were skin prick
tested with a panel of allergens. Blood was drawn to determine the total and allergen-
specific IgE. 
4)  To provide information about the point and period-prevalence of eczema in West and 
Central Africa.
Between 2004 and 2007 cross-sectional studies with 4839 schoolchildren
were conducted in Ghana, Gabon and Rwanda. To determine the point-prevalence of 
eczema all children in all four studies were examined by at least one dermatologist or a 
team of dermatologists. In Ghana the period-prevalence was measured by questionnaires 
adapted from the International Study of Asthma and Allergies in Childhood (ISAAC).
5)  To investigate the prevalence and risk factors of inflammatory acne vulgaris in 
schoolchildren in Ghana.
Between between January 2006 and February 2007 a total of 1394 schoolchildren from 
11 urban and rural schools in the Greater Accra Region of Ghana were screened by two 
dermatologists for inflammatory acne vulgaris and other skin diseases. The height and 
weight of the schoolchildren were measured to calculate the Body Mass Index (BMI) as 
a marker of nutritional status and a questionnaire was administered to each child, 
collecting information concerning living conditions. 
Our studies were supported by the local governments and conducted in cooperation 
with larger studies in which atopy and parasitic infections were investigated.
Our study was facilitated by the fact that the primary investigator worked as a 
dermatologist in these countries at the time of the investigations and had easy access 
to local health care facilities.
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Skin diseases, especially skin infections, among schoolchildren in Africa, can be a major 
health problem. The objective of this study was to determine the prevalence of skin 
diseases among children in rural and urban schools in three different African countries 
and to study the influence of the socioeconomic level.  
Methods 
Cross sectional, population based studies were performed in Ghana, Gabon and 
Rwanda.  Point-prevalences of skin diseases were estimated on the basis of physical 
examination by at least one dermatologist. 
Results 
In total, 4839 schoolchildren were seen. The overall prevalence of schoolchildren with 
any skin disease was high; 34.6 % and 42.0 % in two Ghanaian studies, 45.8 % in Gabon 
and 26.7 % in the Rwanda study. From all children with skin diseases, those with skin 
infections formed the largest part with percentages of 14.7 % and 17.6 % in the Ghanaian 
studies, 22.7 % in Rwanda and 27.7 % in Gabon. The highest prevalences were seen for 
tinea capitis and bacterial skin infections especially in the rural areas and schools with 
lower socioeconomic level. 
Conclusions 
The prevalences of skin diseases among African schoolchildren were high with a leading 
role for skin infections like tinea capitis and pyoderma.
Introduction
Several studies from African countries conducted over the past two decades have 
reported high prevalences of skin diseases among schoolchildren.1-5 These skin diseases 
can affect the well-being and health conditions of the children.6;7 To identify possible 
strategies for their prevention there is a great need to determine the burden of skin 
diseases in these communities.1 
The majority of the data on the prevalence of skin diseases in Africa comes from hospital 
or dispensary-based records and does not necessarily represent the real prevalence of 
skin diseases within populations.8 There are only few population-based studies on this 
subject.8-12 The prevalence of one or more skin diseases among schoolchildren in Africa 
ranges between 35% and 80%.5;9;11 The majority of the skin diseases found among 
schoolchildren are dominated by infections such as fungal infections and pyoderma.5;10;13-15 
Elsewhere in the world similar patterns have been observed among schoolchildren in 
poor socioeconomic circumstances.16-19 In industrialized countries, however, several 
hospital and population-based studies among schoolchildren showed much lower 
point-prevalences of fungal and other skin infections while the highest burden of skin 
diseases in these countries was formed by acne vulgaris and atopic dermatitis.20-23  
The objective of this study was to determine the point-prevalences and the current 
spectrum of skin diseases among schoolchildren in rural and urban schools in three 
different African countries and to study the influence of the socioeconomic level (SEL). 
Materials and Methods
Four cross-sectional studies with 4839 schoolchildren were conducted between 2004 
and 2007. Specifically, these were carried out in Ghana (2004 and 2007), Gabon (2005) 
and Rwanda (2007). Details of the studies are presented in Table 1 and examples of 
some skin diseases are shown in Figure 1. 
Ethical approval for the studies in Ghana was granted by the Institutional Review Board 
of the Noguchi Memorial Institute for Medical Research. The ethical approval number 
was CPN015 ⁄ 02-03. The study in Gabon was conducted with approval of the management 
of the Medical Research Unit of the Albert Schweitzer Hospital. In Rwanda the study was 
conducted in cooperation with a prevalence study of vernal keratoconjunctivitis in 
Rwandan schoolchildren and its association with atopy and parasitic infestation. Ethical 
approval was granted by the Rwandan National Ethics Committee.
The difference between skin diseases and skin disorders is not clear in the literature and 
is often subjective since both terms are used independently but are also often used in 
combination.3;9;11;13;19 We defined skin diseases as an impairment of health or a condition 
of abnormal functioning of the skin, with fungal and bacterial skin infections, eczema 
24 25
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and psoriasis as the most important examples. In our study we considered skin disorders 
as skin diseases. Examples of skin disorders are acne vulgaris, benign nevi, freckles, 
hyper pigmentation, etc. Skin conditions were defined as symptoms or characteristics of 
the skin that were not considered as skin diseases or skin disorders. Examples of skin 
conditions are dry skin, keratosis pilaris, etc. All skin diseases found were subdivided into 
the following four categories: 1) skin infections (mycotic, bacterial, viral and parasitic), 
2) inflammatory skin diseases, 3) benign skin tumors and nevi and 4) miscellaneous skin 
diseases. Skin conditions were categorized into a 5th category. The specific skin diseases 
and skin conditions which belong to these five categories are depicted in Table 2. 
The presence of skin diseases and skin conditions was determined in all four studies by 
physical examination of all children by the same dermatologist (AAH) who was assisted 
by APML in both Ghanaian studies and Gabon and also by JNBB in the first Ghanaian 
study. The children were seen during a site-visit at school where the whole skin was 
inspected. The examination took place in a special room where privacy for each 
individual child was guaranteed. The skin findings were notified on a special intake form 
and in case of the presence of a skin disease photographs were taken of which some are 
shown in figure 1. The skin of each child was specifically examined for tinea capitis, 
pyoderma, inflammatory acne vulgaris, and eczema.24-26 The reason to separate skin 
diseases and skin conditions as different entities is the possibility to compare the found 
prevalences of skin diseases with results of other epidemiological studies. In most 
 epidemiological studies skin condition as depicted in category 5 are not evaluated and 
they increase overall prevalence rates. For the diagnosis of tinea capitis we looked for 
scaling on the scalp, hair loss, black dots, pustules and scars. We did not test for minimal 
infection, termed carrier state, i.e. we did not collect samples from all children. We, 
therefore, may have missed some children with asymptomatic dermatophyte scalp 
carriage so that the real prevalence of tinea capitis may even be higher.24;26 Our clinical 
skills to diagnose tinea capitis were validated in the first Ghanaian study and in Gabon 
by direct microscopic examination and culture in the mycology laboratory of the 
department of Dermatology of the Leiden University Medical Centre (Leiden, the 
Netherlands).10;24;26  The agreement between the clinical diagnosis and the results of 
microscopic examination as well as culture was high. In Ghana 31 (79.5%) of the 39 
clinically suspected tinea capitis and in Gabon 74 (70.5%) of the 105 clinically suspected 
tinea capitis could be confirmed by KOH or culture. 24;26 We therefore did not collect 
hairs and skin scrapings in the Ghana 2007 study as well as in the Rwanda study and 
relied on our clinical diagnosis. In the current study, we only present the data of the 
clinical diagnosis of tinea capitis. 
The diagnosis of pyoderma was used to describe any variant of superficial bacterial skin 
infection like impetigo, ecthyma, folliculitis, furuncle or tropical ulcer.5 The Ghana 2004 
study was performed in an area endemic for Buruli ulcer. The diagnosis of Buruli ulcer 
was made on clinical grounds and this disease was not seen in Gabon and Rwanda. 
Figure 1   Examples of children with dermatomycosis (a); tinea capitis (b); impetigo 
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Number of children 463 1394 454 2528
One or more skin diseases (1-4) 160 (34,6) 585 (42.0) 208 (45.8) 675 (26.7)
One or more skin diseases and skin 
conditions total (1-5) 206 (44.5) 642 (46.1) 220 (48.5) 736 (29.1)
1.  One or more skin infections total  68 (14.7) 245 (17.6) 125 (27.7) 575 (22.7)
One or more mycotic infections 
     Tinea capitis
     Tinea other

















One or more bacterial infections 
     Pyoderma
     Leg ulcers     
     Buruli ulcer





















One or more viral infections 
     Verrucae      
     Mollusca contagiosa
     Herpes simplex





















One or more parasitic infections









2.  One or more inflammatory skin 
diseases total
     Acne vulgaris     
     Eczema
     Seborrheic dermatitis
     Prurigo simplex 
     Lichen simplex
     Orthoergic eczema
     Lichen planus
     Psoriasis vulgaris     
     Pityriasis rosea       
     Alopecia areata






























































3.  One or more benign skin tumors 
and nevi total
     Normal nevi
     Sebaceous nevus
     Epidermal nevus
     Café au lait macula
     Depigmented nevus
     Congenital nevus
     Syringomata
     Lipoma
     Granuloma pyogenicum









































 4.  One or more miscellaneous skin 
diseases total
    Traction alopecia
    Miliaria/ heat rash
    Papular urticaria
    Scars
    Keloids
    Ulcers
    Wounds
    Striae
    Albinism
    Orange hair
    Vitiligo
    Hyperpigmentation
    Freckles
    Varix
    Nail problems
    Acanthosis nigricans
    Neurofibromatosis
    Ichthyosis
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The point-prevalences of skin diseases and skin conditions among the schoolchildren 
are presented in Table 2. The prevalences of children with one or more skin diseases 
(category 1-4) were high; 34.6% and 42% in the Ghanaian studies, 45.8% in Gabon and 
26.7%% in the Rwanda study. 
Skin infections formed the largest group of all skin diseases with percentages of 14.7% and 
17.6% in the Ghanaian studies, 27.7% in Gabon and 22.7% in Rwanda which corresponds 
with percentages of 42.5%, 41.9%, 60.1% and 85.2% relative to all skin diseases in the four 
studies respectively. Within the group of skin infections, the highest prevalences were 
seen for tinea capitis (8.4% in the Ghana 2004 study, 8.7% in the Ghana 2007 study, 
20.6% in the Rwanda study and 23.1% in the Gabon study). 
Relatively high prevalences were also found for bacterial skin infections with prevalences 
ranging between 1.3% in the Rwanda study and 6.8% in the Ghana 2007 study. The 
prevalences found for scabies and viral infections like verrucae vulgaris and mollusca 
contagiosa were very low. Buruli ulcer was only found in Ghana.
The point-prevalences of eczema ranged between 0.8% in Rwanda and 4.0% in Gabon 
and have been published before.27 Acne vulgaris showed prevalences of 3.2 % and 4.7% 
in the studies performed in Ghana while these percentages were lower with 1.1% in 
Gabon and 1.3% in Rwanda. The prevalences of other inflammatory skin diseases like 
lichen planus, psoriasis and CDLE were low in our study.20;21;23;29 
Heat rash (miliaria) was most frequently seen in the Ghana 2007 and Gabon studies with 
percentages of 5.2% and 4.2%. With regards to skin conditions (Table 2, category 5) our 
studies showed much higher prevalences of xerosis cutis in Ghana 2004 and Gabon 
compared with Ghana 2007 and Rwanda. 
In other studies skin infections and inflammatory skin diseases are the most prevalent 
and also have the most impact on the children’s health and, therefore, we present these 
categories separately in figure 2 to allow a better comparison with other past and future 
studies. The combined prevalences of infectious and inflammatory skin diseases (category 1 
and 2) were 22% in the Ghana 2004, 26% in the Ghana 2007, 35 % in the Gabon and 27% 
in the Rwanda study. 
The prevalences of the 8 most frequent skin diseases and skin conditions are presented 
separately for the urban and rural schools in Table 3. In all 4 studies the prevalences of 
tinea capitis were higher in the rural schools (Table 3). The same pattern was seen for 
pyoderma with higher prevalences in the rural school with the exception of the Gabon 
study where a higher prevalence of pyoderma was found in the urban school (Table 3). 
Acne vulgaris was more frequently seen in the urban schools (Table 3). Especially in the 
Ghana 2007 study there was an important difference between the urban and rural 
schools (10.1% versus 0.1%) because in this study two urban schools with a higher/
middle SEL were included where acne vulgaris was more prevalent.25 Prurigo simplex 
and xerosis cutis were most frequently seen in the rural areas (Table 3).
Cases of scabies were confirmed by direct microscopic examination with 20% potassium 
hydroxide (KOH) solution. 
The diagnosis of inflammatory acne was defined by the presence of at least six pustules 
or papulopustules on the face.25 The diagnosis of eczema was determined by the clinical 
diagnosis by a dermatologist.27 Very dry skin among the children was diagnosed as 
xerosis cutis, a skin condition characterized by a dull color, rough texture and an elevated 
number of ridges.28
In Ghana, the rural and urban areas were selected according to the guidelines of the 
Ghana Statistical Service. The urban schools were all located in the Accra Metropolitan 
Area while the rural target areas were all settlements some distance from this area with 
low population densities and where the main income generating activities revolved 
around agriculture (fishing or farming). In Rwanda and Gabon the urban schools were 
located in the middle of the capital city or one of the major towns of the country, close 
to main roads while rural schools were situated in villages some distance from the main 
road with lower population densities than the urban areas.
Schools were selected for recruitment based on a broad social economic classification. 
This broad social economic classification reflects the average socioeconomic level (SEL), 
respectively low, middle and high. Schools located in these urban or rural areas were 
randomly selected from the district school lists, using a random digit generator sheet 
and according to probability proportional to size. Urban middle/high SEL schools were 
private fee-paying schools while urban low schools and rural schools were public, 
government-run schools where no school fees were paid. 
Categorical data were analyzed for statistical differences by chi-square test. Point 
prevalences were estimated by calculating the proportions of children with skin diseases 
compared to the total groups of children with 95% confidence intervals. For the 
statistical analyses, we used SPSS for Windows version 17.0 (SPSS Inc, Chicago, IL, USA) 
and software which is freely available on the internet (http://www.dimensionresearch.
com/resources/calculators/conf_prop.html).
Results
The characteristics of the studies and the baseline characteristics of the children in the 
different countries are presented in Table 1 and have been previously published.27 In the 
two Ghanaian studies out of 15 schools screened 8 were rural schools, 4 were urban 
public schools and 3 were schools with middle to high SEL. In Gabon and in Rwanda 
only schools with a low SEL were screened, equally divided between rural and urban. 
Most children were between 4 and 16 years old and boys and girls were equally 
distributed (Table 1). 
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In Table 4 the differences in prevalences of the 8 most frequent skin diseases and skin 
conditions are shown according to the SEL. Because the schools in Gabon and Rwanda 
were all of low SEL, only the Ghana studies are shown. In the schools with a low SEL 
tinea capitis was seen much more frequently (with percentages of 10.8% and 10.3%), 
compared to the prevalences in schools with a middle/high SEL (with prevalences of 
0.9% and 4.9%). Considerable differences were also seen for pyoderma where we saw 
the same pattern; high prevalences of 5.1% and 7.0% in schools with a low SEL and lower 
prevalences of 1.8% and 3.0% in schools with a middle/high SEL. Among schoolchildren 
with a middle/high SEL the prevalences of acne vulgaris and eczema were significantly 
higher comparing the schoolchildren with a low SEL as has been published before.25;27 
Other significant differences were seen for xerosis cutis. Higher prevalence rates were 
found among schoolchildren with a low SEL (19.7% and 4%) compared with school-
children with a middle/high SEL (5.4% and 0.2%). 



























Distribution of skin infections and inammatory skin disease
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difference may be that both Ghanaian studies also included schools with a high or 
middle SEL where the prevalences of tinea capitis were much lower. Additionally, in 
most schoolchildren in Ghana the scalps were shaven, reducing the contagiousness, 
while in Gabon and Rwanda girls wore longer hairstyles. The Ghana Education Service 
requires that boys and girls in basic and secondary public schools cut their hair very 
short. It seems that this rule is actually beneficial.31 However there is also evidence that 
in some cases the use from a common source (e.g. haircutting or barber) and the cutting 
of the hair itself may introduce an infection. In all four studies tinea capitis was more 
prominent in rural areas and in schools with a low SEL, but the differences in Gabon and 
Rwanda were much smaller. This may be explained by the fact that the differences 
between rural and urban areas in Rwanda and Gabon were less pronounced than those 
in Ghana and the fact that only schools with a lower SEL were studied in these countries. 
Tinea capitis is highly contagious especially at family level. A low SEL and consequent 
overcrowding appears to be a major risk factor for tinea capitis.5;9;11;16 Although the 
clinical appearance is variable, late detection and lack of treatment of this disease can 
result in widespread infections and, in rare cases, permanent alopecia.32 Tinea capitis is 
spread worldwide and a major public health concern.33
With prevalences of 4% and 6% in Ghana and 2% and 1% in Gabon and Rwanda, 
pyoderma was the second highest cause of skin infection in our study. The climate in 
Rwanda is much cooler and the humidity lower which can explain the lower prevalence 
of bacterial skin infections in this country compared with Ghana. For the lower 
prevalence of bacterial skin infections in Gabon we do not have a good explanation. 
Other point-prevalence studies among schoolchildren in Ethiopia, Mali and 2 studies in 
Tanzania showed prevalences of pyoderma comparable with our Ghana studies, while 
another study from Kenya showed a higher prevalence of 12.7%.8;10;13;34;35 In the study 
from Kenya the prevalence of bacterial infections was even slightly higher than fungal 
infections.35 
The low prevalence of scabies in our study is remarkable but not exceptional. Prevalence 
rates ranging from 0.7% to 30.4% in other studies document considerable regional 
differences, probably due to differences in socioeconomic situations in the various 
countries.11;34-37 In some studies high prevalences of parasitic infestations like scabies are 
seen.9-11;13;38 Despite thorough inspection of the scalp we didn’t find any case of 
pediculosis capitis. Although this disease is endemic among Caucasian children in 
Europe and Northern America, it was not observed in studies from west Africa, maybe 
due to the different hair type.11;34;39;40 However in studies from east Africa and especially 
Ethiopia prevalences ranging from 3.6 % to 57.1% are mentioned.8;9;41    
The prevalence of mollusca contagiosa was low; most probably because most children 
who were examined were above the age of 8 years (see Table 1). The low prevalence 
rate found for verrucae vulgaris was comparable with most other community based 
studies among schoolchildren in sub Sahara Africa.9;10;13;35 
Discussion
The prevalences of skin diseases among schoolchildren in Ghana, Gabon and Rwanda 
varied between 27% and 46%. Focusing on only skin infections and inflammatory skin 
diseases these prevalences were 22% and 27% in the two Ghanaian studies and 35% in 
Gabon and 27% in Rwanda, respectively. 
Of all skin diseases, skin infections were the most prominent cause which confirms 
earlier studies in African children.5;9-11 Factors such as overcrowding, malnutrition and 
climatic conditions such as heat and humidity can lead to an increase in fungal and 
bacterial infections in tropical and semi-tropical countries.3;4;9;12;30
Tinea capitis was the most prevalent skin infection in all four studies. With a prevalence 
of 9% the Ghana 2007 study matched the prevalence of 8% found in the Ghana 2004 
study.24 The higher prevalence of 21% in the Rwanda study resembled the prevalence of 
26% found in the Gabon study.26 The difference between the prevalences in the Gabon 
and Rwanda study and both Ghanaian studies is remarkable. One of the reasons for this 
Table 4   Differences in prevalences of the most common skin diseases and 



















351 112 967 427
Tinea capitis 38 (10.8) (7.6;14.1)* 1(0.9) (0.9;2.6)* 100  (10.3) (8.4;12.3)* 21 (4.9) (2.9;7.0)*
Pyoderma 18  (5.1) (2.8;7.4) 2 (1.8) (0.7;4.2) 68 (7.0) (5.4;8.6)* 13 (3.0) (1.4;4.7)*
Acne vulgaris 11 (3.1) (1.3;5) 4  (3.6) (0.1;7.0) 19 (2.0) (1.1;2.8)* 47 (11.0) (8.0;14.0)*
Eczema 2 (0.6) (0.2;1.4) 5  (4.5 ) (0.6;8.3) 12 (1.2) (0.5;1.9) 10 (2.3)(0.9;3.8)
Prurigo simplex 9 (2.6) (0.9;4.2) 0 (0.0) 38 (3.9) (2.7;5.2) 14 (3.3) (1.6;5.0)
Papular urticaria 6 (1.7) (0.4;3.1) 4 (3.6) (0.1;7.0) 10 (1.0) (0.4;1.7) 6 (1.4) (0.3;2.5)
Xerosis cutis 69 (19.7) (15.5;23.8)* 6 (5.4) (1.2;9.5)* 39 (4.0) (2.8;5.3)* 1 (0.2) (0.0;0.7)*
Keratosis pilaris 5 (1.4) (0.2;2.7) 2 (1.8) (0.7;4.2) 26 (2.7) (1.7;3.7) 17 (4.0) (2.1;5.8)
*Italic is statistically significant
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their new study, so that more precise prevalence data of the different skin diseases and 
skin conditions could be obtained.
Most skin diseases found in our and other studies from developing countries were not 
life threatening and could easily be treated.8;35;45-47 However, they can potentially harm 
the skin, the health and well-being of children affected.  Skin diseases are often not 
considered of high priority as was concluded in a recent WHO discussion paper.5  The 
occurrence of skin diseases does not only depend on improved treatment schemes 
within the health system but also on improvement of socioeconomic conditions.45;48 In 
addition to the need to improve the quality and availability of skin disease treatment in 
Africa, there is also a great need to determine the burden of skin diseases in communities 
and to identify possible strategies for their prevention.1
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With the exception of the Buruli ulcer in Ghana, like in other studies, the classical tropical 
diseases such as leprosy or filarial lymph edema were not found among schoolchildren 
in this study. The exotic aspect of tropical dermatology seems to be over-emphasized in 
the literature.5;13;34;35
The prevalences of acne vulgaris and eczema were higher in the urban areas and in 
both Ghanaian studies especially in the schools with a middle/high SES, but were still 
lower in comparison with industrialized countries.25;42 With the arrival of urbanization 
and westernization in developing countries, it is believed that the prevalence of acne 
vulgaris and eczema will increase to the level of industrialized countries.
The prevalence of heat rash (miliaria) was higher in the Ghana 2007 and Gabon studies 
which could be explained by differences in temperature and humidity in the different 
countries and in different time periods. The Ghana 2007 study was performed in March 
which is normally the end of the dry season with high temperatures. The Ghana 2004 
study was performed in June which is in the rainy season when the temperatures are 
somewhat lower. Gabon has a typical tropical climate with high temperatures and high 
humidity. However Gabon also has a dry and wet season similar to Ghana. The 
temperature and humidity in the mountainous Rwanda are much lower. 
In the four studies xerosis cutis was seen most frequently in the rural areas with the 
highest prevalences in the Ghana 2004 and the Gabon study. The etiology of xerosis 
cutis is multifactorial. The role of the barrier function of the stratum corneum is 
important. When the barrier is impaired the skin will be dry because of trans-epidermal 
water loss and will be more vulnerable for both infectious and inflammatory skin 
diseases.43;44  Frequent washing with soap is considered to be a healthy exercise in 
Ghana and can damage the barrier function of the skin. Despite the advice to use less 
soap, children often continue their habits, also due to the hot, humid climate and the 
subsequent sweating which may lead to dry skin.42 Differences between temperature 
and humidity could partly explain the different prevalences of xerosis cutis in the four 
studies. Prurigo simplex, like xerosis cutis, had the highest prevalences in the rural areas 
suggesting a relationship between these two conditions. It is plausible that xerosis cutis 
could lead to prurigo simplex. 
The strength of our study is that we studied large numbers of schoolchildren in three 
different countries and that all children were seen by a dermatologist or a team of 
dermatologists. A limitation of our study is that when one measures a point-prevalence 
there is always a chance of underestimation especially in diseases with a chronic 
relapsing course.
While there are certainly some advantages by differentiating skin diseases from skin 
conditions, this may also lead to some difficulties and limitations. The main problem is 
that most investigators in the past did not make this difference so that their data cannot 
be directly compared with the data of the current study. On the other hand, future 
investigators could use the definitions used in the current study as a guidance to design 
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Infections with tinea capitis are endemic among school children in Africa. The objectives 
of this study were to determine the prevalence and causative species of tinea capitis 
among school children in different rural and urban schools in Ghana.
Methods 
A cross-sectional study was performed from may 31st to June 6th 2004 with 475 children 
aged between 5-17 years, and residing in two rural and two urban schools in the Greater 
Accra Region (Ghana). All children were clinically examined for tinea capitis. Symptomatic 
children were tested by microscopic examination using 20% potassium hydroxide solution 
(KOH) and cultivation on Sabouraud’s dextrose agar with chloramphenicol.
Results 
Based on clinical examination, 39 (8,4%) out of 463 children had tinea capitis. A total of 
31 (6.7%) children were positive by direct examination (KOH) and/or fungal culture. The 
prevalence of tinea capitis largely depended on the school studied, ranging from 0.9% 
in an urban school with a high socioeconomic status to more than 10% in the two rural 
schools with low socioeconomic status. Similarly, the spectrum of causative species varied 
importantly between the different schools. Taken all schools together, T. violaceum 
(25.9%) was the most prominent species, followed by T. tonsurans (22.2%) and M. 
audouinii (14.9%).
Conclusions 
Tinea capitis is endemic among school children in the Greater Accra Region (Ghana). 
The prevalence of tinea capitis and the causative species largely depended on the type 
of school that was investigated.
Introduction
Tinea capitis is a common infection among school children throughout the world.1 It is 
a superficial fungal infection of the scalp, which may be caused by Trichophyton and 
Microsporum species. The most important causative agents are species which are 
causing an endothrix infection, such as T. gourvilli, T. soudanense, T. tonsurans, T. violaceum 
and T. yaoundei and species that cause an ectothrix infection such as M. audouinii, 
M. canis and M. gypseum.2 The causative agent of tinea capitis varies with geography, 
socioeconomic status and time.3
Though the clinical appearance is variable, late detection and lack of treatment of this 
disease can result in widespread infections and, in rare cases, permanent alopecia.4 
More knowledge about the prevalence and causative agents of tinea capitis is necessary 
to improve control and therapeutic measures. Several investigations about this public 
health problem have been published but to our knowledge no research has been 
carried out in Ghana, recently.
In order to provide information about this disease in the country, a cross-sectional study 
was conducted in the Greater Accra Region, comparing two rural schools with two 
urban schools. One urban school had a high, the three others schools a low socioeco-
nomic status. The study was designed a) to access the prevalence of tinea capitis in the 
different schools, and b) to identify the causative agents. 
Patients and Methods
Study site
Accra is the capital city of Ghana, situated about 25 kilometres west of the Greenwich 
Meridian. Ghana lies almost in the middle of West Africa and has a typical tropical 
climate, with average temperatures between 25.5°C and 27°C. The humidity is constant-
ly high, at about 80%. 
Study population and collection of material
From May 31st to June 6th 2004, 463 school children from two public rural schools, one 
public urban school and one private urban school in the Greater Accra Region were 
fully clinically examined for skin diseases by a team of three dermatologists (Figure 1). 
Socioeconomic status was determined by questionnaires on parameters such as  occupation 
of both parents and the educational background of the responding parent. By this 
method, the urban private school (University Primary) had been identified as a school 
with high socioeconomic status and the public urban school (James Town) and two 
rural schools (Mayera and Ayikai Doblo) had been classified as schools with low socio-
economic status. 
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Statistical analysis
Chi-square analyses were used to analyze the different distribution of tinea capitis 
among boys and girls, different age groups and the different schools.
Results
Figure 2 shows examples of clinical fungal infection on the scalp in the study popula-
tion. Of the 463 children examined during the survey, a total of 39 (8.4%) had clinical 
Specific attention was focused on clinical signs of fungal infection on the scalp (scaling, 
hair loss, black dots, pustules and scars). Scalp samples were taken by gentle brushing 
with glass slides and tweezers, and transported at room temperature to the Mycology 
Laboratory of the Department of Dermatology of the Leiden University Medical Centre 
in Leiden, The Netherlands.
Laboratory methods 
The specimens were examined by direct microscopic examination using 20% potassium 
hydroxide solution (KOH). For the cultures modified Sabouraud’s dextrose agar with 
chloramphenicol was used and the specimens were incubated for 28 days at a 
 temperature of 28º degrees Celsius. Species identification was based on growth rate, 
macroscopic aspect and microscopic examination. Four samples that could not be 
identified were sent to the National Institute of Public Health and the Environment 
(RIVM), Bilthoven, the Netherlands for characterisation. 
Figure 1   Photographs of the four participating schools. Clockwise starting in the 
upper left corner: James Town (JT), University Primary (UP), Aykai Doblo 
(AD) and Mayera (MA).
Figure 2   Tinea Capitis caused by T. Violaceum in a 12-year old boy (a) and a 6-year 
old girl (b). Gray patches caused by M. Audouinii in a 5-year old girl (c) and 
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not statistically significant (Table 1). Tinea capitis was, however, significantly more 
prevalent in the rural schools (more than 10%) compared to the urban school with a 
high socioeconomic status (University Primary) (p < 0.001) (Table 1). The urban school 
with a low socioeconomic status (James Town) occupied an intermediate position 
(about 6%) regarding the prevalence of tinea capitis (Table 1).
The frequency distribution of the different species among the different schools is 
depicted in Table 1. Combining the data of the schools together, the most frequently 
detected species were T. violaceum (25.9%), T. tonsurans (22.2%) and M. audouinii 
(14.9%). The frequency distribution of the different species was quite different between 
the different schools. Infection with T. tonsurans accounted for half of the patients in 
the Mayera school and for the single case in the University Primary school, whereas 
 infections with T. rubrum and T. concentricum were only present in James Town, and 
with T. ferrugineum only in the Ayikai Doblo school (Table 2). Infections with T. violaceum, 
M. audouinii, and F. solani were found in different schools.
signs of tinea capitis (Table 1). In 4 out of the 39 clinically suspected cases no sufficient 
material could be collected for microscopic examination and culture. Of the remaining 
35 patients, hair stumps and scales were collected and 27 were positive during micro-
scopic examination and 27 cases were identified by culture (Table 1). 
Figure 3 shows representative cultures of different species from the study group. Of the 
35 samples, a total of 23 samples were positive for both microscopic examination and 
culture, 4 were positive for microscopic examination and negative for culture, 4 were 
negative for microscopic examination and positive for culture and 4 were negative for 
microscopic examination and culture. 
Tinea capitis was slightly more prevalent among boys compared to girls and in the age 
group of 5 to 11 years compared to the 12 to 17 year age group but these variations were 
Table 1   Demographic data for tinea capitis among school children in Greater Accra 
Region, Ghana.
















463 39 (8.4) 27 (5.8) 27 (5.8) 31 (6.7)
Gender
Male 262 26 (9.9) 17 (6.5) 16 (6.1) 20 (7.6)
Female 201 13 (6.5) 10 (5.0) 11 (5.5) 11 (5.5)
Age (years)
5-8 130 10 (7.7) 7 (5.4) 7 (5.4) 8 (6.2)
9-11 196 17 (8.7) 11 (5.6) 13 (6.6) 13 (6.6)
12-17 104 6 (5.8) 5 (4.8) 5 (4.8) 6 (5.8)
Age not known 33
Schools*
Mayera (rural, low SES) 123 15 (12.2) 9 (7.3) 11 (8.9) 12 (9.8)
Ayikai Doblo (rural, low SES) 103 15 (14.6) 10 (9.7) 8 (7.8) 11 (10.7)
James Town (urban, low SES) 125 8 (6.4) 7 (5.6) 7 (5.6) 7 (5.6)
Univ. Prim. (urban, high SES) 111 1 (0.9) 1 (0.9) 1 (0.9) 1 (0.9)
*SES = socioeconomic status; Univ. Prim. = University Primary
Figure 3   Colonies of T. violaceum, T. tonsurans, T. rubrum, T. ferrugineum and T. 
concentricum (from left to right). 
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disease. We, therefore, may have missed some children with sub-clinical infection so 
that the real prevalence of tinea capitis may even be higher.
Taken all schools together, T. violaceum (25.9%) was the most prominent species in our 
study followed by T. tonsurans (22.2%). The percentage of T. violaceum was lower than 
recent figures found in South Africa (90%),8 and Rwanda (42%).9 The percentage of M. 
audouinii (14.8%) was relatively low in comparison to other studies performed in 
Africa.5;9-11 We found T. rubrum, the most common dermatophyte worldwide but not a 
frequently reported cause for tinea capitis, in a percentage of 11.1%. No T. soudanense 
was found, while in other studies performed in the region this species showed to be 
one of the most frequent causative agents.5;7;12
The prevalence of tinea capitis as well as the spectrum of fungal species varied consid-
erably between the schools. Thus it should be noted that prevalence data of studies 
performed in one area of the country cannot be generalized as epidemiological data for 
the entire country.
We did not find any child with extensive disabling scarring tinea capitis. A considerable 
number of children, however, showed some minor scars on the scalp without evidence 
of active infection. Apparently, most children with tinea capitis underwent spontaneous 
recovery without any treatment resulting in no or only minor scarring. 
In summary, our study showed that tinea capitis is endemic among school children in 
the Greater Accra Region in Ghana and that the prevalence largely depended on the 
location and the socio-economic status of the school that was investigated. Addition-
ally, there were important varieties in the causative species described between the 
different schools in our study group and the causative species were also different 
compared to studies conducted in other African countries. 13;14 15
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Our survey showed that tinea capitis is endemic among school children in the Greater 
Accra Region, Ghana. The overall prevalence of tinea capitis was 8.4% and varied from 
1% in the urban school with a high socioeconomic status to more than 10% in the rural 
schools with low socioeconomic status. The higher prevalence of tinea capitis in the 
rural schools with a low socioeconomic status might be explained by a lower availabil-
ity of antifungal treatments, poor hygienic conditions, school and household over-
crowding. The prevalence of tinea capitis was highest among boys in the younger age 
group (5-11 years) as reported in earlier studies,5-7 although in our study statistical sig-
nificance was not reached. A possible shortcoming of the study is that we did not test 
for sub-clinical infection, i.e. we did not collect hairs from children without active 
Table 2   Results of the 35 cultures according to the different schools.
Schools** Distribution 
Isolated species* MA AD JT UP Total (%)***
Total number of cultures
13 12 9 1 35
- Isolation of fungal species 10 8 7 1 27
T. violaceum 3 3 1 0 7 25.9
T. tonsurans 5 0 0 1 6 22.2
M. audouinii 2 2 0 0 4 14.9
T. rubrum 0 0 3 0 3 11.1
T. concentricum 0 0 2 0 2 7.4
T. ferrugineum 0 2 0 0 2 7.4
F. solani 0 1 1 0 2 7.4
M. gypseum 1 0 0 0 1 3.7
- Results of other cultures
Saprophyte 1 2 0 0 3
Bacteria 1 0 0 0 1
Sterile 0 2 2 0 4
*T = Trichophyton; M = Microsporum; F = Fusarium.
**MA = Mayera; AD = Ayikai Doblo; JT = James Town; UP = University Primary school
***Frequency distribution among the 27 cultures with isolation of fungal species.
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Summary
Tinea capitis is endemic among schoolchildren in tropical Africa. The objective was to 
determine the prevalence of symptomatic tinea capitis in schoolchildren in Gabon. 
A cross-sectional study was conducted with 454 children aged 4 to 17 years, and attending 
a rural and an urban school. The diagnosis of tinea capitis was based on clinically 
manifest infection, direct microscopic examination using 20% potassium hydroxide 
(KOH) solution and fungal culture. Based on clinical examination, 105 (23.1%) out of 454 
children had tinea capitis. Seventy-four (16.3%) children were positive by direct 
examination (KOH) and/or fungal culture. The prevalence of tinea capitis depended on 
the school studied and ranged from 20.4 % in the urban school with a higher 
socioeconomic status to 26.3 % in the rural school with lower socioeconomic status. 
Similarly, the spectrum of causative species varied between the different schools. Taken 
the schools together, T. soudanense (29.4%) was the most prominent species, followed 
by T. tonsurans (27.9%) and M. audouinii (25.0%). Clinically manifest tinea capitis is 
endemic among schoolchildren in the Lambaréné region in Gabon. The prevalence of 
tinea capitis and the causative species depended on the type of school that was 
investigated.
Introduction
Superficial fungal infections of the scalp (tinea capitis) are endemic among schoolchildren 
especially in tropical Africa and they can cause significant public health problems.1 
Tinea capitis is caused by Trichophyton and Microsporum species.2 The most important 
causative agents are species which are causing an endothrix infection, such as T. gourvilli, 
T. soudanense, T. tonsurans, T. violaceum and T. yaoundei and species that cause an 
ectothrix infection such as M. audouinii, M. canis and M. gypseum.3 The causative agent 
of tinea capitis varies with geography, socioeconomic status and time.4
Although the clinical appearance is variable, late detection and lack of treatment of this 
disease can result in widespread infections and, in rare cases, permanent alopecia.5 
More knowledge about the prevalence and causative agents of tinea capitis is necessary 
to improve control and therapeutic measures. 
The objectives of this study were to summarize previous prevalence studies in sub-Saharan 
African countries and to determine the prevalence of tinea capitis and identify the 
causative species among schoolchildren in a rural and urban school in Gabon. 
Materials and Methods
To collect information about tinea capitis in Gabon, a cross-sectional study was 
conducted in the Lambaréné Region, comparing a rural school with an urban school 
(Figure1). The rural school (Zile school) had a low and the urban school (Lalala school) 
had a higher socioeconomic status. 
The study was carried out from the Albert Schweitzer Hospital which is located about 6 
km from the city centre of Lambaréné, Gabon. This city is situated at the riverside of the 
Ogooué River – one of the largest rivers in Central Africa. Gabon is sparsely popu lated 
with an estimated total population of around 1.3 mil lion people in a country of 267.667 
km
2
. Most of the territory is covered by dense tropical rainforest. The country has a 
typical tropical climate with two rainy and two dry seasons and average temperatures 
between 25.5°C and 27°C. The humidity is constantly high, at about 80%. 
In January 2005, 454 schoolchildren from the two schools were fully clinically examined 
for skin diseases by two dermatologists (A.A.H., A.P.M.L.). Specific attention was focused 
on clinical signs of fungal infection on the scalp (scaling, hair loss, black dots, chicken 
skin effect, pustules and scarring alopecia). Samples from scales and hairs were taken by 
gentle brushing with glass slides and tweezers (Figure 1), and transported at room 
temperature to the Mycology Laboratory of the Department of Dermatology of the 
Leiden University Medical Centre in Leiden, the Netherlands. The samples can be kept 
at room temperature for several months (and probably longer), without affecting the 
viability of the fungi.6
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The specimens were examined by direct microscopic examination using 20% potassium 
hydroxide solution (KOH). For the cultures modified Sabouraud’s dextrose agar with 
chloramphenicol was used and the specimens were incubated for 28 days at a 
temperature of 28º degrees Celsius. Species identification was based on growth rate, 
macroscopic aspect and microscopic examination. 
Chi-square analyses were used to analyze the different distribution of tinea capitis among 
boys and girls, different age groups and the different schools.
Results
The figure shows examples of clinical fungal infection on the scalp in the study 
population. Table 1 provides the baseline characteristics of the 454 schoolchildren who 
participated in the study. Of the 454 children examined during the survey, a total of 105 
(23.1 %) had clinical signs of tinea capitis (Table 1). Direct examination (KOH) was 
performed in 97 of these 105 children and 1 time in a child without clinical suspicion of 
Figure 1   Panel (a) shows schoolchildren in the urban school (Lalala) and panel  
(b) in the rural school (Zile). Panel (c) shows gentle brushing with glass 
slides and panel (d) collection of scales with tweezers. Panel (e) shows a 
non-inflammatory type of tinea capitis with ‘gray-patch’ scaling caused by 
M. audouinii in a 6-year old boy and panel (f) shows tinea capitis caused  
by T. soudanense in a 4-year old boy.
Table 1   Demographic data for tinea capitis among schoolchildren in Gabon.











by KOH  
and/or culture
N (%)
All children together 454 105 (23.1) 60 (13.2)* 69 (15.2)** 74 (16.3)
Gender
Male 227 58 (25.6) 35 (15.4) 38 (16.7) 41 (18.1)
Female 227 47 (20.7) 25 (11.0) 31 (13.7) 33 (14.5)
Age (years)
4-9 262 71 (27.1)#1 43 (16.4)#2 48 (18.3)#3 51 (19.5)#4
10-12 123 24 (19.5) 11 (8.9) 14 (11.4) 15 (12.2)
13-17 69 10 (14.5) 6 (8.7) 7 (10.1) 8 (11.6)
Schools
Lalala (urban, higher SES***) 245 50 (20.4) 29 (11.8) 30 (12.2) 33 (13.5)
Zile (rural, low SES***) 209 55 (26.3) 31 (14.8) 39 (18.7) 41 (16.9)
SES,socio-economic status.
*There was a clinical suspicion of tinea capitis eight times, but KOH was not performed.
**There was a clinical suspicion of tinea capitis three times, but culture was not performed.
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Table 3 summarizes the previous prevalence studies on fungal cultures in schoolchildren 
carried out in different sub-Saharan African countries and compares those with the 
present study.1,7-15
Discussion
Our study showed that clinically manifest tinea capitis is endemic among schoolchildren 
in the Lambaréné region, Gabon. The overall prevalence of clinically manifest tinea 
capitis was 23% and varied from 20% in the urban school with a high socioeconomic 
status to 26% in the rural school with lower socioeconomic status. The slightly higher 
prevalence of tinea capitis in the rural school might be explained by a lower availability 
of antifungal treatments, poor hygienic conditions, or school and household over- 
crowding. A same pattern was observed in our study in the Greater Accra region in 
Ghana.10 
In our studies we did not test for minimal infection, termed carrier state, i.e. we did not 
collect samples from all children. We, therefore, may have missed some children with 
asymptomatic dermatophyte scalp carriage so that the real prevalence of tinea capitis 
may even be higher. Anthropophilic dermatophytes (i.e. T. tonsurans and T. violaceum) 
have been generally associated with high rates of asymptomatic carriage.16
Like in other studies performed in the region T. soudanense appeared to be one of the 
most frequent causative agents.2,11,17-19 The  percentage of T. violaceum (8.8%) was much 
lower than recent figures found in South Africa (90%),20 Ghana (26%),10 Ethiopia and 
Rwanda (42%),21,22  although in a study in Mozambique also very few cases of T. violaceum 
were found.15 These prevalences are different compared to those provided in an 
excellent review dating from 1974, in which T. violaceum was more prevalent in Northern 
and Eastern Africa (25% or more frequent).19 Changes in geographical distribution over 
time may be related to increasing mobility of the population. The percentage of M. 
audouinii (25%) was comparable to other studies performed in Africa.1,9,11,13,15,22 In other 
studies from Nigeria and Ghana M. ferrugineum was present in a high percentage 
(between 7.7-17.3%),1,7,10 while in the present study this species was not found. The 
percentages of infections with both T. tonsurans and M. audouinii were high (27.9% and 
25.0%). There does not appear to be a replacement of M. audouinii by T. tonsurans as has 
been seen in the past half century in the United States which might have been caused 
by the success of griseofulvin treatment on the US mainland.20
The prevalence of tinea capitis was highest among boys in the younger age group (4-9 
years) as reported in earlier studies,1,2,11,17 although in our study statistical significance 
was not reached. The spectrum of fungal species varied considerably between the 
schools. In the rural school with a lower socioeconomic status the percentage of M. 
audouinii was higher and the percentage of T. soudanense lower than the urban school 
tinea capitis. Culture was performed in 102 children. In total 74 (16.3%) patients were 
positive for both KOH and / or culture, 60 (13.2%) were positive by KOH and 69 (15.2%) 
by culture (Table 1).
Tinea capitis was slightly, but statistically non significant, more prevalent among boys 
compared to girls and in the age group of 4 to 9 years compared to the 13 to 17 years 
age group (Table 1). The prevalence of tinea capitis did not differ much in the rural 
school compared to the urban school with a higher socioeconomic status.
The frequency distribution of the different species among the different schools is 
depicted in Table 2. Combining the data of both schools, the most frequently detected 
species were T. soudanense, T. tonsurans and M. audouinii. The frequency distribution of 
the different species was different between the two schools (Table 2). Infections with T. 
tonsurans and M. audouinii were more prominent in the rural school while T. soudanense 
was more frequently seen in the urban school.
Table 2   Results of the 102 cultures according to the different schools.
Schools Distribution 
Isolated species* Urban (Lalala) Rural (Zile) Total (%)**
Total number of cultures 50 52 102
Isolation of fungal species 30 38 68 100.0
 T. soudanense 14 6 20 29.4
 T. tonsurans 6 13 19 27.9
 M. audouinii 4 13 17 25.0
 T. violaceum 2 4 6 8.8
 T. not determined 1 1 2 2.9
 T. rubrum 1 0 1 1.5
 M. canis 0 1 1 1.5
 T. equinum 1 0 1 1.5
 T. mentagrophytes 1 0 1 1.5
Results of other cultures
 Saprophyte 2 2 4
 Bacteria 0 0 0
 Sterile 18 11 29
*T = Trichophyton; M = Microsporum.
**Frequency distribution among the 68 cultures with isolation of fungal species.
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with a higher socioeconomic status, a pattern seen before in Ghana and Nigeria.7,10 It 
should be noted, however, that prevalence data of studies performed in one area of the 
country cannot be generalized to the entire country.2,7
Different clinical presentations of tinea capitis were sparse, most children presented 
with a non-inflammatory type of tinea capitis especially ‘gray-patch’ scaling alopecia, 
seborrheic-dermatitis like scales and patches of ‘black dot’ and ‘chicken skin’ alopecia. 
We only saw one child with a kerion, an inflammatory form of tinea capitis, which can 
result in alopecia with scarring.
In Conclusion, our study showed that tinea capitis is endemic among schoolchildren in 
the Lambaréné region in Gabon and that the prevalence to a certain extent depended 
on the location and the socio-economic status of the school that was investigated. In 
addition, there were important varieties in the causative species described between the 
different schools in our study group and the causative species were different compared 
to studies conducted in other African countries.
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Eczema is a growing problem in Africa, particularly amongst children.
Objective 
To investigate the point-prevalences of eczema by physical examination in school-
children living in rural and urban areas and with different socioeconomic backgrounds 
in Ghana, Gabon and Rwanda. In Ghana period-prevalences were also astimated by 
questionnaire and compared with the point-prevalences.
Methods  
In total, 4839 schoolchildren in Ghana, Gabon and Rwanda were seen by at least one 
dermatologist. The point-prevalences of eczema were estimated on the basis of physical 
examination.  Period-prevalences were measured in Ghana with questionnaire based- 
interviews adapted from the International Study of Asthma and Allergies in Childhood 
(ISAAC). 
Results 
The point-prevalences were 1.5% and 1.6% in the two Ghanaian studies; 4% in Gabon 
and 0.8% in Rwanda. The period-prevalences were 2.6% and 4.4% in the two Ghanaian 
studies. The prevalences of eczema were not significantly different when comparing 
the urban and rural groups as well as the different socio economic levels. The sensitivity 
and positive predictive value to identify eczema cases based on the questionnaires 
compared to the diagnoses by physical examination were only 33% and 22% in the first 
Ghanaian study and 10% and 4% in the second Ghanaian study, respectively.
Conclusions  
The point-prevalences of eczema in the three African countries studied were low 
compared with industrialized countries. Physical examination by a dermatologist still is 
the gold standard to identify eczema cases because the sensitivity and the positive 
predictive value to identify eczema cases with questionnaires were low in the two 
Ghanaian studies.
Conflict of interest 
The authors state no conflict of interest.
Introduction
Eczema, also called atopic eczema, flexural eczema, atopic dermatitis, neurodermitis or 
atopiform dermatitis, is a chronic relapsing inflammatory skin disorder which is becoming 
increasingly common worldwide.1-3 Because nearly 60 percent of patients do have 
clinical features without IgE-mediated sensitivity to allergens the term eczema instead 
of atopic eczema is preferred.4-7
Physical examination by a dermatologist or a team of dermatologists is still the gold 
standard to diagnose eczema.4;5 The diagnosis of eczema is based on a constellation of 
clinical findings. The most frequently used clinical criteria for the diagnosis of eczema 
are those of Hanifin and Rajka.8 These criteria are based on clinical experience and were 
published in 1980 after a consensus conference. They have since then been widely used 
in genetic, biological, immunological and epidemiological studies. The U.K. Working 
Party has tried to refine the criteria of Hanifin and Rajka by developing a minimal set of 
five diagnostic criteria especially suitable for epidemiological purposes.9 In addition the 
Millennium Criteria were developed in which the presence of allergen-specific IgE in a 
patient is required for making the diagnosis of atopic eczema. In the Millennium Criteria 
the term atopiform dermatitis is reserved for the patients with the clinical phenotype 
but without detectable allergen-specific IgE.2;7;9 
Questionnaires are often used in epidemiological studies to identify persons with 
eczema. The main advantages of questionnaire-based prevalence studies are that 
questionnaires are relatively cheap to distribute and administer to children and their 
parents and / or caretakers. In addition, questionnaires can be used to measure disease 
prevalences in large populations. A major shortcoming of questionnaires however, is 
the fact that eczema is difficult to define because of its variable morphology, distribution 
and its intermittent nature.2;3;10;11 Many itchy, scaly and erythematous skin diseases are 
judged by non dermatologists as being eczema which may lead to an overestimation of 
eczema. 
Physical examination measures a point-prevalence while a questionnaire can also 
measure a period-prevalence. Because eczema is a chronic relapsing disorder a period-
prevalence may be the best method to determine its frequency. When one measures a 
point-prevalence there is always a chance of underestimation.5-7;12
The main purpose of our study was to estimate the point -prevalences of eczema as 
diagnosed by a dermatologist in schoolchildren living in rural and urban areas and with 
different socioeconomic backgrounds in Ghana, Gabon and Rwanda. In Ghana we also 
estimated the period prevalences by questionnaire and compared these with the point 
prevalences by physical examination. A selection of articles reporting prevalence data 
amongst sub-Saharan African schoolchildren is supplied to provide a framework for the 
prevalence data of our study.
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Materials and Methods
To provide information about the prevalence of eczema in West and Central Africa, 
cross sectional studies with 4839 schoolchildren were conducted between 2004 and 
2007 in Ghana (2 studies), Gabon and Rwanda. Details of the studies are presented in 
Table 1. 
Point-prevalences of eczema were determined in all four studies by physical examination 
of all children by at least one dermatologist or a team of dermatologists (Table 1). 
 Period-prevalences were measured by questionnaires adapted from the International 
Study of Asthma and Allergies in Childhood (ISAAC) in Ghana by trained staff with one 
of the caretakers of each child. The three most important questions are detailed in 
Figure 1. Figures 2-4 show clinical pictures of the children with eczema.
Independent persons with advanced levels of English language and mother tongue of 
Twi, Dangme, Ga or Ewe translated the questionnaire into these languages. In Ghana the 
rural and urban areas were selected according to the guidelines of the Ghana Statistical
Service. This service defines an urban area as a settlement with a population greater 
than 5000 individuals. Our target urban area was the Accra Metropolitan Area with an 
estimated population of 1 801 606 in 2002. Our rural target areas were all settlements
some distance from the Accra Metropolitan Area with low population densities. Other 
defining criteria for our rural areas included; settlements where the main income 
generating activities revolved around agriculture (fishing or farming), areas with limited 
access to amenities such as water, electricity, health, education, transportation and 
communication.
In Rwanda and Gabon rural schools were situated in villages, remote from the main road 
with lower population density than the urban areas. The urban schools were located in 
the middle of the capital city or one of the major towns of the country, close to the main 
roads.
Schools were selected for recruitment based on a broad social economic classification. 
This broad social economic classification reflects the average socioeconomic level (SEL), 
respectively low, middle and high. Urban high SEL schools were private fee-paying
schools while urban low schools were public, government-run schools where no school 
fees were paid.
Categorical data were analyzed for statistical differences by chi-square test. Point 
prevalences and period prevalences were estimated by calculating the proportions of 
children with eczema compared to the total groups of children with 95% confidence 
intervals. Sensitivity, specificity and predictive values were calculated according to 
standard methods. For the statistical analyses, we used SPSS for Windows version 16.0 
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An overview of the recent literature is 
provided after searching Pubmed for 
the words ‘atopic dermatitis’ and ‘Africa’. 
The relevant articles were selected and 
the references in these articles were 
checked for additional studies. The 
prevalence data for school children were 
extracted and summarized. Non-English 
articles and hospital-based prevalence 
data were excluded. The aim of this 
literature search was not to perform a 
systematic review of the prevalence of 
eczema in sub-Saharan Africa but to 
provide a framework of other recent 
studies in which we could place and 
compare the prevalence data of our 
own study.
Figure 1 
Three most important questions for a history of symptoms of eczema  
(period-prevalence) translated from English in Twi, Dangme, Ga, and  
Ewe (Ghana).
(Q1)   Has your child ever had an itchy rash which was coming and going for at  
least six months?
If Q1 was answered with yes:
(Q2)   Has your child had this itchy rash at any time in the past 12 months?
(Q3)   Has this itchy rash at any time affected any of the following places:  
the folds of the elbows, behind the knees, in front of the ankles, under  
the buttocks, or around the neck, ears or eyes?
The child was considered to have a history of symptoms of eczema if  
the last two questions were answered confirmative (12).
Figure 2   Danny Morgan folds, hyper - 
 pigmentation in the face and 
anterior neck folds. 
Figure 3   Knee folds with typical  localization of 
hyper pigmentation and lichenification. 
Figure 4   Prurigo and scratch marks with dry skin 
and hyperpigmentation. 
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relation to the diagnoses based on physical examination are presented in Table 4. Table 5 
shows examples of population-based point- and period-prevalences in sub-Saharan 
Africa of recent studies in comparison with the current study.  
Results
The baseline characteristics of the children are presented in Table 2. Most children were 
between 4 and 16 years old and boys and girls were equally distributed (Table 2). 
The point-prevalences of eczema based on physical examination by a dermatologist are 
presented in Table 3 and range between 0.8% in Rwanda to 4.0% in Gabon. The point-
prevalences were slightly higher in the urban schools compared to the rural schools 
with a prevalence reaching 4.5% in the urban private school with high socioeconomic 
level in the first Ghanaian study (5 out of 7 children with eczema were found in the 
urban private rich school), but statistical significance was not reached (Table 3). In 
contrast, in Gabon the point-prevalence of eczema was higher in the rural school (5.7 %) 
compared to the urban school (2.5 %) (Table3).
Questionnaires were available from 345 (74.9%) children of the first Ghanaian study and 
1245 (89.3%) of the second Ghanaian study. The period-prevalences based on these 
questionnaires are also presented in Table 3. The sensitivity, specificity and the positive 
and negative predictive values of the diagnoses of eczema based on questionnaires in 




















































Characteristics of the schools
Rural public (low SEL**)
Urban public (low SEL)
Urban private (middle SEL)

















*In Rwanda the youngest child was 8 years old. 
** SEL: socioeconomic level.
Table 3   Point-prevalence of atopic dermatitis based on physical examination by a 
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4.4 (3.3;5.6) Not measured Not measured
*SEL: socioeconomic level; CI: confidence interval.
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Discussion 
The prevalence of eczema in the industrialized world has increased rapidly in the last 
few decades. 2,13-15 Surveys conducted worldwide revealed period-prevalences between 
15% and 30% in different age groups of children. Most of these data were obtained by
questionnaire.2,13 Generally, high prevalences were found in the developed countries 
such as Northern Europe, North America, Japan and Australasia and low prevalences in 
countries such as China, Iran and Ethiopia.2,6,11,13,16,17 Although the prevalence rates of 
eczema in the developing world are much lower, recent studies show a sharp increase 
due to rapid urbanization, changes in lifestyle and socioeconomic status as well as 
frequent washing.2,13,18–20 In West Africa, the prevalence of eczema has been considered 
Table 4   Sensitivity and specificity of the diagnoses of eczema based on 
questionnaires in relation to the diagnoses based on physical examination 
(reference standard).
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Negative predictive value 332/336
99 (97.7 ; 100)
1172/1190
98 (97.8 ; 99.2)






Country Year References n/N % (95% CI) n/N % (95% CI)
Cameroon 2007 ISAAC16 15/215 7.2% (3.7;10.7)
Congo 2007 ISAAC16 26/164 16.2% (10.421.6)
2007 ISAAC16 35/320 10.9% (7.6;14.4)
Guinea 2007 ISAAC16 112/587 18.8% (15.8;22.2)
Ivory Coast 2007 ISAAC16 109/607 18.2% (14.9;21.1)
Ethiopia 2005 Haileamlak11 79/7915 1.8% (1.5;2.1) 348/7915 4.4% (4.0;4.9)
2007 ISAAC16 115/606 19.0% (15.9;22.1)
Ghana 2009 ISAAC12 5/1325 0.4% (0;0.7) 40/1325 3.5% (2.1;3.9)





Country Year References n/N % (95% CI) n/N % (95% CI)
Ghana 2004 This study 7/463 1.5% (0.4;2.6) 9/345 2.6% (0.9;4.3)
2007 This study 22/1394 1.6% (0.9;2.2) 55/1245 4.4% (3.3;5.6)
Gabon 2007 ISAAC16 65/454 14.4% (11.1;17.5)
2005 This study 18/454 4.0% (2.2;5.8)
Kenya 2007 ISAAC16 81/509 15.5% (12.8;19.2)
2007 ISAAC16 66/449 14.9% (11.4;18.0)
Mozambique 2007 Mavale-Manuel22 466/5013 9.3% (8.5;10.1)
Nigeria 2005 Ogunbiyi26 0/1066 0% (0;0.3)
2007 ISAAC16 19/241 7.9% (4.3;11.1)
Rwanda 2007 This study 20/2528 0.8% (0.4;1.1)
South Africa 1995 Zar18 611/5178 11.8% (10.9;12.7)
2002 Zar18 9775037 19.4% (18.3;20.5)
2007 Chalmer31 31/3067 1.0% (0.6;1.4) 55/ 3067 1.8% (1.3 ;2.2)
2007 ISAAC16 58/520 11.2% (8.4;13.9)
2007 ISAAC16 89/670 13.3% (10.7;15.9)
2007 ISAAC16 401/2996 13.4% (12.2;14.6)
Sudan 2007 ISAAC16 6/137 4.7% (1.2;8.2)
Togo 2007 ISAAC16 36/332 10.7% (7.5;14.2)
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to identify children with eczema remains, physical examination by a dermatologist or 
team of dermatologists, especially when the aim of the study is to find cases to analyse 
risk factors for eczema or to do genetic research.10–12
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to be less than 5%,21–23 though recent studies in this region as well as other parts of 
Africa have shown an increase,particularly amongst infants.24–26  Most of the latter 
studies, however, were hospital-based and therefore are less reliable when estimating 
the prevalence of eczema on a national scale.21,23,25,27–29
The point-prevalences in our study of eczema amongst schoolchildren as measured by 
physical examination by a dermatologist in Ghana (1.5% and 1.6%), Gabon (4.0%) and
Rwanda (0.8%) were comparable with other studies in sub-Saharan Africa (Table 5). 
It was notable that the point prevalence of eczema was significantly higher in the rural 
area of Gabon, for which we do not have a clear explanation. The point-prevalences in our 
study did not differ significantly between rural and urban areas, which is in agreement 
with a recent overview about differences between point-and period- prevalences of 
eczema in rural and urban areas in developing countries.13 This may be explained by the 
fact that rural and urban areas in sub-Saharan Africa are much more comparable than in 
Western countries.
The questionnaire based period-prevalences in Ghana were about twofold higher than 
the point-prevalences as measured by physical examination, which can be explained by 
the chronic relapsing character of eczema.5–7,12 The sensitivity and the positive predictive 
values of the questionnaires, however, were low (33% and 22% in the first and 10% and 
4% in the second Ghanaian study respectively).
The questionnaire-based period-prevalences in other sub-Saharan African countries 
were generally more than 10% (Table 5). Flohr et al. recently showed a poor correlation 
between the ISAAC questionnaires and the presence of permanent flexural eczema in 
non-English speaking and developing countries, although there was a good correlation 
between these two measurements amongst Anglophone children.12 Most probably 
these discrepancies are caused by factors related to translation of the questionnaires 
from the English language as well as cultural and educational differences in developing 
countries.12,30–32 It could be queried whether the questionnaire-based period-prevalences 
in the other sub-Saharan African countries are real or may be an overestimation due to 
difficulties in the definition of eczema.
The strength of our study is that we included thousands of schoolchildren in three 
different countries, that all children were seen by a dermatologist or a team of derma-
tologists and that the definition of rural and urban schools within the countries was the 
same. A potential limitation of our study is that we only evaluated
the period prevalence by questionnaire in Ghana.
Our data indicate that in African countries the use of questionnaires one such as the 
ISAAC is a less reliable method to identify children with eczema.11,12,31 Probably physical 
examination is a better method to measure the prevalence of eczema amongst children 
in these countries. It must be realized, however, that physical examination only measures 
the point-prevalence and may give an underestimation of the real prevalence of a 
disease that ‘comes and goes’ over time, such as eczema. Therefore, the gold standard 
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Atopic eczema is an increasing clinical problem in Africa.
Objective 
To determine allergic characteristics and to identify possible risk factors for eczema 
among schoolchildren in an urbanized area in Ghana.
Patients and Methods
Schoolchildren aged 3-16 years with eczema were recruited. For each patient, one to 
three age and sex-matched controls were selected. All children completed a 
questionnaire and were skin prick tested with a panel of allergens. Blood was drawn to 
determine total and allergen-specific IgE. Conditional logistic regression models with 
the matching factors included in the model wre used to calculate the odds ratios and to 
adjust for possible confounders. 
Results 
A total of 52 children with eczema (27 boys and 25 girls) and 99 controls were included. 
Levels of total IgE were found to be 9.1 (1.1; 78.4)  times more often elevated  in children 
with eczema. This association was mainly driven by elevated IgE levels against cockroach 
antigen. Children with eczema were found to have 2.0 (0.87; 4.7) times more often 
positive skin prick tests (SPT), but this association diminished to 1.2 (0.40; 3.6) after 
adjustment for total IgE levels. Frequent washing with soap was identified as a risk factor 
for the development of eczema among these children.
Conclusion 
Schoolchildren with eczema in Ghana were characterised by elevated IgE levels especially 
against cockroach antigen. The association between eczema and positive SPT was much 
weaker suggesting immune hyporesponsiveness of the skin. After adjustment for IgE 
level, SPT were less suitable to distinguish children with and without eczema.
Conflict of interest 
The authors state no conflict of interest.
Funding
The study was made possible by a gift from the Gratama Foundation, the Netherlands.
Introduction
Atopic dermatitis is a chronic relapsing pruritic inflammatory skin disorder.1-3 Although 
termed atopic, up to 60 percent of children with the clinical phenotype do not have 
demonstrable IgE-mediated sensitivity to allergens.2 Therefore, we prefer to use the 
term “eczema” throughout this paper instead of “atopic dermatitis.” We have used the 
criteria of Hanifin and Rajka4,5 to define our cases with “eczema”. Eczema is widespread 
and its prevalence is rapidly increasing in the industrialized world.2,6 Eczema is also a 
growing clinical problem in developing countries. In West Africa the prevalence of 
eczema was considered to be < 5%,7-11 though recent studies in West Africa and other 
parts of Africa have shown an increase, particularly amongst infants,12-15 perhaps because 
of the improvement of diagnostic measures. 
The rising prevalence of eczema might be related to improved sanitation and reduction 
in childhood infections in developed countries, which is known as the hygiene 
hypothesis.16-19 According to this hypothesis, bacterial and viral infections in early life 
result in the proper maturation of the immune system, thereby reducing the expression 
of pro-allergic T-helper-2 (Th2) responses.19-21 Parasitic infections have also been shown 
to induce hyporesponsiveness and to be negatively associated with clinical atopy or 
allergy,22,23 possibly due to suppression of mast cell function.24
Risk factors for eczema which are related to the hygiene hypothesis are increasing 
gross national per-capita income,11 changes in lifestyle due to a higher socio-economic 
status,25 reduced crowding at home,26 sleeping on mattresses, changes in food 
consumption patterns, and more frequent washing.6,19,27 Eradication of endoparasites, 
vaccinations and the treatment of other infections may also increase the risk of 
eczema.22,23 Frequent washing can affect the skin barrier function, providing a non-im-
munological explanation why frequent washing may increase the risk of eczema.19,28-30 
The growing urbanization in Africa has been associated with an increased risk of 
eczema,31 supporting the fact that changes in the environment and habits may be 
resulting in the allergic march, as seen in highly developed countries.
The role of atopy in the pathophysiology of eczema is still under debate.1,32 One 
hypothesis states that immunological disturbance causes IgE-mediated sensitization 
resulting in epithelial-barrier dysfunction as a consequence of local inflammation; the 
second hypothesis proposes an intrinsic defect in the epithelial cells, leading to barrier 
dysfunction.19,28-30 In the latter model, the immunologic aspects are secondary to the 
epithelial-barrier dysfunction and could be considered as an epiphenomenon.19,28-30 
The purpose of this matched case-control study was to determine the allergic 
 characteristics of urban African schoolchildren and to identify possible risk factors for 
eczema in these children. 
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The presence of malaria parasites was assessed at the Noguchi Memorial Institute, Accra 
by examining thick and thin blood smears for each participant. Intestinal helminth 
infection in stool and Schistosoma haematobium in urine were assessed at the same 
centre by standard parasitological examination.
Definition of elevated IgE tests
The values of total IgE were considered elevated when the value was 100 kU/L or higher 
for children who were 10 years and older; 50 kU/L or higher for children between 7 and 
9 years of age; and 25 kU/L or higher for children between 4 and 6 years of age. The 
values of IgE specific for house dust mite, cockroach, cats dogs, peanuts and grasses 
were considered elevated when the value was 0.35 kU/L or higher.
Definition of positive skin prick tests
A skin prick test reaction was considered positive when the average of the longest 
wheal diameter (D1) and its perpendicular length (D2) was >= 3mm for the test allergen 
Patients and Methods
Study design
Between February and December 2005, 86 schoolchildren with moderate to severe 
eczema were selected at the dermatological out-patient clinics of 3 hospitals in Accra, 
Ghana by a dermatologist (A.H.) according to the criteria as defined by Hanifin and 
Rajka.4,5 For each included child with eczema two controls matched for age and sex 
without any visible symptoms of eczema were selected from the same school and class. 
Study Area
Both the hospitals and schools are located in the urbanized area of the Greater Accra 
region of Ghana, West Africa. The study area’s climate is warm with the rainy season in 
April to June and September to November.
Informed Consent and Ethical approval
Information sheets and consent forms were given to the cases and potential controls in 
school to take home to their parents. Interested parents filled the consent forms and 
returned them to the schools. Ethical approval was granted by the Institutional Review 
Board of the Noguchi Memorial Institute for Medical Research. The ethical approval 
number was CPN015/02-03.
Questionnaires
Questionnaire-based interviews were completed by trained staff with one of the care- 
takers of each child in the study. The questionnaire was adapted from the International 
Study of Asthma and Allergies in Childhood (ISAAC)33 and had, among others, questions 
on symptoms of eczema, asthma and allergic rhino conjunctivitis, and sleeping and 
washing habits. The most important questions regarding eczema, asthma and allergic 
rhino conjunctivitis are summarized in Figure 1.
Collection and work-up of samples 
All cases and controls were skin prick tested on non-affected skin of the forearm with a 
panel of allergens (house dust mite (Dermatophagoides pteronyssinus, D. farinae), 
cockroach (Blatella germenica), cat, dog, grass and peanuts) to determine the sensitivity 
of the study population to specific allergens. Peripheral blood was drawn to collect sera 
for the determination of the levels of total IgE (enzyme-linked-immunosorbent serologic 
assay) and allergen-specific IgE  Immuno-CAP TM  (Phadia AB, Uppsala, Sweden) in the 
Netherlands according to the standard protocols.
Figure 1 
Three most important questions for a history of symptoms of eczema: 
(1)   Has your child ever had an itchy rash which was coming and going for at least  
six months?
(2)  Has your child had this itchy rash at any time in the past 12 months? 
(3)   Has this itchy rash at any time affected any of the following places:   
the folds of the elbows, behind the knees, in front of the ankles, under the buttocks, 
or around the neck, ears or eyes?The child was considered to have a history of 
symptoms of eczemaif all three questions were answered confirmative.
Two most important questions for a history of symptoms of asthma: 
(1)  Has your child had wheezing or whistling in the chest in the past 12 months?”
(2)   In the past 12 months, has wheezing ever been severe enough to limit your 
child’s speech to only one or two words at a time between breaths? The child 
was considered to have a history of symptoms of asthmaif the first question was 
answered confirmative and of severe asthma if the second question was also 
answered confirmative.
Two most important questions for symptoms of allergic rhino conjunctivitis: 
(1)  In the past 12 months, has your child had a problem with a runny or blocked nose? 
(2)   In the past 12 months, has this nose problem been accompanied by itchy-watery 
eyes? The child was considered to have a history of symptoms of allergic rhino 
conjunctivitis if both questions were answered confirmative.
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Association of eczema with symptoms of eczema, asthma or allergic 
rhino conjunctivitis as collected by questionnaire
Using the data from questionnaire most cases reported symptoms of eczema during 
the last year (P=0.003; Table 2). Although the controls had no visible signs of eczema at 
the time of investigation still 9.6 % (seven of 73) of the children had reported symptoms 
of eczema during the last year by questionnaire (Table 2). Symptoms of asthma were not 
associated with eczema (P=0.555), but symptoms of allergic rhino conjunctivitis were 
more often reported among cases compared with controls (P=0.051; Table 2).
Association of total and allergen-specific IgE responses with eczema
Children with eczema had significantly more often elevated levels of total IgE than the 
controls (P=0.023; Table 3). This association was driven by the specific IgE response 
against cockroach antigen, as in the logistic regression model, the specific IgE responses 
against house dust mite, peanut and grasses decreased after adjustment for the IgE 
response against cockroach antigen (Table 3). Performing backward stepwise regression 
and histamine, while that to the negative control was < 3mm. The results of the skin 
prick tests were excluded from the analyses when the average histamine response was 
less than 3 mm and/or the average physiological salt response was 3 or more mm.
Statistical Methods
Logistic regression models were used to calculate odds ratios with 95 percent confidence 
intervals for the different variables and to adjust for possible confounders as indicated 
in the Tables. For all statistical analyses we used SPSS for Windows version 16.0 (SPSS Inc, 
Chicago, IL).
Results
Available and missing data
A total of 52 (60.5%) out of 86 children with eczema who were initially selected for this 
study could be included (Figure 2). The remaining 34 children who were excluded from 
the study were those for whom parental consent was not obtained or could not be 
retraced (they had either left school, changed addresses, or simply could not be found). 
Accra is a typical big city in a developing country where some people have no fixed 
addresses and in some areas there is no proper street plan. It was, therefore, often 
difficult to find the children’s residences. In addition, during this study only few of the 
parents/ caretakers had a mobile telephone, which made retracing the children difficult. 
Data on missing questionnaires and sera are provided in Figure 2. Skin prick tests were 
performed in all 52 children with eczema and all 99 control children. The results of five 
(9.6%) children with eczema and 18 (18.2%) control children were excluded because the 
response to histamine was less than 3 mm (20 boys and 2 girls) or the physiological salt 
controls were 3 or more mm in diameter (1 boy). Not all paired eczema-control sets 
were complete because of missing values for some children with eczema or their paired 
controls. The numbers of complete data sets of children with eczema and 1, 2 or
3 of their paired controls, respectively, which were used for analysis in the conditional 
logistic regression model, are provided in Fig. 2.
Baseline characteristics of the children with and without eczema
The baseline characteristics of the children are presented in Table 1. The cases and 
controls were well-matched. Unintentionally, however, boys with eczema and their 
controls were significantly younger than the girls with a mean age of the boys with
eczema of 8.4 (SD 4.5) compared with a mean age of the girls with eczema of 11.0 (SD 
4.2). The difference (with 95% CI) between the age of the boys and girls with eczema 
was 2.6 (1.3;4.0) years. 









No consent or were not retraced N = 34
Data available for analysis Controls Eczema
• Questionnaire N = 79 N = 47
• IgE N = 68 N = 37
• Skin prick tests N = 81 N = 47
Not available for children with eczema
Questionnaire N = 5
Sera for IgE N = 15
Skin prick test N = 0
Results skin prick test excluded N = 5
Not available for control children 
Questionnaire N = 20
Sera for IgE N = 31
Skin prick test N = 0
Results skin prick test excluded N = 18
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only the specific IgE response against cockroach antigen remained in the model 
resulting in the non-adjusted odds ration as presented in Table 3. Levels of cat- and 
dog-specific IgE antigens were too low for any conclusions (data not shown). 
Association between total IgE responses and skin prick tests
Altogether 28 eczema-control sets (28 children with eczema and 48 controls) had 
complete data for both IgE and SPT. Not surprisingly, there was a strong association 
between total IgE responses and SPT (P = 0.009). Of the 57 (75%) children with an 
elevated total IgE level, 21 (36.8%) showed a positive SPT for any of the antigens tested 
(38.5% in the children with eczema and 35.5% without eczema: the difference between 
these 2% was not significant; P = 0.816), whereas only one child in the control group 
with a non-elevated total IgE level had a positive SPT. Conversely, of the 22 children with 
or without eczema who had a positive SPT for any of the antigens tested, all except one 































Table 3   Distribution of elevated IgE levels in children with and without eczema.
Controls








odds ratios**  
(95% CI)








10.9 (1.4 - 85.0)








3.2 (1.1 - 9.3)
1
2.1 (0.53 - 8.2)










4.2 (0.92 - 19.1)








1.7 (0.54 - 5.3)
1
1.3 (0.08 - 19.2)








1.6 (0.56 - 4.3)
1
0.29 (0.02 - 4.4)
CI Confidence Interval
* Odds ratios were calculated with conditional logistic regression models with the matching factors included 
in the model.
** Odds ratios are adjusted for the other specific IgE outcomes.
# Elevated total IgE when IgE ≥25 kU/L for 4-6 year old children; ≥50 kU/L for 7-9; ≥100 kU/L for 10 years and 
older.
$ Specific IgE elevated when IgE ≥ 0.35 kU/L.
Table 2   Association between the clinical characteristics of the children and the 
answers to the questionnaire.
Controls







Symptoms of eczema  








112.9 (4.9 - 2617)
Symptoms of asthma  








1.3 (0.5 - ;3.6)
Symptoms of severe asthma  








1.9 (0.38 - 9.7)
Symptoms of allergic rhino conjunctivitis 








3.4 (1.0 - 11.4)
CI, Confidence Interval
*Odds ratios were calculated with a conditional logistic regression model with the matching factors 
included in the model.
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Malaria was tested in 52 eczema children and 98 controls. Malaria parasites were present 
in blood smears of 2 (3.8%) cases and 4 (4.1%) controls.
Association of environmental risk factors with eczema
Children with eczema were washing themselves before attending school 4 times more 
often than the controls and were 2 times more often sleeping on mattresses than their 
controls without eczema (Table 5). However, both associations did not reach statistical 
significance (P=0.085 and 0.195; Table 5).
Discussion
Elevated total IgE levels were significantly associated with eczema (atopic dermatitis) 
among urban schoolchildren in Ghana, West Africa. The association was apparent 
despite the high proportion of elevated total IgE levels in children without eczema (70 
%). Although most children with eczema showed elevated total IgE levels, there were 2 
who did not show an elevated level, suggesting that not all children with eczema had 
an atopic constitution.
In tropical countries, house dust mites (Dermatophagoides pteronyssinus) have been 
recognized as dominant species of clinical importance, and sensitization to house dust 
mite allergens could be as high as 80–90% among asthmatic and allergic people.34,35 
Cockroach allergens are also associated with an increased risk of asthma and allergy in 
tropical countries.36 Several allergens from house dust mites and cockroaches have 
been cloned and IgE cross-reactivity between the allergens of both species has been 
child in the control group had an elevated total IgE level (P = 0.009). Analysing the 
specific IgE responses and SPT to house dust mite and cockroach antigens gave similar 
strong associations. The chances of having positive SPT in the presence of elevated IgE 
levels were 10.5 (1.3; 84.4; P = 0.009) for all tests together and were 82.5 (9.4; 723), 
P < 0.001 and 10.7 (2.5; 45.9), P < 0.001 for house dust mite and cockroach respectively.
Association between skin prick tests and eczema
A positive SPT for any of the antigens tested was associated with a 2.0 times increased 
risk of eczema, but statistical significance was not reached (P = 0.104; Table 4). Additional 
adjustment for total IgE level decreased this association to 1.7 (0.52; 5.2; P = 0.391). There 
was only a trend of an association with eczema when SPT for house dust mite were 
considered separately (P = 0.457), and there was no positive association with positive 
SPT for cockroach antigen (P = 0.755; Table 4). Positivity for SPT with cat, dog, grass and 
peanuts antigens was too low for any relevant conclusions (data not shown).
Helminth infections and malaria
With the exception of one child with eczema who showed an infection with Schistosoma 
haematobium no infections were detected with Schistosoma mansoni, Ascaris  lumbricoides, 
Trichuris, hookworm, or Enterobius vermicularis in either the children with eczema or in 
the controls.
Table 4   Distribution of positive skin prick tests in children with and without eczema.
Controls








odds ratios#  
(95% CI)








2.0 (0.87 - 4.7)








1.5 (0.50 - 4.6)
1









0.84 (0.29 - 2.8)
1
0.74 (0.24 - 2.3)
CI, Confidence interval
*Odds ratios were calculated with a conditional logistic regression model with the matching factors included 
in the model.
# Odds ratios are adjusted for the other SPT outcome.
Table 5   Bathing habits and sleeping place of the children in association with 
eczema.
Controls


























*Odds ratios were calculated with a conditional logistic regression model with the matching factors included 
in the model.
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described.37 Elevated cockroach specific IgE levels appeared to be the driving force 
behind the association between elevated total IgE levels and eczema in our study. 
More than half of the children with elevated total IgE levels did not show any positive 
skin prick tests, suggesting immune hyporesponsiveness. The association between any 
positive skin prick tests and eczema was less pronounced than for elevated total IgE 
levels and this association importantly diminished after adjustment for elevated total 
IgE levels. There is increasing evidence for a causal relationship between helminth 
infection and reduced skin prick test responsiveness to allergens.38 Unfortunately, the 
protective effect of helminth infections on the development of eczema, as described 
in earlier studies20 could not be addressed in this study, since only very few children in 
this urban population had a helminth infection at the time of the study. We cannot 
exclude, however, that helminth infection in the past may have induced immune hy-
poresponsiveness in these children. Other environmental factors or genetic factors may 
be alternative explanations for the apparent immune hyporesponsiveness in these 
children.
We observed a non-significant positive association between frequent bathing and the 
presence of eczema in this study. Frequent washing with soap is considered to be a 
healthy exercise in Ghana. Washing with soap can impair the skin barrier function by 
increasing the pH of the skin surface. This increased pH of the skin induces increased 
activity of skin proteases, resulting in premature breakdown of the corneodesmosomes. 
This thinning of the stratum corneum facilitates penetration of irritants and allergens 
inducing an immune response.27 Despite the advice to use less soap children often 
continue their habits, also due to the hot, humid climate and the subsequent sweating. 
Nevertheless, despite the frequent use of soap, the prevalence of eczema in Ghana is 
still very low (around 2%).39 Factors such as the humid climate and other environmental 
factors are supposedly compensating for the frequent washing habits. 
There was also a weak non-significant association between sleeping on a mattress and 
eczema. It is possible that parents were allowing children with eczema to sleep on a 
mattress more often than children without eczema and this may be even more explicit 
among boys. Use of mattresses could also be an indicator of socio-economic status 
because children slept on mattresses only when these were available in the home. 
Sleeping on mattresses could also lead to higher exposure to house dust mite or 
cockroach antigens, thus influencing the occurrence of eczema.
The difficulties that we encountered when we tried to collect complete data for all 
children decreased the power of our study. Nevertheless we were able to collect 
valuable information about eczema in Ghana which should stimulate other groups to 
design additional studies to examine eczema in African countries.
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We aimed to investigate the prevalence and risk factors of inflammatory acne vulgaris in 
schoolchildren visiting rural and urban schools in Ghana.
Methods 
Data on acne, age, sex, height and weight were collected from 1394 schoolchildren. The 
prevalence of acne was calculated for 1061 children between 9 and 16 years of age. 
Potential risk factors were estimated by logistic regression. 
Results 
In the rural schools only 1 (0.2%) out of 572 children had acne, compared to 63 (12.9 %) 
out of 489 children in the urban schools (P< 0.001). The prevalence of acne in the urban 
areas increased from 4.1% in girls and 1.3% in boys between 9 and 10 years old to 28.4% 
in girls and 16.4% in boys between 13 and 14 years old and leveled off in children 
between 15 and 16 years of age. The risk adjusted for age and BMI with 95% confidence 
interval of girls developing acne compared to boys was 3.2 (1.7-6.1). The risk of 
developing acne for children with a high BMI was 2.0 (0.9-4.3) and for children with a 
low BMI 0.7 (0.2-2.4) compared to children with a normal BMI.
Conclusion 
The prevalence of inflammatory acne vulgaris in Ghanaian schoolchildren was very low 
in the rural areas and ranged between 1.3% and 28.4% in the urban areas, depending on 
the sex and age of the schoolchildren. Living in an urban area, increasing age, female 
gender and high BMI were the main risk factors associated with an increased risk of 
acne. 
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Introduction
Acne vulgaris is a common skin condition in children and adolescents between the age 
of 10 and 18 years.1 The prevalence of acne strongly depends on its definition and the 
age categories of the studied populations. In industrialized countries this condition 
affects between 31% and 95% of the adolescent population.1-4 Acne can also persist 
beyond adolescence.5
The prevalence of acne is considerably lower in developing countries.6-9 Community-
based studies, specifically studying acne vulgaris in African countries are scarce and are 
summarized together with studies performed in other developing countries in Table 1. 
Hospital-based studies on skin diseases, among which acne, in a population of people 
of all ages were more frequently reported (Table 1). The prevalence of acne in hospital- 
based studies in Africa ranged between 2.8% and 8.9% with the exception of a 
hospital-based study performed in South Africa which showed a prevalence of 16%.10-17 
Only few studies compared the prevalence of acne in schoolchildren who are living in 
rural and urban areas (Table 1). One study performed in Ethiopia showed a higher 
prevalence of acne in rural areas (3.3%) compared to urban areas (0.8%).18 Another study 
performed in Brazil, however, found the opposite with a prevalence of acne in the rural 
areas ranging between 0% and 0.7% compared to prevalences ranging between 0.7% 
and 3.5% in the urban areas.8
Different prevalences of acne between industrialized and developing countries may be 
explained by differences in genetic and environmental risk factors such as diet, usage of 
medication or cosmetics, and body weight, reflecting the nutritional status of the 
children. The difference in acne prevalence between rural and urban areas within one 
country, however, cannot easily be explained by genetic factors and is probably 
influenced by environmental differences or different food habits. 
The purpose of this study was to estimate the prevalence of inflammatory acne vulgaris 
in schoolchildren living in rural and urban areas of the Greater Accra Region of Ghana 
and to study risk factors of inflammatory acne vulgaris.
Methods
Recruitment of schoolchildren and Ethical Approval
This cross-sectional study is part of a larger project in which the association of helminth 
infection and other potential risk factors with allergic sensitization and atopic eczema 
among school children in Ghana are studied.19 The children were recruited from 13 
schools between January 2006 and March 2007. Between 5 and 16 February 2007 two 
dermatologists (A.P.M. Lavrijsen and A.A. Hogewoning) visited 11 of these schools in 
rural and urban areas in the Greater Accra Region of Ghana and screened a total of 1394 
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schoolchildren for inflammatory acne vulgaris, atopic eczema and other skin diseases. 
A questionnaire was administered to each child, collecting information concerning 
living conditions. The skin of each child was fully examined by one or both dermatologists. 
All skin diseases observed, with special attention for inflammatory acne vulgaris and 
atopic eczema were recorded on the questionnaire.
Children whose parents consented by signing or thumb printing an informed consent 
form were enrolled in the study. The Institutional Review Board of the Noguchi Memorial 
Institute for Medical Research in Ghana granted ethical approval for this study.
Definition of acne
The clinical diagnosis of inflammatory acne vulgaris, ascertained by two dermatologists 
experienced in dermatology of African skin, was used for recording the presence of 
inflammatory acne. The diagnosis of inflammatory acne was defined by the presence of 
at least 6 pustules or papulopustules on the face.20 The severity grade was not assessed 
separately.
BMI 
The height and weight of the schoolchildren were measured to calculate the Body Mass 
Index (BMI) as a marker of nutritional status. The measurements of height and weight 
were done in a period ranging between 12 months before and 1 month after the 
dermatological examination. The BMI was calculated by dividing the body weight with 
the square of height (kg/m2). 
The BMI in childhood is strongly dependent on age and to a lower extent on sex.21 Two 
recent studies of Cole et al. have provided cut-off points for BMI in childhood that are 
based on international data.21;22 The cut-off point for overweight was linked to a BMI of 
> 25 kg/ m2 (high BMI) and for underweight linked to a BMI of < 17 kg/ m2 at age 18 years 
(low BMI).
Statistical Analysis
The differences in prevalence (point prevalence) of inflammatory acne vulgaris, BMI and 
age in relation to the four types of schools were analyzed with the Pearson’s chi square 
test and ANOVA test. Comparison of age, sex, height, weight and BMI between children 
with and without inflammatory acne was made with the Pearson’s chi square test and 
an independent T-test.
Logistic regression analyses were performed taking the presence or absence of 
inflammatory acne as the dependent variable. The model included gender, age and 
BMI. The odds ratios, 95% confidential intervals and, where appropriate, p-values were 
reported. In all cases, statistical tests were considered significant when p-values were 
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Study Area and Socio-economic Status
The general study area was in the Greater Accra Region of Ghana between longitudes 
W 000.35377° and E 000.42752° and latitudes N 005.72647° and N 005.53550°. All the 
urban schools were in the Accra Metropolis where we included two private rich schools 
with a high socio-economic status (Mona Lisa School where 36 and Morning Star where 
35 children were seen); two private schools with middle to high socio-economic status 
(Greenhill International where 189 and The Youngster International where 167 children 
were seen) and one public school with low socio-economic status (Immanuel Presbyterian 
Primary School where 214 children were seen). Five rural schools were located in 
Dangme East (Agbedrafor where 119, Anyamam where 214, Goi where 79, Koluedor R/C 
Primary School where 128 and Toflokpo where 108 children were seen) and one rural 
school was located in Ga East (Pantang Primary and JSS where 105 children were seen). 
Main income earning activity in the Ga district is farming, while fishing, salt mining and 
farming are characteristics of Dangme East. 
Results
A total of 1394 children participated in the study (Table 3). No statistically significant 
difference in gender distribution among the four types of schools was found (Table 3). 
The children in the rural schools were, however, significantly shorter and weighted less 
than those in the urban schools, except for the 4-8 year old children in the urban public 
schools. This difference was also reflected in significant differences in median BMI in 
older children between the schools. The children in the urban private rich schools had 
a higher median BMI compared with the other types of school, which was also reflected 
by a higher percentage of children with a high age-adjusted BMI in the urban private 
rich schools (Table 3).  
Under the age of 9 years we did not observe inflammatory acne vulgaris in any of the 
schoolchildren. Children in this age category were therefore excluded from further 
analysis. Children in the age category between 17 and 20 years were also excluded from 
further analyses since there were only 13 children in this age group (Table 3). 
In the rural schools only 1 (0.2%) out of 572 children had acne, compared to 63 (12.9 %) 
out of 489 children in the urban schools (P< 0.001). Figure 1 shows the distribution of 
inflammatory acne vulgaris in the urban schools amongst 9 to 16 year old boys and girls. 
The prevalence of acne in the urban schools increased from 4.1% in girls and 1.3% in 
boys between 9 and 10 years old to 28.4% in girls and 16.4% in boys between 13 and 14 
years old and leveled off in children between 15 and 16 years of age to 18.8 % in girls 
and 13.3% in boys (Figure 1). This confirms that girls develop acne at a younger age than 
boys. At the age of 15 years the prevalence of inflammatory acne among boys appeared 
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Discussion
The prevalence of inflammatory acne vulgaris in Ghana was less than 1% in the rural 
schools and varied between 1.3% and 28.4% in the urban schools depending on the 
age and sex of the schoolchildren. The prevalence of acne in Ghana was low in 
comparison with some industrialized countries1-4 but was higher in the urban schools 
compared to other community-based studies of schoolchildren in developing countries 
like India, Ethiopia and Brazil (Table 1).8;9;18 Although the diagnoses of acne in the latter 
studies were not clearly defined, these studies support our finding that the prevalence 
of acne is much lower in developing countries than in industrialized countries. 
With the changing socio-economic situation in developing countries, especially 
westernization in urban areas, it is believed that the prevalence of acne vulgaris in 
developing countries will increase to the level of industrialized countries. This has 
already been observed among the Inuit people in Canada who had given up nomadic 
life and had moved into settlements adopting a western lifestyle. Acne vulgaris has 
become common among the Inuit, although the condition used to be rare among this 
ethnic group.23
In our study girls appeared to develop acne at a younger age than boys, but boys were 
catching up as they became older (Figure 1). Between the ages of 16 and 18 boys are 
more likely to have acne.1;24;25 
The striking difference between the prevalences of acne in rural and urban schools may 
reflect differences in genetic background or differences in environmental exposure. It is 
not likely that genetic factors explain the different prevalences of acne between rural 
and urban schools in our study. The most important environmental differences between 
the rural and urban areas in the greater Accra region are the lower food intake and the 
higher exposure to helminth infections in the rural areas, which are factors that both 
can lead to a lower nutritional status of the children. The significantly lower height and 
weight of the rural children may reflect chronic malnutrition in the rural areas.26 
A lower nutritional status may protect against the development of acne. The observed 
association between a higher BMI and acne among the children who were attending 
the urban schools would nicely fit in this hypothesis. An association between overweight 
and acne has also been described by Tsai et al. 27 and Bourne. 28 However, Bourne et al. 
found this association only in adult males.28 
The observed differences in height and BMI reflecting the nutritional status of the children 
may not be the only factors explaining the profound difference in the prevalence of 
acne between the rural and urban schools. Other factors which could explain this 
difference may be the use of cosmetics or the consumption of different types of food. 
In urban areas cosmetics with comedogenic ingredients, bleaching creams containing 
corticosteroids and pomade are much more available and potentially could contribute 
to the higher prevalence of acne in urban areas.
Since there was only one child with acne in the rural schools and since rural schools 
significantly differed from urban schools with respect to length, weight and BMI, the 
analyses of risk factors for acne were restricted to the 9-16 year-old children attending 
the urban schools (Table 4). Children with inflammatory acne were significantly older 
and more often girls compared to children without acne. They more often showed 
a high BMI in comparison with children without inflammatory acne (Table 4). The 
percentage of acne was not significantly different between the public, private and 
private rich urban schools (Table 4). Female gender, increasing age and high BMI 
appeared to be independent risk factors for inflammatory acne vulgaris after adjustment 
for these factors (Table 4). 
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1.5 (0.82-2.9)
0.94 (0.34-2.6)
*The odds ratios are adjusted for sex age, BMI and type of school.
**This information is missing from 3 children without acne.
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Additional community-based studies in developing countries are necessary, especially 
studies comparing rural with urban areas to confirm the profound difference in the 
prevalence of acne between these areas. 
An association between diet and acne has long been suggested.29 This has also been 
suggested by Cordain et al.6 who found no cases of acne among non-Westernized 
societies like the Kitavan Islanders of Papua New Guinea and Ache hunter gatherers 
of Paraguay. They postulated that the difference in the prevalence of acne between 
developing and industrialized countries cannot be solely attributed to genetic differences 
but likely results from different environmental factors such as diet, which have a substantially 
lower glycemic index than Western diets.6 
Evidence for the relation between diets with high glycemic index and acne is gradually 
accumulating.29 Insulin-like growth factor 1 (IGF-1) and high levels of insulin, induced by 
a high glycemic-load diet, stimulate sebaceous glands and the synthesis of androgens.6;29-
33 A recent randomized controlled trial using a high-protein, low glycemic-load diet 
versus a high glycemic-load diet showed a decrease in acne severity and improved 
insulin sensitivity.32;33 It is likely that rural children in our study may have had limited 
access to processed products and products with refined carbohydrates and this may be 
one of the possible reasons to explain the difference in acne prevalence in urban and 
rural children.34-37 Consumption of milk, containing hormonal constituents, is also 
described to contribute to the formation of acne.29;38;39
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Skin diseases among children in Africa
Arjan Hogewoning, Sjan Lavrijsen, Colette van Hees
This chapter of the thesis reflects the wish of putting acquired knowledge and 
information into a format which is useful in daily practice in Africa. It describes the 
epidemiology, etiology and pathogenesis, clinical symptoms and the management 
and treatment of common and typically tropical skin diseases among children in 
Africa. The described management of the diseases is experience based. There is 
little evidence based pharmacotherapy in children.
This chapter is complementary to the book ‘Common Skin Diseases in Africa. 
An illustrated Guide’ by Colette van Hees and Ben Naafs (ISBN/EAN: 978-90-
808016-2).  There is some overlap in text and illustrations. However “Skin diseases 
among children in Africa” focuses specifically on children, and, in line with the 
rest of the thesis, on epidemiology. Illustrations were provided by Arjan 
Hogewoning, Sjan Lavrijsen, Colette van Hees, Ben Naafs, Johan van der Stek and 
Rosemarie Moser.
This chapter is meant to be a practical guide for general practitioners, health care 
workers, students and all others who are working in the medical field. The list 
of skin diseases described is far from complete and will benefit from continuous 
improvements and additions. Modern communication tools like websites 
provide these functionalities. We created a freely accessible website named 
www.africanskindiseases.org to cater for this. “Skin diseases among children in 
Africa” and “Common skin diseases in Africa” are the first of hopefully many 
publications accessible through this website. 
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(Impetigo, ecthyma, folliculitis, furuncle)
The majority of the skin diseases found among schoolchildren in Africa are dominated 
by fungal infections and pyoderma.1-4 Factors like overcrowding, malnutrition and climatic 
conditions such as heat and humidity lead to an increase in bacterial infections in tropical 
and semi-tropical countries.5;6 
The term pyoderma is used to describe bacterial skin infections; impetigo, ecthyma, 
folliculitis, furuncle or carbuncle.  It is usually caused by staphylococci and/ or pyogenic 
streptococci which may penetrate the skin primarily or secondary to trauma or other 
infections. Invasive infections may spread from superficial infections or enter through a 
defect in the skin such as interdigital tinea pedis.7;8 A problem is the misuse of antibiotics 
available without prescriptions.
Reasons for concern are recent reports of growing incidences of S.aureus bacteraemia 
coupled with high prevalences of methicillin resistance (MRSA), particularly in HIV-infected 
children.9 This growing rate of resistance to currently recommended antibiotics for skin 
and soft tissue infections could pose a significant health threat in sub-Sahara Africa, 
especially in regions with limited access to microbiological laboratory facilities and to 
adequate antimicrobial agents.10;11
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Management
•  Impetigo is highly contagious, spreading needs to be prevented. Do not share the 
same towels and change clothes and towels frequently.
•  In limited cases local therapy is usually sufficient. Wash with betadine shampoo daily 
and apply gentian violet paint 0.5%, mupirocin ointment, fusidic acid cream, sulphur 
5% in zinc oxide cream or betadine ointment twice daily on the lesions.
•  In moderate /severe cases an oral antibiotic, active against both streptococci and 
staphylococci (also beta-lactamase producing strains) like dicloxacillin is the drug of 
first choice. In case of penicillin-allergic patients, erythromycin can be given. When 
MRSA is suspected, cefalexin is an option.
* Flucloxacillin (British National Formulary)
§	Child under 2 years: quarter of the adult dose: 62.5-125 mg every 6 hours. 
 Oral solution (Syrup, flucloxacillin, 25 mg/1mL) 2.5 mL-5 mL 4 times daily.
§	Child 2-10 years : half of the adult dose: 125mg-250mg every 6 hours. 
 Oral solution (Syrup, flucloxacillin, 25 mg/mL) 5 mL 4 times daily or
 Capsules (flucloxacillin, 250 mg) 1 capsule 4 times daily.
§		Child above 10 years: adult dose: 250-500 mg 4 times daily. 
 Capsules (flucloxacillin, 250 mg or 500 mg) 1 capsule 4 times daily. 
* Erythromycin (British National Formulary)
§	Child up to 2 years: 125 mg 4 times daily. 
 Oral solution (Syrup, erythromycin, 25 mg/1mL) 5mL 4 times daily. 
§	Child 2-8 years: 250 mg 4 times daily. 
 Oral solution (Syrup, 50 mg/1mL) 5 mL 4 times daily or 
 Capsules (erythromycin, 250mg) 1 capsule 4 times daily.
§	Child above 8 years: adult dose: 250-500 mg 4 times daily. 
 Capsules (erythromycin, 250 mg or 500 mg) 1 capsule 4 times daily.
* Cefalexin (British National Formulary)
§	Child under 1 year: 125 mg every 12 hours.
  Oral solution (Syrup, cefalexin 25 mg/1mL) 5 mL 2 times daily. 
§	Child 1-5 years: 125 mg every 8 hours.
 Oral solution (Syrup, cefalexin 25 mg/1mL) 5 mL 3 times daily. 
§	Child 6-12 years: 250 mg every 8 hours.
 Oral solution (Syrup, cefalexin 50 mg/1mL) 5 mL 3 times daily or
 Capsules (cephalexin 250 mg) 1 capsule 3 times daily.
§	Above 12 years: adult dose: 250 mg every 6 hours or 500mg every 12 hours.
 Capsules (cefalexin 250 mg) 1 capsule 4 times daily or 2 capsules 2 times   daily or 1 
capsule (cefalexin 500mg) 2 times daily.
8.  Mahe A, Faye O, N’diaye HT et al. Definition of an algorithm for the management of common skin diseases 
at primary health care level in sub-Saharan Africa. Trans R Soc Trop Med Hyg 2005; 99: 39-47.
9.  Groome MJ, Albrich WC, Wadula J et al. Community-onset Staphylococcus aureus bacteraemia in 
hospitalised African children: high incidence in HIV-infected children and high prevalence of multidrug 
resistance. Paediatr Int Child Health 2012; 32: 140-6.
10.  Ateba NU, Schaumburg F, Adegnika AA et al. Epidemiology and population structure of Staphylococcus 
aureus in various population groups from a rural and semi urban area in Gabon, Central Africa. Acta Trop 
2012; 124: 42-7.
11.  Truong H, Shah SS, Ludmir J et al. Staphylococcus aureus skin and soft tissue infections at a tertiary 
hospital in Botswana. S Afr Med J 2011; 101: 413-6.
Impetigo
Epidemiology
Impetigo is a frequently observed superficial, very contagious, bacterial infection which 
can be divided in a non-bullous and a bullous form. Non-bullous impetigo accounts for 
more than 70% of cases of impetigo. It is frequently diagnosed in regions with a warm 
humid climate. Overcrowding, malnutrition and lack of hygiene also play an important role.
Etiology and pathogenesis
The predominant cause of non-bullous impetigo is Staphylococcus aureus although also 
Streptococcus pyogenes can be involved, especially in tropical countries. Bullous impetigo 
is nearly always caused by a coagulase positive S. aureus. These bacteria belong to a 
specific group (phage group 2) which produces an exfoliative toxin responsible for the 
blister formation. Phage group 2 S. aureus are also responsible for the development of 
the staphylococcal scalded skin syndrome (SSSS) which occurs mainly in neonates and 
infants.
Clinical findings
Impetigo usually occurs on exposed areas like the face and extremities. Non-bullous 
impetigo starts often with a pustule which can develop rapidly and lead to the formation 
of yellow or brown colored crusts. Usually there is no pain but the lesions may be itchy. 
In the majority of cases regional lymphadenopathy can be found. Bullous impetigo 
presents with large blisters which rupture easily. They are usually localized on the face, 
extremities and the diaper area and they heal without scarring.
Differential diagnosis 
•  Herpes simplex
•  Varicella
•  Candidiasis
•  Insect bites (hypersensitivity response)
•  Pemphigus
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Management
•  Local therapy is usually sufficient. As local treatment 
wash with betadine shampoo daily and apply 
mupirocin ointment, fusidic acid cream, sulphur 
5% in zinc oxide cream, gentian violet paint 0.5% 
or betadine ointment twice daily on the lesions.
•  Avoid oil and vaseline based topical products.
•  Severe or recurrent infections may be treated 
systemically with oral antibiotics. like flucloxacillin. 
In case of penicillin-allergic patients, erythromycin 
can be given. For the dosages see impetigo.
Reference list see Pyoderma
Ecthyma
Epidemiology
Ecthyma describes deeper punched out lesions which can be complicated by 
lymphangitis and cellulitis. Overcrowding, poor hygiene and malnutrition are important 
factors in its development. Ecthyma often occurs as a secondary lesion after scratching 
itchy lesions such as insect bites or after local trauma.
Etiology and pathogenesis
Ecthyma is usually caused by Streptococcus pyogenes but may be caused by Staphylococcus 
aureus as well. It occurs mostly on the legs where infection extends into the sub- 
cutaneous tissue. 
Clinical findings
The initial lesion is a blister, surrounded by redness and edema. In the beginning it can 
resemble impetigo but ecthyma extends into the sub-cutaneous tissue and causes a 




•  Ecthyma gangrenosum (caused by Pseudomonas aeruginosa). This usually occurs 
  in patients with immunedeficiency 
•  Anthrax
Reference list see Pyoderma
Bacterial folliculitis
Epidemiology
Bacterial folliculitis is mainly diagnosed among children and caused by S.aureus. 
Etiology and pathogenesis
Folliculitis is an inflammation of hair follicles which, when bacterial, is usually caused by 
staphylococci. Sometimes also other causative agents like streptococci or Pseudomonas 
aeruginosa are involved. Minor trauma caused by scratching, physical or chemical injury 
and the use of topical steroids can induce folliculitis. 
Clinical findings
Follicular dome shaped yellow papulopustules are surrounded by a red areola. Lesions 
develop in crops; the most affected areas are the scalp, thighs and buttocks. 
Differential diagnosis 
•  Insect bites 
•  Pityrosporum folliculitis
•  Acne vulgaris
•  Folliculitis caused by oily or tar products















Non-bullous impetigo: Small erosions 
with brown-yellow crusts
Bullous impetigo: Superficial blisters/ 
erosions
Folliculitis on a leg
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Clinical findings
A furuncle presents as a painful, deep-seated well circumscribed papulopustule which 
develops into a nodule with central necrosis and pus. Sites of predilection are: the neck, 
buttocks, groin and armpits. When there is a group of furuncles which form one nodular 
lesion with multiple drainage points it is called a carbuncle. 
Differential diagnosis 
•  Hidradenitis suppurativa
•  Folliculitis
•  Acne vulgaris
•  Sinus pilonidalis
•  Myiasis
Management
•  Frequent application of a moist compress to stimulate drainage.
•  Do not share the same towels and change clothes and towels frequently.
•  In uncomplicated lesions local therapy is usually sufficient. As local treatment wash with 
betadine shampoo daily and apply fusidic acid cream, sulphur 5% in zinc oxide cream or 
betadine ointment twice daily on the lesions.
•  Lesions with surrounding cellulitis, or furuncles located on the face demand systemic 
antibiotic treatment. Flucloxacillin (which is active against beta- lactamase producing 
strains) is the drug of first choice. In case of penicillinallergic-patients, erythromycin or 
cefalexin can be given. For dosages see impetigo.
•  When furuncles recur and S. aureus carriage is suspected, the patient can be treated 
with mupirocin nasal ointment, to apply three times daily to the inner surface of each 
nostril for the first 5 days of each month. In poor resource countries the use of gentian 
violet paint 0.5% is an option. 
Reference list see Pyoderma
Management
•  Removal of the crust.
•  As local treatment wash with betadine 
shampoo daily and apply Gentian violet 
paint, mupirocin ointment, fusidic acid 
cream, sulphur 5% in zinc oxide cream 
or betadine ointment twice daily on 
the lesions.
•  A small spectrum antibiotic therapy 
against Strep.pyogenes and Staph.aureus 
is recommended. Phenoxymethylpeni-
cillin can be given. In case of penicillin-
allergic patients, erythromycin is a good 
alternative. For the dosage see impetigo.
*Phenoxymethylpenicillin (British National Formulary)
§	Child up to 1 year: 62.5 mg 4 times daily.
 Oral solution (Syrup, phenoxymethylpenicillin, 25 mg/1mL)
 2.5 mL 4 times daily.
§	Child 1- 5 years: 125 mg 4 times daily. 
 Oral solution (Syrup, phenoxymethylpenicillin, 25 mg/1mL) 5mL 4 times daily. 
§	Child 6-12 years: 250 mg 4 times daily.
 Tablets (phenoxymethylpenicillin, 250 mg) 1 tablet 4 times daily.
§	Above 12 years: 500 mg 4 times daily.
 Tablets (phenoxymethylpenicillin, 250 mg) 2 tablets 4 times daily.
Reference list see Pyoderma
Furuncle
Epidemiology
A furuncle is a painful abscess around the hair shaft and in the perifollicular skin. Furuncles 
are more common in boys than in girls. 
Etiology and pathogenesis
Furuncles occur in hair-bearing skin. The causative agent is nearly always Staphylococcus 
aureus. Risk factors for the development of furuncles are: a humid environment, obesity or 
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Management 
•  In the recent past excision was the treatment of choice but now serves more as an 
adjunct to antibiotic treatment.13-15
•  A combination of rifampicin and streptomycin for 8 weeks should be given. Rifampicin, 
10 mg/kg body weight by mouth daily for 8 weeks and streptomycin, 15 mg/kg body 
weight by intramuscular injection daily for 8 weeks. Because its side effects (ototoxicity 
and nephrotoxicity) streptomycin is more and more replaced by clarithromycine, 
ciprofloxacin, moxifloxacin or amikasin.
•  If surgery is combined with antibiotic therapy only minimal surgery to excise necrotic 
tissue is required when antibiotics have arrested progression of the disease.
•  Interventions to minimize or prevent disabilities.
•  BCG Vaccination programmes, though the protective effect is short-term and 
according to some studies non existing13
•  The treatment depends on the different clinical categories.
*  Category I (small early lesion), if possible a direct excision and suturing is recommended. 
Antibiotics should be started at least 24 hours before surgery and continue for 4 
weeks. If surgery is not possible all lesions in this category can be treated with 
antibiotics for 8 weeks. Category I can be treated in smaller clinics / primary health 
care centers and referral hospitals.
*  Categories II and III should be treated with antibiotics for at least 4 weeks, then surgery 
(if necessary), followed by another 4 weeks of antibiotics. Both categories should be 




Buruli ulcer is caused by Mycobacterium ulcerans. It is the third most common 
mycobacterial disease among humans, after tuberculosis and leprosy. The incidence is 
highest in children up to 15 years old. Among the younger children males are more 
infected. Buruli ulcer is endemic in Africa and most patients live in West Africa. In Ghana 
seasonal variation has been described.1-3 Environmental factors like deforestation, 
increased manual agriculture of wetlands, illegal diamond or gold digging etcetera 
seem to play an important role.3-7 
Etiology and pathogenesis
Most probably the mode of transmission is by skin trauma at sites contaminated by M. 
ulcerans. The pathway of transmission remains unknown, despite many years of research. 
The primary risk factor associated with Buruli ulcer is proximity to slow moving water 
and direct water contact. In arid regions Buruli ulcer is usually absent. M.ulcerans contains 
a plasmid that produces a diffusible necrotizing toxin in tissues, mycolactone, which 
gives the ulcers the typical undermining aspect. 
Clinical findings
Buruli ulcer is a necrotizing skin disease that can leave patients with prominent scars 
and lifelong disability. After infection a painless nodule is formed which eventually 
ulcerates. This process evolves very slowly, and large body areas may eventually be 
affected. Despite their impressive appearance the lesions are strikingly painless and 
patients are usually otherwise healthy. There are several types of lesions:
•  I    Small early lesion (eg, nodules, papules, plaques, ulcers < 5 cm in diameter)
•  II   Non ulcerative and ulcerative plaque and edematous forms     
•  III Large ulcerative lesions (>5 cm in diameter) 
Besides the skin and the subcutis deeper structures may be affected, leading to osteo -
myelitis and bone destruction. 8-10 11
Differential diagnosis  
•  Other tropical ulcers12
•  Leishmaniasis 
•  Cutaneous tuberculosis
•  Onchocerciasis nodules















Ghanaian boy 12 year, ulcerating plaque Ulcerative lesion on the foot with typical 
“undermining”
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The newly detected number of patients (NCD) with leprosy in 2010 was 228.474, which 
is about 50% of the NCD in 1985. Up to 10% of new leprosy cases occur in children under 
15 years.1;2 This means that even though elimination strategies have had a positive 
effect, leprosy is still endemic in South East Asia, South America and Africa, India and 
Brazil being the most affected. An explanation may be that contagious  patients are not 
discovered in time.
Etiology and pathogenesis 3
Leprosy is an infectious and immunological disease caused by Mycobacterium leprae. It 
is transmitted by leprosy patients who may carry many bacilli, particularly multibacillary 
patients, usually by sneezing or coughing. Of those infected only few develop leprosy. 
Leprosy is a generalized disease which especially affects skin and nerves. The clinical 
presentation and damage done depend on host immunity. Skin and nerve involvement 
and damage may occur by infiltration with M. leprae, or in particular during leprosy 
reactions, which may occur before, during or after treatment.
Clinical findings 4-6
In paucibacillary (PB) leprosy there is strong cellular immunity. Five or less well 
demarcated hypopigmented or slightly erythematous skin patches with loss of 
sensation are seen on the skin and no bacilli are found in the patches. One or more local 
or regional nerves may be enlarged.  In multibacillary (MB) leprosy there are more than 
five skin lesions which may be flat, popular,  nodular or plaques. In total absence of a cell 
mediated immune response the whole skin may be infiltrated (Lepra bonita). MB 
patients have positive skin smears and are contagious.
Leprosy reactions may cause severe nerve damage if not recognized and treated 
properly. Symptoms of reversal reactions (RR) are erythema and swelling of previous 
lesions, appearance of new lesions or enlargement, tenderness and loss of function of 
nerves.7 Sometimes there is acral edema. In erythema nodosum leprosum (ENL) tender 
erythematous nodules appear, nerves may become tender and the patient usually feels 
sick. Other organs may be affected too, causing for example arthritis, lymphadenitis, 
orchitis and iridocyclitis. Ulceration is secondary to the loss of protective sensation and 
may lead to cellulitis, deep infections, osteomyelitis and consequently loss of digits, 
causing deformity.
Differential diagnosis
•  Tinea corporis
•  Lupus vulgaris 
•  Atypical mycobacterial infection
•  Leishmaniasis
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Ghanaian boy, 12 years old
Large ulcerative lesion with undermining
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•  ENL: Mild ENL: acetylsalicylic acid 1000 mg 3 times daily (or less according to age) for 
1-2 weeks. Severe ENL: prednisolone high dose eg 1-1.5 mg kg for two days, tapering 
off in two weeks. To be repeated if necessary.
Reference List
1.  Cortes SL, Rodriguez G. Leprosy in children: association between clinical and pathological aspects. J Trop 
Pediatr 2004; 50: 12-5.
2.  Rao AG. Study of leprosy in children. Indian J Lepr 2009; 81: 195-7.
3.  Naafs B, Silva E, Vilani-Moreno F et al. Factors influencing the development of leprosy: an overview. Int J Lepr 
Other Mycobact Dis 2001; 69: 26-33.
4.  Leprosy in childhood.  2012. 
5.  Naafs B. Leprosy in children.  2008.  
6.  Naafs, Noto S, Schreuder PAM. The diagnosis of leprosy, part I and II.  2011.
   Leprosy mailing list oct.2011
7.  Naafs B. Treatment duration of reversal reaction: a reappraisal. Back to the past. Lepr Rev 2003; 74: 328-36.
•  Neurofibromatosis
•  Sarcoidosis
•  Pityriasis versicolor
•  Granuloma annulare
•  Vitiligo
•  Erythema nododum
•  Yaws
•  Kaposi sarcoma
Management of uncomplicated leprosy as advised by the WHO
•  PB leprosy, children under 10 years: Rifampicine 300 mg once a month under supervision 
plus dapsone 25 mg daily unsupervised for 6 months (sometimes 12 months treatment 
may be needed), 6 monthly doses in 9 months are considered enough.
•  PB leprosy, children 10-14 years: Rifampicine 450 mg once a month under supervison 
plus dapsone 50 mg daily unsupervised for 6 months (sometimes 12 months treatment 
may be needed), 6 monthly doses in 9 months are considered enough.
•  PB leprosy above 14 years: Rifampicine 600 mg under supervison plus dapsone 100 
mg daily unsupervised for 6 months (sometimes 12 months treatment may be 
needed), 6 monthly doses in 9 months are considered enough.
•  MB leprosy children under 10 years: Rifampicine 300 mg and clofazimine (lampren) 
100 mg under supervision monthly plus dapsone 25 mg daily and clofazimine 50 mg 
twice a week unsupervised for 12 months. (sometimes 24 months treatment may be 
needed), 12 monthly doses in 18 months are considered enough.
•  MB leprosy children 10-14 years: Rifampicine 450 mg and clofazimine (lampren) 150 
mg under supervision plus dapsone 50 mg daily and clofazimine 50 mg every other 
day unsupervised for 12 months. (sometimes 24 months treatment may be needed), 
12 monthly doses in 18 months are considered enough.
•  MB leprosy above 14 years (50-80 kg): Rifampicine 600 mg and clofazimine (lampren) 
300 mg plus dapsone 100 mg plus dapsone 100 mg daily and clofazimine 50 mg daily 
unsupervised for 12 months (sometimes 24 months treatment may be needed), 12 
monthly doses in 18 months are considered enough.
•  Single lesion PB children 5-14 years: Rifampicin 300 mg, Ofloxacin 200 mg, Single 
lesion PB adults: Rifampicin 600 mg, Ofloxacin 400 mg, Minocyclin 100 mg
•  Minocyclin 50 mg (not recommended under age 5).
•  In younger children treatment regimens should be adjusted according to age and weight. 
•  Always check for reactions and complications, particularly haemolysis in Northern and 
Western Europeans. 
•  RR: prednisolon 0,5 mg/kg daily, tapering down slowly but remaining above 0,25 mg/
kg/day  for 3-6 months according to clinical signs and symptoms, then taper down to 















Girl with TT leprosy, hypopigmented 
patch with loss of sensation
11 year old boy with BT leprosy
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Management
•  Oral antifungal treatment is always 
indicated
* Griseofulvin 
§	 The dose is based on body weight 
and is usually 20 mg/kg of body 
weight once a day for 6-8 weeks. 
Oral solution (Syrup, griseofulvin 
microcrystalline, 25 mg/ml) or tablets 
(griseofulvin 125 mg or 500mg).
§	 Dosing recommendations have not 
been established for children  
< 2 years of age.
§	 Children above 30 kg  500 mg daily 
for 6-8 weeks.
§	 For tinea capitis Griseofulvin is the 
treatment of choice.
*Terbinafin
§	 In certain countries not approved for 
children below 2 years of age. 
§	 The dose is based on body weight. 
§	 Children below 20 kg 62.5 mg daily 
for 6 weeks. (Syrup, terbinafin, 25 mg/ 
ml), 2.5 ml Syrup daily or tablet 
(terbinafin 250 mg), ¼ tablet daily.
§	 Children between 20 and 40 kg 
125mg daily for 6 weeks.  
Oral solution (Syrup, terbinafin,  
25 mg/ml) 5 ml daily or tablets  
(terbinafin 250 mg) ½ tablet daily.
§	 Children above 40kg and adults 250 
mg daily for 6weeks. Tablets 
(terbinafin 250 mg), 1 tablet daily. 
§	 To prevent shedding, apply 
Whitfield’s cream or miconazole 
cream twice daily topically, 
preferably after shaving or use anti - 
fungal shampoo (like 2% ketoconazole 




Fungal infections of the scalp (tinea capitis) are endemic among schoolchildren in 
tropical Africa and they can cause significant public health problems. The prevalence of 
tinea capitis is higher among schoolchildren in rural schools and schools with a lower 
socioeconomic status.1-5 
Etiology and pathogenesis 
It is an infection of the hair shaft on the scalp, which may be caused by Trichophyton and 
Microsporum species. It is predominantly a disease of prepubertal children and the 
incidence of Microsporum species is higher in boys than in girls. The causative agent of 
tinea capitis varies with geography, socioeconomic status and time.6 
Antropophilic infections like Trichophyton tonsurans, violaceum, sudanense and Microsporum 
audouinii, are most prominent in Africa.
Clinical findings
The clinical appearance can vary from scaling (diffuse scaling with discrete patches of 
hair loss), hair loss, black dots and sometimes pustules, nodules to massive purulent 
secretion (Kerion).
Late detection and lack of treatment can result in widespread infections and, in rare 
cases, permanent alopecia. Because the fungus has grown into the hair follicle, systemic 
treatment is necessary.7;8
Differential diagnosis
•  Seborrheic dermatitis
•  Atopic dermatitis
•  Tinea amiantacea 
•  Psoriasis
•  Alopecia areata 
•  Trichotillomania 
•  CDLE















Scaling and hair loss
Secondary infection
Kerion and possible permanent alopecia
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•  Pityriasis versicolor /  rosea
•  Granuloma annulare
•  Psoriasis
•  Acne vulgaris
•  Leprosy
Management
•  Application of an imidazole cream or Whitfield’s ointment twice daily for 6 weeks.
•  In case of large and multiple lesions oral treatment with griseofulvin or terbinafin is 
preferred during 2-4 weeks. See for the dosages tinea capitis.
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3.  Gupta AK, Ryder JE, Nicol K et al. Superficial fungal infections: an update on pityriasis versicolor, seborrheic 
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4.  Woldeamanuel Y, Leekassa R, Chryssanthou E et al. Clinico-mycological profile of dermatophytosis in a 
reference centre for leprosy and dermatological diseases in Addis Ababa. Mycopathologia 2006; 161: 167-72.
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§	 Infected siblings and friends of affected children should also be treated.
§	 Appropriate adjunctive treatment for household contacts includes daily use of an 
antifungal shampoo. 
§	 In case of a secondary bacterial infection oral antibiotics like cloxacilline or 
erythromycine can be given. For dosages see impetigo.
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Tinea corporis
Epidemiology
Superficial fungal infections (“ringworm”) of the skin are common in sub-Sahara Africa, 
especially on exposed skin surfaces, though tinea corporis is less common than tinea 
capitis and pedis. It is found mostly in rural areas.1;2 
Etiology and pathogenesis
Zoophilic fungal infections like Microsporum canis and Trichophyton verrucosum 
normally present on the exposed surfaces of the body like the face, arms and shoulders. 
On the trunk and the legs antropophilic infections like Trichophyton tonsurans, violaceum, 
sudanense and Microsporum audouinii, which are most prominent in Africa, are more 
frequently found.3;4
Clinical findings
Tinea corporis presents as typical round lesions with central healing, hair loss and 
scaling on the edges.  They can be large and widespread, due to lack of treatment or in 
case of immunosuppression. The clinical and social impact of fungal infections on 
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Pityriasis versicolor
Epidemiology
Pityriasis versicolor is a chronic benign fungal infection frequently seen among young 
adults, more commonly in a tropical environment.1;2
Etiology and pathogenesis
Pityriasis verscicolor is caused by the yeast Malassezia which is  a normal resident of the 
skin and  is usually asymptomatic.3 In favorable circumstances such as a hot and humid 
climate, and / or sweating the infection becomes symptomatic.  
Clinical findings
Clinically it is characterized by well-defined scaly hypo-or hyper pigmented patches 
primarily affecting the upper trunk, neck or upper arms, in areas with active sebaceous 
glands.4 In longstanding disease the patches become confluent and may cover large 
Tinea pedis (Interdigital type)
Epidemiology
Hot, humid climate and a changing, more western lifestyle of wearing closed shoes 
makes tinea pedis an increasing problem among African schoolchildren, especially in 
urban areas. The prevalence rate is still low.1;2
Etiology and pathogenesis
Trichophyton rubrum, mentagrophytes and Epidermophyton floccosum account for most 
cases of tinea pedis. In a tropical environment Hendersonula toruloidea is also frequently 
involved. Interdigital infections are often mixed infections of the above mentioned 
fungi and bacteria (Nocardia minutissima) which can cause erythrasma. Dermatophyte 
infection provides a portal of entry which may lead to bacterial infection with 
Streptococci or S.aureus.3;4 
Clinical findings
Tinea pedis or athlete’s foot causes cracking, maceration and inflammation with itching 
between the toes, most commonly between the 4th and 5th toe.5 
Differential diagnosis 
•  Erythrasma
•  Bacterial infection
•  Eczema (dyshidrotic or contact allergic)
Management
•  Topical treatment is always necessary. 
•  An imidazole containing cream, ciclopirox cream twice daily or terbinafine cream once 
daily for 6 weeks or longer, until a week after the symptoms subside. The web spaces 
between the toes should be kept dry, especially after washing. Also cotton socks 
should be used and changed daily.
•  When the complaints are often recurring, the inderdigital spaces can be treated twice 
weekly with the above mentioned creams as prophylaxis.   
•  Oral antifungals alone are usually ineffective because topical treatment is essential 
and infections are often mixed. 
•  Children should be advised to wear well ventilated shoes.
•  If there is a superimposed bacterial infection, topical antibiotic treatment can be 
applied like Gentian violet paint 0.5%, mupirocin ointment or betadine ointment 
twice daily on the lesions. In severe cases oral antibiotics can be given like cloxacillin 














Typical white macerated lesions of 
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Common warts are caused by a small group of Human Papilloma Virus types. They 
penetrate the skin after skin to skin contact or through contaminated surfaces and 
objects (e.g. at home, public showers, swimming pools). Prevalences of 20% are reported 
among schoolchildren in industrialized countries although the prevalences found in 
most community based studies in sub-Sahara Africa are much lower.1-5 
Etiology and pathogenesis
Papillomavirus infect squamous epithelia of the skin and mucous membranes in most 
vertebrate species. Many types of HPV have been identified and are associated with 
various clinical lesions. HPV types 1, 2 and 4 infect the skin and induce common warts. 
They are found at any age but are most common in teenagers. The extent of lesions is 
determined by the immune status of the host.6 
Clinical findings
The lesions are discrete, round papules and nodules with verrucous surface. They can 
be small papules (1-10mm) or large plaques. Sometimes the lesions become confluent 
and form a mosaic. In the majority of patients with a normal immune system warts will 
disappear spontaneously within several months to years. Treatment is sought for when 
lesions are painful (eg on the soles) or unsightly but is not always necessary. Treatment 
results are unpredictable and often disappointing. Warts may spread fulminantly and 
persist indefinitely.7;8
areas. After treatment hypopigmented macules without scaling may persist but these 
will disappear after sun exposure. 
Differential diagnosis 
•  Vitiligo
•  Pityriasis alba
•  Sarcoidosis
•  Epidermodysplasia verruciformis
•  Verrucae planae (in a HIV+  patient)
Management
•  Avoid the use of vaseline, olive oil and other greasy products.
•  Ketoconazol, miconazol or terbinafin cream twice daily on the lesions for 3 weeks.
•  Apply selenium sulphide shampoo as a lotion on the whole body overnight, wash off in 
the morning and wash the scalp extra.
•  Selenium sulphide shampoo or 
ketoconazole 2% shampoo daily for 7 
days or  twice weekly for 4 weeks. 
The shampoo should be left on the 
skin for at least 15 minutes before 
being rinsed off.
•  Salicylic acid 5% + sulphur 5% ointment 
during the night for 4 weeks.
•  Recurrences can be prevented by once 
monthly preventive treatment with any 
of the above mentioned medications.
•  Because of the risk of hepatotoxicity 
and the high recurrence rate in the 




















Hypopigmented patches with fine 
scaling
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scaling
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Mollusca contagiosa
Epidemiology
Mollusca contagiosa are frequently seen in children under the age of 5 years which can 
be the reason of a low prevalence found among schoolchildren in sub-Sahara Africa.1-3 
They can be localized anywhere on the body but are often seen in areas of warmth, 
moisture and friction such as the armpits and groins. In cooler climates the infection 
seems to be more common at a later age. The use of public swimming pools has been 
correlated with childhood infections.4
Etiology and pathogenesis
It is a common cutaneous infection caused by a pox virus and can affect both children 
and adults. The virus can be transmitted directly from person to person or by autoin-
oculation, the incubation time can vary from weeks to months. In adults it is regarded 
as a sexually transmitted infection and one should consider the possibility of co-existent 
HIV infection. Therapy is not always necessary but may be beneficial in preventing 
transmission or autoinoculation.5-7
Clinical findings 
Pearl-like, dome shaped nodules with a dimple on top can be seen, the diameter varies 
from 5 to 10 mm. If squeezed a white/yellow greasy mass comes out of it. Sometimes a 
single lesion can be seen but normally there are several and sometimes hundreds. Most 
cases are self-limiting within 6-9 months.
Differential diagnosis 
•  Lichen planus
•  Psoriasis
•  Plantar callus (corns)
•  Mollusca contagiosa
•  Verrucous tuberculosis
Management
•  Apply salicylic acid 25% ointment 
daily (possibly under occlusion) and 
cut the warts with a razorblade. 
Repeat this for weeks to months.
•  Apply trichloro or monochloro acetic 
acid.
•  Freeze with liquid nitrogen. Warn  
the patient for post-treatment hypo 
or de pigmentation which is usually 
temporary. (see picture 2).
•  Curettage (after local analgesia with 
Emla cream).













Hyperkeratotic papules and nodules
The differential diagnose with Lichen 
planus is not always easy….
Depigmentation after cryotherapy
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Varicella zoster virus (VZV) has a worldwide distribution, 98% of the adult population is 
seropositive. The first manifestation of a VZV infection is varicella (chickenpox). Varicella 
affects 90% of unvaccinated children under 10 years of age and less than 5 % over 15 
years. Several point prevalence studies in Africa showed low percentages but epidemics 
occur seasonally.1-3 It predisposes to the development of herpes zoster later in life. 
Immunization reduces the incidence of herpes zoster markedly.4-6
Etiology and pathogenesis
Varicella is very contagious and is spread by airborne droplets or direct contact with 
vesicular fluid. After primary infection it moves from cutaneous and mucosal lesions to 
dorsal root ganglion cells. From there it can be reactivated in a later stage.7 
Clinical findings 
Prodromes of primary varicella vary from mild fever to general malaise and are followed 
by multiple pruritic, erythematous papules and vesicles which become pustules and 
hemorrhagic crusts. From the scalp and face they spread to the trunk and extremities. 
Any numbers of vesicles varying from a few to several hundreds are seen in all stages of 
development at the same time. Itch is the major complaint and scratching may lead to 
secondary infection. The disease is normally self- limiting and lesions heal in 7 to 10 
days. Common complications are secondary infection with scarring and pneumonia.
In immunocompromised patients varicella can lead to severe morbidity and even death 
(see picture 3).8 
Differential diagnosis 
•  Disseminated herpes simplex infection
•  Disseminated herpes zoster infection
•  Hand, foot and mouth disease
•  Insect bites and scabies
•  Bullous impetigo
•  Pityriasis lichenoides et varioliformis acuta (PLEVA)
Management
•  Calamine lotion or phenol-zinc lotion as necessary for itch and drying in.
•  Sedating oral antihistamines like piriton and phenergan. For the dosages see urticaria.
•  Limited secondary infection: use betadine scrub, apply betadine ointment, fucidin 
cream or ointment, mupirocin ointment, sulphur 5% in zinc oxide cream or gentian 
violet paint 0.5% 2 times daily. 
•  Severe or widespread bacterial secondary infections can be treated with systemic 
antibiotics like cloxacillin or erythromycin. For the dosages see impetigo.
Differential diagnosis 








•  Most treatment options are 
mechanical, sometimes causing 
discomfort but in the majority of 
cases therapy is not necessary and 
natural resolution can be awaited.
•  Curettage with a sharp curette after 
applying 1% iodide tincture. Local 
anesthesia can be accomplished 
after application of Emla cream 
during 30 minutes.
•  Cryotherapy with liquid nitrogen to 
be repeated every 3 weeks.
•  Prick the center with a toothpick and press out the contents.
•  Apply 50-88% trichloro acidic acid.
•  Apply retinoid cream / tincture 0.05-0.1% 2 times daily.
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*Valaciclovir: The dosage which is recommended  in pediatric patients who are at least 
2 years old  to less than 18 years  is 20 mg/kg administered 3 times daily for 5 days. The 
total dose should not exceed 1 gram 3 times daily. 
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Herpes zoster
Epidemiology
Varicella Zoster Virus (VZV) can produce two different clinical manifestations, varicella 
(chickenpox) and herpes zoster (shingles). The point-prevalence of both skin diseases 
found among schoolchildren in sub-Sahara Africa was low,1;2  most probably because 
affected children tend to stay at home. Chickenpox is primarily a disease of children and 
shingles a disease of adults but they may both occur at any age. VZV is distributed 
worldwide and 98 % of the adult population is seropositive. These figures become 
lower after vaccination campaigns.3;4
Each person with a history of varicella has approximately 20% chance of acquiring 
shingles in his/her lifetime. These figures are much higher in those infected with HIV.5-7 
Etiology and pathogenesis
During the course of a primary varicella infection the VZV spreads from the skin and 
mucosal lesions into the sensory nerve endings. Reactivation of the VZV may occur 
spontaneously or may be triggered by fever, trauma, stress or immunosuppression. It 
can spontaneously lead to a clinical herpes zoster which is usually more severe in young 
children than in adults. Herpes zoster is more severe in the immune suppressed. 6;7
•  Immunization has 80% effectivity. Recommended for HIV+ children or children on 
HAART.9
•  In immunocompetent children oral medication with aciclovir is only indicated in 
severe infections.
•  Immunocompromised children should be referred to a specialist.
*Aciclovir  
§	 Child under 2 years: 200 mg 5 times 
daily for 5 days. Oral suspension (Syrup 
40mg/mL or 80mg/mL) 5 ml (40mg/
ml) 5 times daily for 5 days.
§	 Children between 2-5 years: 400mg 
5 times daily for 5 days. Oral 
suspension (Syrup 40mg/mL or 
80mg/mL) 5 ml (80mg/ml) 5 times 
daily for 5 days or tablets 400 mg 5 
times daily for 5 days.
§	 Children above 6 years of age 800 
mg 5 times daily for 5 days. Tablets 














Widespread lesions on the back. The 
different stages of lesions, arising over  
7 to 10 days, is typical of varicella.
This HIV positive boy died two days later 
due to a generalized infection.
Multiple, pruritic, papules, vesicles and 
pustules on the face  of a young female. 
The different stages of lesions, arising 
over 7 to 10 days, is typical of varicella.
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Clinical findings
Herpes zoster can be preceded by a severe itchy, burning pain sensation in the involved 
dermatome.  This prodrome may also consist of fever, headache and general malaise. 
The rash which develops within a sensory dermatome starts with erythematous 
macules and papules which later progresses to vesicles, pustules and crusts. There may 
be secondary bacterial infection. Especially in Africans the infection can lead to the 
formation of keloids but this is uncommon among immunocompetent children. Herpes 
zoster can be complicated by post herpetic neuralgia (rare among children). Herpes 
zoster of the ophthalmic branch of the facial nerve may be complicated by keratocon-
junctivitis and lead to blindness, therefore ophthalmologic care should be sought.5;6;8
Differential diagnosis 
•  Insect bites
•  Papular urticaria
•  Herpes simplex (especially in the genital area)
•  Contact dermatitis
•  Localized bacterial or viral infections
Management
 In a healthy child usually analgesics and local therapy are sufficient.
•  Calamine or phenol-zinc lotion for vesicular stage.Gentian violet paint 0.5% may be 
used as well.
•  Use betadine scrub/shampoo as a soap to prevent secondary infection. Do not use vaseline.
•  In case of a secondary infection oral antibiotics like cloxacillin or erythromycin can be 
given. For the dosages see impetigo.
•  Refer to the eye specialist when the eye is involved.
•  In immunocompetent children oral medication is only indicated in severe infections.
•  Immunocompromised children can better be referred for treatment with aciclovir 
or valaciclovir.
*Aciclovir  
§	Child under 2 years: 200 mg 5 times daily for 5 days. Oral suspension (Syrup 40mg/mL 
or 80mg/mL) 5 ml (40mg/ml) 5 times daily for 5 days.
§	Children between 2-5 years: 400mg 5 times daily for 5 days. Oral suspension (Syrup 
40mg/mL or 80mg/mL) 5 ml (80mg/ml) 5 times daily for 5 days or tablets 400 mg 5 
times daily for 5 days.
§	Children above 6 years of age 800 mg 5 times daily for 5 days. Tablets 400mg 2 tablets 
5 times daily for 5 days.
§	*Valaciclovir: The dosage which is recommended  in pediatric patients who are at 
least 2 years old  to less than 18 years is 20 mg/kg administered 3 times daily for 













Herpes zoster of the shoulder
Multiple vesicles and open lesions on a 
leg of a 3 year old boy
Multiple vesicles following a dermatome
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Management 7
 In case of a primary infection analgesics are indicated.
•  In recurrent infections: A lip cream / stick with a sun blocker daily to prevent recurrences.
•  In immunocompetent persons oral medication with aciclovir is only indicated in severe 
primary infections or very frequent recurrences. For dosages see varicella/chicken pox. 
•  In the immunesuppressed oral (val)aciclovir is recommended. 
•  Warn for meningitis.
*Aciclovir  (British National Formulary)
§	Child under 2 years: 200 mg 5 times daily for 5 days. Oral suspension (Syrup 40mg/
mL or 80mg/mL) 5 ml (40mg/ml)  or 2.5 ml (80mg/mL) 5 times daily for 5 days.
§	Child over 2 years adult dose: 400mg 5 times daily for 5 days.  
Oral suspension (Syrup 40mg/mL or 80mg/mL) 10 ml (40mg/ml) or 5ml (80mg/mL) 
5 times daily or tablets ( 200mg) 5 times daily for 5 days.
*Valaciclovir: The dosage which is recommended  in pediatric patients who are at least 
2 years old  to less than 18 years  is 20 mg/kg administered 3 times daily for 5 days. The 
total dose should not exceed 1 gram 3 times daily. 
6.  McCrary ML, Severson J, Tyring SK. Varicella zoster virus. J Am Acad Dermatol 1999; 41: 1-14.
7.  Naburi AE, Leppard B. Herpes zoster and HIV infection in Tanzania. Int J STD AIDS 2000; 11: 254-6.




Herpes simplex infections commonly take place in early childhood and are often 
asymptomatic. The clinical prevalence among schoolchildren is low. More than 60% of 
infected children remain carriers of the virus. Percentages of 90% antibodies against 
herpes simplex virus 1 (HSV1) have been found among young adults worldwide. The 
percentage of antibodies against HSV2 is much lower before adolescence as it is usually 
sexually transmitted. Minor epidemics of HSV1 may occur among schoolchildren or in 
nurseries.1;2
Etiology and pathogenesis
HSV1 is usually transmitted by direct contact with saliva. After an often asymptomatic 
infection viral elements persist as a latent infection for life. Reactivation occurs during 
periods of immunosuppression like fever, stress, exposure to UV light, HIV infection, menstrual 
period or infectious diseases like malaria.3 Recurrent herpes simplex is common and 
may be the result of an endogenous reactivation or an exogenous reinfection.1;4 
Clinical findings
Most infections are asymptomatic. Symptomatic primary infections in children often 
present as a gingivostomatitis together with an increased salivation and difficulty in 
eating. On the lips multiple painful, burning vesicles appear and develop into pustules 
and ulcerations. In recurrent infections the clinical picture is usually much milder.1 
In HIV positive children the symptoms are more severe and the attack rates are higher 
but this improves after initiation of HAART.5;6
In cases of genital herpes in young children sexual abuse should be considered.
Differential diagnosis 
•  Angina
•  Aphthous stomatitis
•  Oral candidiasis













Secundary infected Herpes simplex lesion 
in a HIV+ child 
Herpes simplex infection of index finger 
in a small child
Herpes simplex with secondary 
 impetigenisation in a caucasian boy
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Clinical findings 
One week to three months after an infected bite or bites solitary or multiple lesions 
appear. A red or skincoloured papule develops into a non-healing plaque or nodule 
which often shows central ulceration with a well demarcated with a violaceous border. 
It is usually painless unless superinfected. Regional lymphatic tissue can be involved, 
leading to a lymphadenitis. Untreated it usually leaves an ugly atrophic scar. Continuous 
ulceration and diffuse cutaneous infection may occur.
Differential diagnosis 
•  Leprosy
•  Impetigo / ecthyma
•  Insectbite
•  Cutaneous tuberculosis
•  Atypical mycobacterial infections
•  Syphilis
Management 4  
•  The choice of treatment depends on the type of leishmania and the number of lesions.
•  Preventive measures like protective clothing and avoidance of bites.
•  When there are single or limited number of localized lesions cryotherapy, electroco-
agulation and surgery are treatment options.
•  Single or limited number of lesions Pentostam or sodium stibogluconate (SSG):  6 to 
10 times once or twice weekly intralesional injections (inject 0.5 to 1.5 ml of 100 mg/ml). 
•  Glucantine or Pentostam 20 mg/kg/day for 20-30 days i.v or i.m. 
•  Pentamidine  4mg/kg/weekly i.m. as long as necessary in cases of diffuse cutaneous 
leishmaniasis by L. aethiopica.
•  Miltefosine, for children from 3 years 
and older: 1.5-2.5 mg/kg/daily orally 
for 28 days.
•  Itra-, keto-, fluconazole depending 
on species.
•  Amphotericine B  (Amphotericin B 
and liposomal Amphotericin B are 
especially effective in visceral 
leishmaniasis and PKDL and should 
be administered in a specialized 
centre).
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Leishmaniasis in its various forms is present on all continents except Australia and 
Antartica.1 It is a widespread disease with 350 million people at risk. There are around 2 
million new cases a year of which 500,000 cause visceral and 1,500000 cause (muco) 
cutaneous disease.2;3 The epidemiology and age range affected depend on the charac-
terististics of the parasite species and exposure history. In areas with high transmission 
rates the adult population will generally have acquired immunity and more children will 
be affected.4 Most CL cases occur in the Middle East and in South and Central America 
but it is also endemic around the Mediterranean basin and in South Sudan, Kenya and 
especially Northern Ethiopia.5;6 
Etiology and pathogenesis
The leishmaniases are a complex of diseases caused by the intracellular protozoaLeish-
mania. Disease transmission occurs through the bite of an infected sandfly. CL in Africa 
is mainly caused by Leishmania major. There are smaller foci of L. tropica, L. infantum and 
L. Aethiopica.
CL usually affects the exposed skin, of the face, neck and arms. Poorly functioning health 



















Typical lesion on the cheek of a young 
east African boy
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Management
•  Treat all individuals living in same household at the same time.
•  Wash sheets and clothes or hang them outdoors for at least 24 hours.
•  Sulphur ointment 5-10% to apply twice daily for at least one week. 
•  Benzyl benzoate emulsion (10 to 25%) is applied over the entire body and left on the skin 
for up to 24 hours before washing off. Treat during 3 nights and repeat after one week.
•  Epidemics in institutions like prisons and boarding schools may be treated with 
Ivermectin on day 1 and day 10 . Not suitable for children below 5 years of age. See for 
the dosages cutaneous larva migrans.
•  In case of secondary infection oral antibiotics like cloxacillin or erythromycin can be 
given. For the dosages see impetigo.
•  For severe itchiness sedating oral antihistamines like Piriton or promethazine can be 
used. For the dosages see urticaria.
•  After treatment complaints of itch may persist for weeks. This can be treated with mild 
topical steroids like hydrocortisone cream or ointment two times daily.
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Scabies
Epidemiology
Scabies is a common ectoparasitic infestation caused by Sarcoptes scabiei, a human- 
specific mite that is highly prevalent in some areas of the developing world, though the 
prevalence of infection in communities may be cyclical.1-3
Etiology and pathogenesis
It is mostly spread by close personal contact but can also be spread by clothing, sheets 
and towels. Secondary bacterial infection of scabies is common and might increase the 
risk for glomerulonephritis.4;5 
Clinical findings
Typical sites of involvement are the interdigital spaces of the hands, the flexural parts of 
the wrists, the armpits, the feet and the genitals. One of the clinical signs, though not 
always present in warm climates, is the burrow (S- shaped ridge) caused by the 
excavation of the female mite for her eggs. Small erythematous papules can be present 
together with excoriations. Itching, especially at night, is the main complaint which 
often results in scratch marks and secondary infection.6-8
Differential diagnosis 
•  Eczema
•  Contact dermatitis
•  Pyoderma
•  Bullous pemphigoid
•  Insect bites















Interdigital papules Papules, pustules and scratchmarks
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Ivermectin 
§	Preferably not for children below 5 years of age.
§	Dosage depends on bodyweight and is usually given in a single dose. 
§	Child between 15-25 kg: 1 tablet of 3 mg ; Child between 25-35 kg: 2 tablets of 3 mg; 
Child between 35-50 kg: 3 tablets of 3 mg; Child between 50-65 kg 4 tablets of 3 mg; 
Child above 65 kg: adult dose 5 tablets of 3 mg
*Albendazole
§	Children below 2 years of age: 200 mg once or twice daily for 1 to 3 days. Oral suspension 
(40 mg/mL) 5 ml syrup once or twice daily for 1 to 3 days. Children of 2 years and above: 
400 mg once or twice daily for 1 to 3 days. Oral suspension (40mg/mL), 10 ml syrup 
once or twice daily for 1 to 3 days or tablets (200mg), 2 tablets once or twice daily for 1 
to 3 days.
•  Secundary infection can be treated with betadine scrub, potassium permanganate 
solution or Gentian violet paint.
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Skin infections
Cutaneous larva migrans/creeping eruption 
Epidemiology
Cutaneous larva migrans (CLM) is endemic in resource-poor communities in the developing 
world and occurs sporadically in high-income countries, where it is commonly seen as 
an imported skin disease in travelers1-4
Etiology and pathogenesis
Cutaneous larva migrans (CLM) in humans is usually caused by the penetration of cat or 
dog hookworm larvae into human skin. The presence of animal reservoirs like cats and 
dogs ensures ongoing transmission. Anyone walking barefoot or sitting on a contaminated 
beach is at risk. Transmission occurs when skin is in direct contact with soil, contaminated 
by dog or cat faeces and/or urine or indirect via towel and underware. Humans become 
a dead-end host because the migrating parasite cannot penetrate into the dermis and 
eventually dies in the epidermis. Its cutaneous manifestations usually resolve within weeks 
or months. 2;5
Clinical findings
The lesions are characteristically urticarial, raised and vesicular. The diagnosis is made 
clinically in the presence of a linear serpiginous track moving forward in the skin at a 
speed of 1 to 5 cm per day. The lesions can be intensely pruritic and bacterial super 
infection often occurs as a result of scratching. Most lesions are located on the trunk, 
legs, and feet.6;7
Differential diagnosis 
•  Larva currens (Strongyloides stercoralis infection)
•  Folliculitis
•  Scabies and other ectoparasites
•  Insect bites
•  Urticaria
Management
•  Cryotherapy with liquid nitrogen may be tried for limited lesions. Treat the skin at 1 cm 
ahead of the visible trail; this is where the larva is found.
















Cutaneous larva migrans on the leg of a 
Kenian toddler 
Cutaneous larva migrans detail
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Onchocerciasis
Epidemiology 
Onchocerciasis is a chronic  tropical parasitic disease, caused by the nematode 
Onchocerca volvulus, most widely known for causing “river blindness” and severe 
dermatological problems.1 It is found in 28 African countries with  the highest 
prevalences in sub-Saharan West African nations like Ghana, Nigeria, Liberia and Mali.2
Around 17 million people are affected worldwide.3  In Africa, where the the burden of 
onchocerciasis is greatest, years of treatment and eradication programmes have led to 
a dramatic decrease of transmission.4;5 
Etiology and pathogenesis
The vector of Onchocerca volvulus is the Simulium or black fly which lives close to fast 
moving, oxygen rich water. After infection it takes 12 to 18 months before the first 
Lymphatic Filariasis
Epidemiology
Lymphoedema in the tropics can have several causes, but is usually caused by inflammation 
and consequently adenitis due to bacteria, fungi or minerals. Secondary lymphoedema 
due to filariasis has a high prevalence and is considered by many the most prevalent 
cause. In Africa Wuchereria bancrofti, a parasitic worm infection transmitted by mosquitoes, 
is responsible for the majority of cases of lymphatic filariasis. Out of the 120 million infected 
patients worldwide 40 million develop clinical symptoms.1-3
Etiology and pathogenesis 
Lymphatic filariasis is a helminth disease that causes chronic and long-term infection 
with host inflammation due to the antigenic determinants of the parasite. Adult worms 
are present in the lymphatics and the resulting inflammatory response can cause 
obstruction. This obstruction is often acquired in childhood and leads to acute attacks 
of dermato-lymphangio-adenitis and elephantiasis, lymphoedema of limbs and 
genitals. Like in other filarial infections the symbiosis with the Wolbachia bacteria is 
likely to be essential for the multiplication and development of the parasite.2;4 
Clinical findings
After an incubation period of 5 to 15 months the presence of adult worms can lead to 
lymphangitis and lymphadenitis with localized pain and pitting oedema starting in the 
upper legs. These attacks can become chronic and cause lymphatic vessel dysfunction 
and damage.2;4-6
Differential diagnosis
•  Kaposi sarcoma
•  Lymphoedema caused by bacterial or fungal lymphangitis.
•  Lymphoedema caused by podoconiosis (silicates in red volcanic soil which enter 
  the soles and block the lymphnodes after an inflammatory reaction).6
Management 
•  Prevent secondary infections.
•  Lymph massage, elastic compression bandages and or stockings.
•  (Breathing) exercise. 7
•  Ivermectin plus albendazol in a single dose. To be repeated yearly during 5 years.2;8;9 
For the dosages see cutaneous larva migrans.
•  Together with the ivermectin and albendazol treatment, a 6-week course of doxycycline 
(100–200 mg per day) has been recommended (not in young children). This treatment 















A late consequence of filariasis
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•  Together with the ivermectin treatment a 6-week course of doxycycline (100–200 mg 
per day) given to eliminate the Wolbachia bacteria. Because of the deposition of 
tetracyclines in growing bone and teeth it should not be given to children under 12 
years or to pregnant or breast-feeding women. 2 
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Eczema is widespread in the industrialized world and a growing clinical problem in sub- 
Sahara Africa.1;2 In West Africa, the prevalence of eczema was considered to be < 5% 
although recent studies in West Africa and other parts of Africa have shown an increase, 
particularly amongst infants.3;4 However, recent point-prevalence rates among 
schoolchildren in West and Central Africa, derived after physical examination by a 
dermatologist, were considerably lower.5
Etiology and pathogenesis
Atopic dermatitis or eczema is a chronic relapsing, pruritic inflammatory skin disorder. 
Although termed atopic, up to 60% of the children with the clinical phenotype do not 
clinical signs present. The female larvae develop to adulthood and form fibrous capsules, 
the so called onchocercomata. During adulthood, the female worm sheds hundreds of 
thousands of microfilaria which migrate through the skin of the human host and cause 
severe itch, and, after repeated infections, in some regions blindness. Like in other filarial 
infections symbiosis with the Wolbachia bacteria is essential for multiplication and 
development of the parasite. A biopsy or skin snip test may show microfilaria.
Clinical findings
The most common skin problem in the first stage is troublesome itching with some 
erythematous hyper pigmented papules and patchy lichenification. In the chronic 
stage there can be pruritic generalized lichenification and depigmentation (“Leopard 
skin”) later on. Sub dermal nodules (“onchocercomata,”) are mostly seen over bony 
prominences like the hips but can be present anywhere. The loss of elasticity may cause 
so-calles hanging groins and lymph edema.7;8
Differential diagnosis
•  Food allergy




•  The standard treatment is ivermectin orally every 6 to 12 months). For the dosages see 
cutaneous larva migrans. Single-dose ivermectin effectively kills microfilariae but has 
little effect on adult worms; therefore, it controls but does not cure the disease. 
•  A patient staying in an endemic area needs treatment every 3 to 12 months, not only 
















Itch and lichenification “Leopard” skin
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because of the risk of atrophy and bleaching. The use of potent corticosteroids should 
be avoided for use on the face or intertriginous sites like the groin or armpits.
•  If available topical calcineurin inhibitors (TCI) like tacrolimus (0.03% and 0.1% ointment) 
or pimecrolimus (1% cream) can be used as maintenance treatment. The TCI don’t 
cause skin atrophy. They may however cause a burning sensation upon application 
especially in the beginning of the treatment. 
•  In case of secondary infection oral antibiotics like cloxacillin or erythromycin can be 
given. For the dosages see impetigo.
•  For severe itchiness sedating oral antihistamines like Piriton or promethazine can be 
used. For the dosages see urticaria.
•  In more severe cases, when phototherapy or systemic therapy might be needed, 
patients should be sent to a referral / university hospital.  
have demonstrable IgE-mediated sensitivity to allergens. Therefore it is preferable to 
use the term ‘eczema’.6;7 
Eczema is a multifactorial skin disease. Some risk factors for eczema are; genetic pre-
disposition (like asthma and hay fever which may run in the family), emotional stress and 
change in lifestyle (such as changes in food patterns, contact with irritants or frequent 
washing).8-11 Mutations in the filaggrin gene (FLG) are a major predisposing factor for 
ichthyosis vulgaris and eczema in individuals of European and Asian descent. These 
genetic findings provide an important support for the well known impairment of the
epidermal barrier observed in eczema and could also deliver further clues to the natural 
history of the disease. Recent research indicates that FLG loss-of-function variants are 
less common in Africa.12
Clinical findings 
Clinically eczema in the acute stage is characterized by itching, redness, oozing, crusts 
and often secondary infection with Staphylococcus aureus. The chronic stage is 
characterized by lichenification, excoriations and a very dry skin. Especially elbow-and 
knee folds, wrists, ankles, face and neck are affected.13;14
Three distinct clinical phases of eczema can be observed according to the age. In the 
infantile phase the eruption characteristically starts on the cheeks and scalp but the 
whole body can be affected. In the childhood phase especially the flexural areas of the 
knee and elbows are affected but also the wrists, ankles and buttocks can be involved. 
In the adult phase especially the neck and face are affected with a more diffuse scaling 
and erythema.Xerosis and lichenification are important characteristics.
Differential diagnosis
•  Seborrheic dermatitis




•  HIV related dermatoses
Management
•  Explain the multifactorial and chronic character of the disease to the patients, parents 
and / or care takers.
•  The use of soap and the frequency of washing should be reduced. Cotton clothing is 
preferred to wool or synthetics. Children should not be dressed too warm.
•  Moisturize the skin regularly with an emollient cream or ointment like aqueous cream, 
coco butter or shea butter.
•  In severe cases a potent steroid ointment like betamethasone can be applied once daily 
















Eczema: elbow and knee folds, typical localizations
Eczema: detail: lichenification, hyper-
pigmentation and scratch marks
Eczema: secondary infection
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suggested. Recently some studies described a relationship between the development 
of acne and Body Mass Index.4;8;9 The use of oil, bleaching and cosmetic creams is 
another important factor. 
Clinical findings
The sites most affected are the face, back, chest and shoulders. Non inflammatory acne 
may consist of open comedos (blackheads) or closed comedos (whiteheads). In 
inflammatory acne the comedos expand to form erythematous papules, pustules, 
nodules or cysts. Pomade acne is very frequently seen in Africa due to the use of 
petrolatum or petroleum jelly (e.g. Vaseline as brand name). The nodulocystic form of 
acne can lead to severe scarring.
Differential diagnosis 
•  Folliculitis due to yeasts (Pityrosporum) or bacteria
•  Perioral dermatitis
•  Milia
Management
•  Stop the use of oily cosmetics or petrolatum on the skin and hair.
•  Apply benzoyl peroxide 5-10% preparations at night (because of its photosensitive 
effect) and warn the patient that it can bleach the pillows and pyjamas. Benzoyl 
peroxide preparations are available in creams, gels, lotions and washes.
•  Apply topical retinoids at night (because of their photosensitive effect).Options are 
tretinoin (0.05% -0.1% solution or 0.02%-0.05% cream), adapalene and tazarotene (0.1% 
gel). Start at low concentrations to prevent irritation and hyperpigmentation.10 Greater 
tolerability can be achieved by applying it the first two weeks of treatment on 
alternate nights. 
•  Apply topical clindamycin 1% lotion or erythromycin 2% lotion or gel in the morning.
•  In case of moderate/ severe acne, use oral tetracyclines like tetracycline 250 mg twice 
or four times daily, doxycycline 100 mg once daily or erythromycin 4 times daily 250 
mg and after one month 2 times daily 250 mg. The treatment has to be continued for 
several months and repeated when the acne comes back. Oral tetracyclines should 
not be given to young children.
•  In case of moderate acne in women oral contraceptives may be given like Diane- 35 
(cyproteronacetaat). 
•  Postinflammatory hyperpigmentation commonly occurs in a dark skin. Acne treatment 
should be started  in an early phase in order to prevent this occurring.
•  In case of severe acne or nodulocystic acne oral isotretinoin may be considered. The 
patient should be referred to a dermatologist for this treatment because of its 
potentially severe side effects among which teratogenicity.
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Acne vulgaris
Epidemiology
Acne vulgaris is common in children and adolescents from age 10 and commonly 
persists up to age 25. In industrialized countries it affects between 30% and 100% of the 
adolescent population.1-3 The prevalence of acne is considerably lower in developing 
countries though Westernization in urban areas in developing countries has been 
shown to lead to higher prevalence.4-7 
Etiology and pathogenesis
Several factors play an important role in the etiology of acne: follicular epidermal hyper 
proliferation, excess of sebum production, activity of Propionibacterium acnes and 
inflammation. Androgenic hormones stimulate the hyperproliferation of the follicular 
keratinocytes and lead to an increased sebum production which is followed by the 
formation of comedones. Especially P. acnes is an important factor in the process of 




















Psoriasis is a common skin disease in children although the prevalence is much lower 
than in adults. The total rate of psoriasis in children younger than 18 years found in 
Germany was 0.71% while this was 1.4% in Great Britain.1;2 In the Netherlands and the US 
even lower figures were found and juvenile psoriasis seemed to be less common in the 
US among African Americans than among Hispanics and Caucasians.3-5 The prevalence 
among girls is normally higher than in boys. Hospital based studies from Africa show 
prevalences of 1.5% in Egypt, 0.9% in Nigeria, 0.05% in Mali and 3.5% in Kenya.6-9 
Population based studies among schoolchildren in West and Eastern Africa showed 
very low prevalences.10
Etiology and pathogenesis
Psoriasis is characterized by the proliferation of keratinocytes and inflammatory cell 
infiltration of the dermis and epidermis. This reaction is caused by dermal infiltration of 
T lymphocytes and macrophages and leads to a fast turnover and hyperplasia of the 
epidermis. This results in a chronic inflammatory condition affecting the skin, nails, and 
joints.11 Patients are genetically predisposed to psoriasis. Psoriasis in adults is associated 
with comorbidities such as obesity, hyperlipidemia, diabetes mellitus (metabolic 
syndrome), rheumatoid arthritis and Crohn’s disease.12 Physical trauma may trigger 
psoriatic lesions at sites of injury (Koebner’s phenomenon).4;11 Other triggers are 
antimalarials, lithium, beta blockers, stress, infections such as streptococcal angina and 
a cooler climate.
Clinical findings
The plaque type; this is the most frequently observed variant of psoriasis. It is 
characterized by sharply demarcated erythematous plaques covered by silvery white 
scales which shows the typical candle wax phenomenon after scratching. Lesions 
commonly appear on the elbows, knees, scalp, umbilicus, and lumbar area. The scalp is 
the most frequently affected site of involvement in pediatric psoriasis. Facial and 
intertriginous lesions may be difficult to differentiate from seborrheic eczema if there 
are no other typical psoriasis lesions. 
Guttate psoriasis; is more frequently seen in children and consists of numerous papules 
and plaques (like “drops”) all over the body. Guttate psoriasis is often preceded by a 
streptococcal throat infection.11;13 The prognosis is good, with spontaneous remissions 
in weeks to months.
The inverse type of psoriasis; in this type of psoriasis the lesions appear as sharply 
defined erythematous plaques which show no or minimal scaling in intertriginous areas 
like the groin and armpits. 
Erythrodermic psoriasis; nearly the whole body surface can be involved but this is rare 
in children. 
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severe arthropathic psoriasis. These cases are  rare and need to be referred to an 
university hospital or specialized centre.
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Nail involvement (especially the fingernails) is uncommon in children with psoriasis. If it 
occurs nail-pitting is the common manifestation. Onycholysis and the “oil drop” sign are 
rare.13  
Psoriatic arthritis; is an extracutaneous manifestation which is rare among children in 
Africa. A recent African review suggested an association between psoriatic arthritis and 
HIV infection.9
Differential diagnosis 
•  Tinea capitis and corporis
•  Seborrheic dermatitis
•  Eczema
•  Lichen planus
•  Pityriasis rosea / secondary syphilis (d.d. psoriasis guttata)
Management
•  Discuss the chronic character (“come and go”) of the disease with the patients and the 
parents / caretakers. Explain that psoriasis is not contagious but can be triggered by 
an infection. Natural sunlight has a beneficial effect. 
•  Approximately 70 to 80 percent of all patients with psoriasis can be treated adequately 
with use of topical therapy!
•  Salicylic acid 5-10% in an oil, lotion, cream or ointment base 2 times daily to reduce the 
scaling.
•  A moderate to strong topical steroid like betamethason ointment can be applied daily 
on the lesions. Cannot be used continuously for a long time because of side effects like 
atrophy and bleaching. Can be used in combination with salicylic acid 2-10% ointment.
•  Coal tar 5-10% ointment or sulphur 5% in coal tar 5-10% at night.
•  Vitamin D3 analogue like calcipotriol 2 times daily on the lesions, especially with 
plaque psoriasis. Can be used in combination with corticosteroids.
•  Anthralin 0.1-1% cream or ointment. Especially for plaque psoriasis. Has to be wiped or 
washed off after 10-60 minutes. Not always suitable for children because of the 
irritative reaction.
•  Find the possible bacterial sources of streptococcal infection (pharyngeal and perianal) 
and treat with antibiotics like erythromycin, penicillin or cephalosporines. For dosages 
see impetigo and ecthyma.
•  If possible refer the patient to a dermatologist for phototherapy in the case of guttate 
psoriasis (UVB is the preferred form of phototherapy for pre-adolescent pediatric 
psoriasis).
•  Systemic therapy with Methotrexate, Ciclosporin, Retinoids and Biologicals  may be used 
for severe cases of chronic plaque psoriasis, guttate psoriasis in children who are 
















Multiple hyperkeratotic plaques on the 
trunk and arms
Multiple hyperkeratotic, well 
circumscribed plaques on both knees
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•  Topical calcineurin inhibitors like 0.1% tacrolimus ointment may be useful for facial 
lesions; it is too greasy for the armpits and groins.
•  In severe and widespread lesions oral ketoconazole can be used. Usually it is given 
only to children above 2 years of age. The dosage in a child is 3 mg/kg daily for 2 
weeks from 15 kg body weight onwards.
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Seborrheic dermatitis
Epidemiology
Seborrheic dermatitis is one of the most frequent skin disorders, especially the infantile 
form which affects as many as 70% of the newborns but disappears by the age of 1 
year.1;2 The prevalence in immunocompetent adults is between 1% and 3%, and is more 
common in men than in women. The prevalence is low in children over one and under 
12 years of age3;4  However  in children of all ages, as in adults, it is frequently seen in 
combination with a HIV infection.5
Etiology and pathogenesis
The cause of seborrheic dermatitis is not completely understood. It occurs most often 
during periods of active sebum production (e.g., the neonatal period) and in areas of 
the skin where sebum is produced. There is no clear genetic predisposition but climate, 
stress and immunologic factors play an important role.2;6 
Malassezia yeasts  may play a role in the pathogenesis of seborrheic dermatitis since 
they are present on affected skin, and antifungal agents are useful in the treatment.7 
Especially in HIV-infection they appear to play a role. 
Clinical findings
Seborrheic dermatitis is characterized by scaling and poorly demarcated erythematous 
patches that vary from pink yellow to red brown in color. In the African skin they are 
often hypopigmented. There is a predilection for places which are rich in sebaceous 
glands like the scalp, the nasolabial folds, glabella and the hairline, the sternum, the 
armpits and the groins.2;6;8 The morphologic characteristics depend on the area of the 
skin involved. In healthy people the face and scalp are commonly affected, in the 
HIV-infected, armpits and groins also show lesions and they easily become superinfected. 
The lesions cause normally mild itching. Seborrheic dermatitis can give reason to social 
problems, especially with severe / moderate scaling of the scalp.9;10 
Differential diagnosis
•  Psoriasis
•  Atopic dermatitis
•  Tinea capitis
Management 2;11
•  In infantile seborrheic dermatitis the application of an emollient cream can be useful. 
•  Sulphur 3-5% cream to apply 2 times daily.
•  Ketoconazole 2% cream or cicloporox 0.77% cream to apply 2 times daily. 
•  Ketoconazole or cicloporox shampoo. Low potency topical corticosteroids like 
















Boy 7 years old, HIV+  Seborrheic dermatitis of the scalp and the groin
Girl 6 years old, the differential diagnose 
with psoriasis capitis can be difficult. 
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Differential diagnosis
•  Lupus erythematosus
•  Lichen sclerosus and striatus
•  Pityriasis rosea
•  Secondary syphilis
Management 5;7;8
•  Parents and patients should be reassured that lichen planus is a benign non- infectious, 
self limiting disease.
•  Moderate to strong topical corticosteroids like betamethasone 2 times daily, preferably 
combined with salicylic acid 5 % are the treatment of choice.
•  Topical calcineurin inhibitors like tacrolimus 0.1% 2 times daily.
•  In severe cases oral corticosteroids can be given (0.5-1 mg/kg daily) as a tapering dose 
over a 2-6 week period. Long term maintenance therapy with systemic corticosteroids 
should be avoided.
•  Dapson 1mg/kg daily has been reported to be very helpful in severe cases.9 
•  Severe cases, unresponsive to treatment, should be referred to a dermatologist for 
phototherapy, intralesional therapy with triamcinolone 5-10 mg/ml, or systemic 
therapy with methotrexate or cyclosporine.
4.  Komba EV, Mgonda YM. The spectrum of dermatological disorders among primary school children in Dar 
es Salaam. BMC Public Health 2010; 10: 765.
5.  Mahe A, Simon F, Coulibaly S et al. Predictive value of seborrheic dermatitis and other common dermatoses 
for HIV infection in Bamako, Mali. J Am Acad Dermatol 1996; 34: 1084-6.
6.  Gupta AK, Bluhm R, Cooper EA et al. Seborrheic dermatitis. Dermatol Clin 2003; 21: 401-12.
7.  Faergemann J, Jones JC, Hettler O et al. Pityrosporum ovale (Malassezia furfur) as the causative agent of 
seborrhoeic dermatitis: new treatment options. Br J Dermatol 1996; 134 Suppl 46: 12-5.
8.  Gupta AK, Ryder JE, Nicol K et al. Superficial fungal infections: an update on pityriasis versicolor, seborrheic 
dermatitis, tinea capitis, and onychomycosis. Clin Dermatol 2003; 21: 417-25.
9.  Hay RJ, Graham-Brown RA. Dandruff and seborrhoeic dermatitis: causes and management. Clin Exp 
Dermatol 1997; 22: 3-6.
10.  Shuster S. The aetiology of dandruff and the mode of action of therapeutic agents. Br J Dermatol 1984; 111: 
235-42.





Lichen planus is frequently encountered in hospital based studies in sub-Sahara Africa.1;2 
In childhood it is unusual and pediatric patients comprise only 2% to 3% of all those 
affected.3;4 There is no consistent gender predilection for childhood. In the USA it has 
been reported to be more prevalent among African American children.5
Etiology and pathogenesis
Lichen planus is an inflammatory dermatosis of unknown origin. Several reports have 
shown an association between lichen planus and liver disease such as chronic active 
hepatitis and as a complication of hepatitis B vaccination.6 Also a positive history of auto 
immune diseases like myasthenia gravis, alopecia areata and lupus erythematosus has 
been described. In several studies there was a positive correlation with atopic dermatitis.5 
Quinine has also been described as initiating or worsening lichen planus. 
Clinical findings
Lichen planus often presents with pruritic violaceous, polygonal, flat-topped papules 
and plaques most frequently seen on the flexor surfaces of the wrists and forearms (see 
picture 1) but the anterior side of the lower legs, the lumbo sacral region (see picture 2) 
and the neck are also common sites. Papules can develop at sites of trauma which 
represents the Koebner phenomenon. In the African skin, the lesions have a more grey 
aspect. With a drop of oil the striae of Wickham become visible. It can also affect the skin 
of the genitals and mucous membranes although this is very uncommon in young 
people. Lichen planus may resolve spontaneously with time ranging from a few months 
















Multiple polygonal flat-topped papules and plaques especially on the wrists 
(differential diagnose verrucae vulgares!) and the lumbo sacral region.
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Differential diagnosis 3;8;10
•  Androgenetic alopecia
•  Traction alopecia
•  Tinea capitis
•  Trichotillomania
•  Syphilis
•  Atopic dermatitis
•  Vitiligo
Management 5;11
•  Because of the high rate of spontaneous recovery a "watch-and-see" approach is often 
recommended.
•  Psychological support may be offered if necessary.
•  For patients who actively desire treatment, topical or intralesional corticosteroids are 
the treatments of choice. Betamethasone dipropionate lotion 0.05% can be applied 2 
times daily for 12 weeks or betamethason cream 2 times daily for 1-2 months. If there 
is no improvement after 12 weeks the treatment should be stopped. Intralesional cor-
ticosteroids are appropriate for older children. Triamcinolon acetonide 10 mg/ml 
diluted with 2% lidocaine with epinephrine (to reduce the pain with the injections) 
can be injected intradermal once monthly and not longer than 6 months. 
•  Topical sensitizers like Anthralin (Dithranol) can be used in concentrations of 0.25-1% 
cream. Anthralin cream may be applied overnight, initially for 30 minutes and gradually 
to 1 hour. If there is no result it can be stopped after 3 months. Another possibility is 
the treatment with diphenylcyclopropenone (DPCP) but this is usually done under the 
supervision of a dermatologist.
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Alopecia areata
Epidemiology
Alopecia areata generally concerns pupils or students although the prevalence among 
schoolchildren in Africa was less than 1%.1-4 The life-time risk of alopecia areata in the 
general population is approximately 1.7%. and in as many as 60% of  patients the disease 
starts before the age of 20 years.5 In patients with alopecia areata a considerable amount 
had episodes before or has a positive family history.4
Etiology and pathogenesis
Alopecia areata is an autoimmune disease that presents with nonscarring hairloss.4 The 
pathogenesis is not completely clear.6;7 Atopy, autoimmune thyroid disease, a positive 
family history and vitiligo are commonly associated. The course of the disease is 
unpredictable. Early and severe cases which last long have a less favorable prognosis.8
Clinical findings
Alopecia areata most commonly manifests as sudden loss of hair in a well demarcated, 
localized area in the scalp. The hair loss is usually limited to a single patch. The lesion is 
usually round or oval. “Exclamation point hairs” are frequently seen at the periphery of 
the lesion.5 
The majority of patients present with limited alopecia. Approximately 80%  present with 
one patch, about 12% with multiple patches on the scalp and possibly also in the 
eyebrows, lashes, and beard area, and about 7 % develop total baldness of the scalp 
(alopecia totalis), some even of all body hair (alopecia universalis).9 The clinical diagnosis 
















Alopecia areata in a young child.
A round well circumscribed area with 
hairloss...
Traction alopecia in a young girl...
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to identify until the appearance of characteristic smaller oval shaped secondary lesions 
that follow the cleavage lines. These lesions can form a so called “Christmas tree pattern” 
on the back. Pityriasis rosea is usually asymptomatic but can sometimes itch.7;8 
Differential diagnosis 
•  Secondary syphilis
•  Eczema (especially the herald patch)
•  Psoriasis
•  Tinea corporis
Management
•  To differentiate between pityriasis rosea and secondary syphilis serologic testing for 
syphilis (VDRL or FTA-ABS) is necessary.
•  Because in most cases it is self-limited and asymptomatic, a good explanation and 
reassurance of the patient is very important.
•  In case of pruritus Calamine lotion or low to medium potent topical corticosteroids 
like hydrocortison1% or triamcinolon acetonide 0.1% cream can be applied 2 times 
daily.
•  For severe itchiness oral sedating antihistamines like piriton or promethazine can be 
used. For the dosages see urticaria.
•  Natural sunlight exposure can be beneficial.
•  Ultraviolet A phototherapy (PUVA) is another option for which the patient has to be 
referred to a dermatologist.
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Pityriasis rosea
Epidemiology
Pityriasis rosea is a common, acute, self-limiting papulosquamous eruption. It typically 
affects children and young adults. There is a worldwide distribution and no ethnic 
predilection has been found. The prevalence among females seems to be slightly 
higher than males.1 The point prevalence found among schoolchildren in Africa in 
several studies was low but in other, hospital based studies the period prevalences were 
higher.1-3
Etiology and pathogenesis
Pityriasis rosea is possibly of viral etiology (“flu of the skin”), it has been linked to human 
herpes virus 6 (HHV6). About a quarter of the patients have a history of a viral infection 
with upper respiratory symptoms shortly before or during the occurrence of the rash. 
Several medications can cause a rash similar to pityriasis rosea. It is self-limited and 
normally the eruptions last for 6 to 8 weeks.4-6
Clinical findings
Pityriasis rosea is characterized by an initial “herald patch” (“plaque mère”), followed by 
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During the regression phase they can bleed easily or become necrotic. Ulceration is the 
most common complication occurring in approximately 15% of the patients. Regression 
can be complete and leaves no residual change at the site in most lesions (80%).In some 
areas it can leave atrophy, depigmentation, teleangiectasis and scarring.6     
Differential diagnosis
•  Capillary malformations or teleangiectasias
•  Pyogenic granuloma
•  Vascular malformations
Management
•  Most cases need no treatment and have an excellent functional and cosmetic prognosis. 
Active intervention has to be avoided. Explanation to the parents / caretakers is essential.
•  Proper follow up and management of ulceration. Local wound care with topical 
antibiotics like mupirocin or bacitracin ointments and occlusive dressings. 
•  When vital organs and functions like vision, hearing and breathing are impaired, the 
patient should be referred to a dermatologist and/or pediatrician for treatment with 
intralesional or systemic corticosteroids or interferon. Recent publications show good 
results with the treatment with local or systemic propanolol and systemic atenolol.7;8 
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Benign skin tumors and nevi
Infantile Hemangioma (IH) 
Epidemiology
Infantile hemangiomas are common, benign tumors of blood vessels, observed in 1-4 % 
of infants during the first year of life. Although most cases progress without problems, a 
small proportion can experience life-threatening complications.1 They are more prevalent 
in female, caucasian infants and related with prematurity, advanced maternal age and 
multiple gestations.2
Etiology and pathogenesis
IHs are primarily composed of endothelial cells and can grow rapidly in the first 6 months of 
life, the proliferation phase. This phase can cause great concern to the parents. Normally it 
is followed by slow involution, leading to complete regression in about 70% of the 
patients  in 5 to 10 years. The etiology of both stages is still not completely understood.3;4
Clinical findings
Most infantile hemangiomas occur within the first weeks of life. They vary in size from 
less than 1 cm to more than 10 cm. They can occur anywhere on the skin and mucosal 
surfaces though the preferred site is the face. Hemangiomas which are located in the 
superficial dermis are bright red in color (“strawberry “).Deep hemangiomas can be 
located in the deep dermis or subcutis and present as blue purple tumors. They may 
pose a problem during the growth phase when they can cause obstruction of vision or 
























•  Nutritional deficiencies
Management
•  Protect the skin and eyes from sun damage: avoid the midday sun, wear a wide 
rimmed hat, protective clothing (long sleeves, long skirts and trousers) and sunglasses.
•  Always use a sun block or a sun screen with a high sun protection factor (SPF) (PABA, 
zinc oxide, titanium dioxide).
•  Use a sun block (e.g. zinc oxide or titanium dioxide) for the lips.
•  Regular ophthalmological and dermatological check-ups.
•  Treat solar keratoses with liquid nitrogen, curettage or topical 5% 5-fluoro-uracil.
•  Malignancies should be excised, preferably in a specialized clinic.
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Miscellaneous skin diseases
Oculocutaneous albinism (OCA) 
Epidemiology
The prevalence of OCA is relatively low at general schools in sub-Sahara Africa.1;2 Children 
affected with OCA are more commonly found in schools for the blind. Several prevalence 
studies in South Africa, Tanzania, Nigeria and Zimbabwe show figures of 1/5000-1/15000 
but prevalences as high as 1 in 1000 were reported for selected populations.1-6 The 
medical and social issues facing children with OCA are enormous and life expectancy is 
decreased compared with the general population.7
Etiology and pathogenesis
Oculocutaneous albinism (OCA) is an inherited functional disorder of melanin production 
which results in hypo or depigmentation of the skin, hair and eyes and extreme sensitivity 
to UV-damage. There are different types of OCA all of which have an autosomal recessive 
inheritance pattern.7
Clinical findings
People with OCA have a hypopigmented retina and fovea which leads to photophobia, 
nystagmus and lower vision. Exposure of the yellowish or white skin to the sun leads to 
sunburn, blisters, freckling and the formation of solar keratoses. Without sun protection 

















Multiple lentigenes due to ultra violet 
damage
Without sun protection basal and 
squamous cell carcinomas appear in  
an early age...
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•  Pityriasis versicolor
•  Pityriasis alba
•  Onchocerciasis
•  “Bleaching” practices like the misuse of potent  topical corticosteroids as adjuncts 
   with hydroquinone 
•  Lichen sclerosus
Management
•  Therapeutic treatments are not yet available. Proper explanation and reassurance of 
the patient is important. Good and practical advice about sun protection and local 
camouflage can often decrease the psychological burden of the disease a lot.
•  Topical treatment (for small localized areas) with intermittent potent corticosteroids 
during a set period of time, eg four days a week for 6 months, in combination with 
controlled UV exposure.
•  If available topical calcineurin inhibitors (TCI) like tacrolimus (0.03% and 0.1% ointment) 
or pimecrolimus (1% cream) may be used. The advantage is that they don’t cause 
cutaneous atrophy.8
•  Sometimes dapson can be useful. Dosage: 1-2mg/kg daily. 
•  UVB 311 nm phototherapy can be given in a specialized centre.
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Vitiligo
Epidemiology
Vitiligo may appear at any age. It affects around 0.5% of the world population. In hospital 
based studies from West Africa percentages between 2.8 and 6% have been presented.1;2 
In several community based studies among schoolchildren in Africa the prevalences 
were rather low.3-6 The average age of onset found  in a Nigerian study 7 was approximately 
20 years.
Etiology and pathogenesis 
The etiology of vitiligo is not exactly known though several studies point towards 
an autoimmune base, indicating the importance of a positive family history and 
the presence of  other autoimmune diseases, such as diabetes mellitus and hyper-
thyroidism.7 There is an absence of melanocytes in the affected skin. Vitiligo is usually 
slowly progressive and seldom regresses spontaneously; sometimes the involved skin 
is pruritic.
Clinical findings
Vitiligo is characterized by sharply demarcated white macules surrounded by normal 
skin. It can be present on any part of the body but it is frequently localized on the face, 
the dorsal side of the fingers, the anogenital region and on sites of stretch and pressure. 
In an affected person it also occurs in traumatized skin, the Koebner phenomenon.
On darkly pigmented skin it is more obvious than on light skin. It can lead to a high level 
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Keloids
Epidemiology
For centuries, keloids have been a well known clinical problem and despite considerable 
research to unravel this phenomenon there is still no universally accepted or effective 
treatment.1 Keloids and hypertrophic scars occur worldwide in all skin types but they are 
more common in people of African descent. Incidence rates of 16% among adult 
Africans have been reported while  these percentages were considerably lower among 
schoolchildren.2;3 In severe forms they can become disabling. 
Etiology and pathogenesis
Hypertrophic scars and keloids are formed from excessive scar tissue formation at the 
site of prior skin injury. There is often a familial tendency for developing hypertrophic 
Fixed drug eruption
Epidemiology
Fixed drug eruption (FDE) is one of the most common types of drug eruption among 
children presenting in (dermatology) clinics.1;2  The incidence of fixed drug eruptions 
among both children and adults in several studies from Asia varied between 1 to 9%.3;4 
In recent studies from Nigeria, the hospital based prevalence of drug eruptions was 1% 
of which half was caused by FDE. 5;6
Etiology and pathogenesis
Lesions develop up to several weeks after first exposure to the causative drug but may 
develop within 24 hours after subsequent exposures. Although the pathogenesis 
remains unclear positive patch test results suggest type IV hypersensitivity. Patch test 
results vary greatly, depending on the causative drugs.1;2;7 The drugs most frequently 
associated with FDE are barbiturates, paracetamol, sulphonamides (e.g. trimethoprim-
sulfamethoxazole), anti malarials and various other antibiotics, especially tetracyclines. 
FDE caused by Sulfa-based antimalarials frequently affect the face, lips, and limbs, 
whereas co-trimoxazole frequently causes genital and oral lesions. 1;6;8
Clinical findings
The characteristic finding in FDE is recurrence of the lesions at the same sites. Lesions 
are sharply demarcated round or oval erythematous to violaceous / black plaques 2 to 
10 cm in diameter. Usually they present as a single lesion or in limited numbers and are 
localized.  Any cutaneous or mucosal surface can be involved including lips and genitals. 
With repeated episodes, the lesions may increase in size and/or number and present 
with more profound hyperpigmentation.1;2;6;8 
Differential diagnosis 
•  Insect bites
•  Urticaria
•  Erythema multiforme
Management
•  Prevent recurrence by identification of the responsible drug. 
•  Counsel the parents / caretakers about proper drug use and avoidance of responsible 
drugs.
•  When itchy : Calamine lotion to apply 2 times daily.
•  For severe itchiness oral antihistamines like piriton or promethazine can be used. For 
















Sharply demarcated, round lesions with 
a hyper pigmented centre and an 
erythematous edge
Detail, round lesion with a 
hyperpigmented centre
180 181
chapter 8 SkindiSeaSeS among children in africa
8
Reference List
1.   Louw L. Keloids in rural black South Africans. 
Part 1: general overview and essential fatty 
acid hypotheses for keloid formation and 
prevention. Prostaglandins Leukot Essent Fatty 
Acids 2000; 63: 237-45.
2.   Alhady SM, Sivanantharajah K. Keloids in 
various races. A review of 175 cases. Plast 
Reconstr Surg 1969; 44: 564-6.
3.   Hogewoning A.A., et all. Skindiseases among 
schoolchildren in Ghana, Gabon and Rwanda. 
August 2012 ; accepted for publication in the 
International Journal of Dermatology.
4.   Gauglitz GG, Korting HC, Pavicic T et al. Hyper- 
trophic scarring and keloids: pathomechanisms 
and current and emerging treatment strategies. 
Mol Med 2011; 17: 113-25.
5.   Louw L, Dannhauser A. Keloids in rural black 
South Africans. Part 2: dietary fatty acid intake 
and total phospholipid fatty acid profile in the 
blood of keloid patients. Prostaglandins Leukot 
Essent Fatty Acids 2000; 63: 247-53.
6.  Al-Attar A, Mess S, Thomassen JM et al. Keloid pathogenesis and treatment. Plast Reconstr Surg 2006; 117: 
286-300.
7.  Berman B, Flores F. Recurrence rates of excised keloids treated with postoperative triamcinolone acetonide 
injections or interferon alfa-2b injections. J Am Acad Dermatol 1997; 37: 755-7.
Urticaria
Epidemiology
Urticaria is seen in 1-5% of the population and may present at any age. There are no known 
racial differences. It is more common among women with a female: male ratio of 2:1.1-3 
Etiology and pathogenesis
Urticaria is a vascular reaction of the skin characterized by mast cell degranulation In 
children they  caused by several factors like allergic or hypersensitivity reactions  food 
(fish, milk, tomatoes, citrus fruits, cocoa, strawberries), drugs (aspirin, pethidine, hydralazine, 
ibuprofen) insect bites (bee, wasp, mosquito). 4Also viral infections, mycotic infections, 
helminthic infections and skin contact with allergens can be a cause. Physical urticaria 
may be induced by cold, heat, pressure and exercise. In the majority of the cases, the 
cause remains unidentified.5 
Clinical findings
Urticaria are well demarcated small (< 1 cm) to large (> 8cm) smooth, slightly elevated 
patches (wheals) which can itch severely. Individual lesions are self-limiting and resolve 
scars and keloids but the pathogenesis remains unknown. Most probably nutritional, 
biochemical, immunological, and genetic factors play a role in the abnormal wound 
healing.1;4;5  Another hypothesis is the influence of  change in  hormonal status. This 
might be the reason that in children before puberty there is no keloid formation after 
piercing the earlobes. Unfortunately prevention is often not successful. 
Clinical findings
Keloids are fibrous tumors caused by overgrowth of connective tissue. They occur as a 
result of skin injury, such as burns, surgical or tribal cuts and ear piercing but also after 
inflammatory skin diseases like acne and herpes zoster. 
Sites of predilection are shoulders, upper back, chest and earlobes. At first lesions are 
pink-to purple and often pruritic and painful. Hypertrophic scarring is restricted to the 
area of the original lesion and has a tendency of gradual resolution over time. Keloids 
can migrate into adjacent tissue to form hard, irregular shiny ridges or plaques and are 
persistent. 4;6
Differential diagnosis 
•  Differentiating between a hypertrophic scar and keloid can be difficult.
•  Scleroderma
•  Dermatofibroma
•  Kaposi sarcoma
Management
•  Keloids and hypertrophic scars are chronic skin conditions, their treatment also takes 
time!
•  One of the most important things that one can do to prevent the formation of keloids 
is to  avoid trauma to the skin, attend to cuts or abrasions immediately to minimize 
inflammation and infection, avoid ear piercing and refrain from elective surgery unless 
medically indicated.
•  Intralesional steroid injections: eg kenacort (1:40) on a 1:1 dilution with lidocain 2% 
once every 3 weeks.
•  The following treatments should be preferably carried out in a specialized or university 
hospital:
	Ø		Surgical excision of keloids leads to recurrence and more deformity. In severe 
cases debulking may be needed, and should be followed by regular intralesional 
steroid injections (7)
	Ø		Cryosurgery in combination with intralesional corticosteroids can be used for 
small lesions.
	Ø		Pressure with silastic gel sheets or pressure garments at night for several months. 
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§	Child 2-5 years : 5-15 mg daily in 1-2 divided doses. 
 Oral solution (Syrup, promethazine, 5mg/5mL) 5-15ml daily in 1-2 divided doses.
§	Child 5-10 years: 10-25 mg daily in 1-2½ divided doses. 
 Tablets (promethazine 10 mg) 1- 2½  tablet in 1-2 divided doses.
§	Above 10 years: 25 mg at night, increased to 25 mg twice daily if necessary.
 Tablets (promethazine 25 mg) 1  tablet  2 times daily.
Non-sedating antihistaminica
*Cetirizine (cetirizine) ( British National Formulary)
§	Child under 2 years not recommended.
§	Child 2-6 years: 5 mg daily or 2.5 mg twice daily.
 Oral solution (Syrup, cetirizine hydrochloride, 5mg/5mL) 5 mL daily or 2.5ml twice daily.
§	Child over 6 years: 10 mg daily or 5 mg twice daily.
 Tablets (cetirizine hydrochloride 10mg) 1 tablet daily or ½ tablet twice daily.
•  If the first antihistamine is not effective, it might be necessary to increase the dose, or 
use a different antihistamine. Sometimes a combination of antihistamines is effective.
•  In case of dermographism a combination of H1 (like Piriton) and H2 (like cimetidine) 
antihistamines is advisable.
•  Oral steroids (prednisolon) in moderate dose for a few days can be helpful in severe 
cases of acute hives. They are not recommended long term because of adverse effects. 
Topical steroids like betamethason cream might be used twice daily for a short period 
in the case of severe itching.
•  Avoid the use of aspirin, codeine and nonsteroidal anti-inflammatory drugs like ibuprofen.
in several hours but may be recurrent over weeks. Chronic urticaria is defined as urticaria 
with episodes lasting longer than 6 weeks.6
They are erythematous or white with an erythematous rim. The erythema which may 
be prominent in a light skin is not visible on a dark skin. Lesions can be oval, annular or 
serpiginous. They can appear anywhere and at any interval on the body and as 
angioedema in the face. The lesions are prutitic. Some patients also show dermographism. 
Normally urticaria in children is an isolated event, a massive reaction may occur which 
can lead to an anaphylactic shock.5;7;8 
Differential diagnosis 
•  Contact dermatitis
•  Maculopapular drug eruptions
•  Insect bites
•  Pityriasis rosea
•  Leprosy reactions
Management 6;8;9
•  Avoid or treat the cause if possible. A thorough history is essential.The treatment 
depends on the severity, the duration  and the type of hives.
•  Further investigations, unless aimed at a specific suspected cause, are usually negative 
and not helpful. Only in debilitating chronic urticaria the following may be considered: 
Blood count, liver function test, kidney function test, infection parameters, allergy test 
and tests for autoimmune diseases.
•  The most common treatment is oral antihistamines which controls the itching. Wheals 
may still be visible. 
Sedating antihistaminica
 *Piriton (chlorphenamine maleate) ( British National Formulary)
§	Child under 1 year not recommended.
§	Child 1-2 years: 1 mg twice daily.
 Oral solution (Syrup, chlorphenamine, 2mg/5mL) 2.5ml twice daily.
§	Child 2-5 years: 1 mg 4 to 6 times daily, maximum 6 mg daily.
 Oral solution (Syrup, chlorphenamine, 2mg/5mL) 2.5ml 4 times daily.
§	Child 6-12 years: 2 mg 4 to 6 times daily, maximum 12 mg daily.
 Tablets (chlorphenamine, 4 mg) ½ tablet 4 times daily.
§	Above 12 years: 4 mg 4 to 6 times daily, maximum 24 mg daily.
 Tablets (chlorphenamine), 4 mg) 1 tablet 4 times daily.
*Phenergan (promethazine) ( British National Formulary)
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•  Dermatitis herpetiformis
•  Papular pruritic rash (in HIV infection) 
Management
 Prevention: use insect repellents and impregnated bed nets.
•  Mild topical steroids like hydrocortisone 1% two times daily.
•  Topical antipruritics such as calamine lotion. Gels or lotions containing menthol or 
camphor may also be used sparingly in children. Do not use in infants.
•  Systemic sedating antihistamines like piriton or promethazine can be tried for relief of 
the itching. For dosages see urticaria.
•  In case of a secondary infection oral antibiotics like cloxacillin or erythromycin can be 
given.For dosages see impetigo.
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Papular urticaria
Epidemiology
Papular urticaria is regularly seen among schoolchildren in sub-Sahara Africa, especially 
in countries with a hot and humid climate.1-3 The prevalence rate in Europe and the USA 
is unknown but it tends to be more evident during spring and summer months.4 Papular 
urticaria are mainly seen among children between the age of 2 and 12. 
Etiology and pathogenesis
Papular urticaria is a hypersensitive reaction to contact with arthropods, especially 
insects such as mosquitoes, fleas, mites, flies and bedbugs.4;5 A type I hypersensitivity 
reaction plays a role in the pathogenesis of papular urticaria but delayed type (type IV) 
reactions are more important. Children eventually outgrow this disease, probably through 
desensitization. There may be a relation with atopy and poverty.
Clinical findings
The classic presentation of papular urticaria includes crops recurrent pruritic papules 
and papulovesicles and varying degrees of local edema. Individual papules may 
surround a wheal and display a central point. Scratching causes erosions and ulcerations, 
so secondary pyoderma is common.8;9
Differential diagnosis 
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Management
•  Explain to the patient that it is a chronic skin condition and it can be a part of other 
skin diseases like ichthyosis vulgaris. Improvement often takes months and the bumps 
are likely to come back.
•  To prevent excessive dryness the skin should be treated regularly with an emollient 
cream or ointment like aqueous cream, emulsifying ointment, creams or ointments 
containing lactic acid 5%, coco butter or shea butter.
•  Topical treatment with keratolytic ointments 3%-5% salicylic acid or ureum in the 
same dosage. In case of inflammation topical mild / moderate steroid ointments like 
hydrocortisone 1% or triamcinolon acetonide 0.1% can be used two times daily.
•  Scrubbing the skin, eg. with a pumice stone.
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Keratosis pilaris is a common and harmless condition of keratinized hair follicles, 
especially among children.1;2 It can also be seen as a symptom of the skin disease 
ichthyosis vulgaris and considered a symptom of atopy. It is more common in people 
who have a dry skin, or who have eczema.3In the USA between 50-80% of children, the 
majority of them female, are affected. Among schoolchildren in sub-Sahara Africa and 
other parts of the world these numbers are much lower.2;4-6
Etiology and pathogenesis
This disorder is characterized by grouped, horny, keratotic follicular papules predominantly 
located on the extensor surfaces of the proximal limbs, the posterolateral upper arms 
and anterior thighs. It is usually asymptomatic, sometimes slightly itchy especially when 
the skin is dry, and it may be disturbing cosmetically. Treatment is marginally effective 
and only provides temporary relief. The cause is unknown but there is hyperkeratinization 
which is partly inherited. This skin condition seems to run in families, which is consistent 
with autosomal dominant transmission. Ichthyosis vulgaris is caused by a mutation in 
the filaggrin gen and there is a close relationship with dry skin, allergies and eczema.7 
Clinical findings
Numerous small, rough papules around hair follicles on the upper arms, legs, and 
buttocks can be seen, leading to a “chicken skin” appearance. Inflammation can be 
present and scratching can cause secondary infection. In the dark skin it often leads to 





•  Xerosis cutis
•  Pityriasis rubra pilaris
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Pityriasis alba occurs mainly in infants, children and adolescents and is more often 
diagnosed among children with a darker complexion but may occur in individuals of all 
skin types.1 It is seen more frequently among male than female and among eczema 
patients.2  Prevalences of 8.4 % in India, 5,4 % in Ethiopia and 13.1 % (among children 
with eczema) in Nigeria have been published.3-5 
Etiology and pathogenesis
The etiology and pathogenesis are still poorly understood. Recent studies have found 
direct correlations between the incidence of pityriasis alba and atopy, the amount of 
sun exposure, and the frequency of bathing. Because it is usually asymptomatic, findings 
are often incidental. Without intervention, the lesions can persist for months to years 
and the hypo pigmentation usually does not clear with steroids but will clear in time.6;7 
There is no difference in the number of melanocytes between lesional and normal skin 
which can be of help when diagnosing and differentiating pityriasis alba from other skin 
disorders with hypo pigmentation.1
Clinical findings
Pityriasis alba is a skin disorder characterized by asymptomatic, hypo pigmented, slightly 
scaling patches with unclear margins. It is one of the minor features of eczema and is 
primarily seen on the face and the trunk.  Although treatment with emollients and mild 
topical corticosteroids may accelerate the repigmentation, they have limited efficacy. 
Xerosis Cutis / Dry skin
Epidemiology
A very dry skin xerosis cutis or asteatosis cutis has been seen in several studies among 
schoolchildren in sub-Sahara Africa. Frequent washing with soap due the hot, humid 
climate and subsequent sweating, could explain the high prevalence.1-4 
Etiology and pathogenesis
The etiology of xerosis cutis is multifactorial. The role of the barrier function of the 
stratum corneum is important. When the barrier is impaired the skin will be dry because 
of trans-epidermal water loss and will be more vulnerable for both infectious and 
inflammatory skin diseases.5 Several studies suggest that black skin has a higher trans-
epidermal water loss than light skin types.6 
Clinical findings
Dry skin is characterized by a dull color, rough texture and elevated number of ridges.7;8 
Dry skin often itches and could lead to prurigo simplex and eventually to secondary 
infection; it can also trigger or worsen eczema. 
Differential diagnosis 
•  Allergic contact dermatitis
•  Nummular dermatitis
•  Scabies
Management
•  The use of soap and the frequency of washing should be reduced. The skin should be 
treated twice daily with an emollient cream or ointment like aqueous cream, emulsifying 
ointment, coco butter or shea butter.
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•  Pityriasis versicolor
Management 
•  Explain that the condition is not serious and will disappear in time.
•  The skin can be treated regularly with an emollient cream or ointment like aqueous 
cream, coco butter or shea butter.
•  Apply a mild topical corticosteroid cream like hydrocortisone 1% in case of inflammation.
•  If available topical calcineurin inhibitors (TCI) like tacrolimus (0.03% and 0.1% ointment) 
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General Discussion






The aims of this thesis were to measure the prevalence of different skin diseases among 
schoolchildren in three sub-Saharan African countries, Ghana, Gabon and Rwanda. 
 Population-based prevalence figures are needed for reliable planning of national health 
and prevention programmes but are scarce in Africa because of the laborious and thus 
expensive way to achieve them. We were especially interested in the differences of the 
prevalence between schools in rural and urban areas and between schools with a 
different socio economic level (SEL) based on school fees paid.
Because of the high prevalence of tinea capitis we analyzed the causative agents in the 
Ghana 1 and Gabon studies. We also made a summary of other cross-sectional studies 
restricted to tinea capitis in schoolchildren and carried out in other sub-Saharan 
countries (Table 3 Chapter 4).
Besides the point-prevalence we also estimated the period-prevalence and possible risk 
factors of eczema in a case control study. During our research in Ghana we unexpectedly 
discovered a significantly higher prevalence of acne vulgaris in urban areas as compared to 
rural areas, after which we decided to analyze the possible risk factors. 
If we want to improve the quality and availability of skin disease treatment in Africa, 
community based studies like our study are very important.1-3 
Although we got a good impression of the prevalence of skin diseases among 
schoolchildren we didn’t investigate the disease burden. In future studies it would be 
interesting to assess the impact of skin disease on the quality of life in comparison with 
that of chronic nondermatological diseases. Several studies like this have been carried 
out in the industrialized world but they are rare in developing countries.4 
The outcomes of the different studies in relation to the literature are discussed in the 
following sections.
The prevalence of skin diseases among schoolchildren in Africa 
Not many population based studies about skin diseases among schoolchildren have 
been conducted in Africa.5-7  Population based prevalence studies are important in 
order to plan health care services.8-10  The strength of our population based study is the 
large number of schoolchildren investigated; the research was conducted by a 
dermatologist or a team of dermatologists; and it was performed in three different 
countries in different regions in Africa (Chapter 2). We separated skin diseases and skin 
conditions as different entities, because several skin conditions like dry skin can be 
indicative of skin disease but not necessarily so. In other epidemiological studies skin 
conditions like keratosis pilaris and xerosis cutis are counted as skin diseases and increase 
the overall prevalence rates. The found prevalences in our study are figures of real skin 
diseases and can now be set against other epidemiological studies to allow a better 
comparison with other past and future studies. Measuring a point-prevalence, as we did 
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The prevalence and causative organisms of tinea capitis in Africa
Infections with tinea capitis are endemic among schoolchildren in sub-Sahara-Africa.
Tinea capitis is very contagious especially within big families and when there is 
overcrowding at schools. In several other studies performed in Africa prevalences were 
found of 29% in Zimbabwe23, 9.8% in Mozambique24, and 9.4% in Nigeria25 (table 3 
Chapter 4 ) 
In our study there were quite some differences between the different prevalences in 
tinea capitis (8% and 9% in both Ghana studies and 26% and 21% in Gabon and Rwanda). 
One of the reasons that the prevalences in the Ghana studies were lower than in Gabon 
and Rwanda may be that both Ghanaian studies also included schools with a high or 
middle SEL where prevalences of tinea capitis were much lower. A lower SEL and the 
consequent overcrowding appear to be a major risk for tinea capitis (Chapters 3 and 4).
In several studies from the industrialized world much lower prevalences for tinea capitis 
are found.26-29 Apparently, the prevalence rate of tinea capitis is going down rapidly as 
soon as the SEL increases.
Because little was known about the causative agents of tinea capitis in Ghana and 
Gabon we send samples from scales and hairs of clinically positive tinea capitis of the 
Ghana 1 and Gabon studies to the Mycology Laboratory of the Department of 
Dermatology of the Leiden University Medical Centre in Leiden, the Netherlands for 
species identification (Chapters 3 and 4). T. violaceum (26%) was the most prominent 
species in Ghana, followed by T. tonsurans (22%) and M. audouinii (15%). No T. 
soudanense was found while in other studies in the region this species was the most 
frequent causative agent. 25;30-33 Also in our study in Gabon T. soudanense (29.4%) was 
the most frequent causative agent followed by T. tonsurans (27.9%) and M. audouinii 
(25%). Although T. violaceum was the most prominent species in the Ghana study (26%) 
it had a low prevalence in Gabon (8.8%). In South Africa (90%), Tanzania (14.3%) and 
in our studies, creates a chance of underestimation especially when chronic, relapsing 
diseases like eczema are involved.6;11 Also in this respect our figures can be considered 
as conservative.
The prevalences of one or more skin diseases per child were high: 34.6% and 42% in 
both Ghana studies and 45.8% and 26.7% in the Gabon and Rwanda studies. For the 
percentages of infectious and inflammatory diseases together the prevalences were 
22% and 26% for both Ghana studies and 37% and 27% in the Gabon and Rwanda 
studies. In our study the majority of skin diseases found were skin infections.11 (figure 2 
Chapter 2)
In a review of prevalence studies of skin diseases in children in sub-Sahara Africa, the 
prevalences were ranging from 21% to 87%.12 The major causes of infection in our 
studies were tinea capitis and pyoderma, this pattern was conform other African studies. 
The point prevalence of any skin disease in a recent study among schoolchildren from 
Dar es Salaam (urban environment) in Tanzania was 57% which was comparable with a 
study from rural Tanzania which showed a prevalence rate of 55%.6;8  The point-preva-
lence of infectious skin diseases in the latter study was 30.4% which was comparable 
with our studies and other studies from African countries like Nigeria, Ethiopia and 
Kenya.5-7;13 Also among schoolchildren in other parts of the world, living in poor 
conditions, the same pattern can be observed.14;15 Climatic conditions as heat and 
humidity, overcrowding, malnutrition and other aspects of poverty and negligence can 
lead to high figures of infectious diseases in the developing world.12 
The percentages of bacterial infections in our studies were higher in both Ghanaian 
studies, most probably due to climatic factors like heat and humidity. Pyoderma was the 
second cause of skin infection. Among pyoderma we considered bacterial skin diseases 
like impetigo, folliculitis, abscesses, furuncles and carbuncles.  In other studies performed 
in Africa like in Ethiopia, Mali and Tanzania percentages are mentioned between 5.6% 
and 4%.5;6;16-18 In one study from Kenya10 and one from India14 higher prevalences of 12,7% 
and 11.4% have been found. In our studies we found a low prevalence of scabies and 
other infestations like pediculosis capitis. In several other studies prevalence rates 
between 0.7% and 30.5% are mentioned.5;6;19-21 A recent review commented upon this 
considerable differences in prevalence and stated that scabies is quite common in 
developing countries but its distribution can be subject to a cycle of infection and can 
also have considerable regional differences.22 Since dermatologists in our study checked 
all suspect cases using direct microscopy of material mounted in 20% potassium 
hydroxide it is not likely that we missed many.
High prevalences of infectious skin diseases as seen in our study and other studies from 
developing countries can be seen as a sign of poverty and negligence.  Although most 
skin infections are not life threatening and have a lower mortality rate compared with 
other diseases they can damage the skin and harm the health and wellbeing of children 
infected. 
Prevalence figures of clinically positive tinea capitis in Ghana, Gabon 
and Rwanda
  Ghana 2004 Ghana 2007 Gabon 2005 Rwanda 2007





30 ( 13.3 )
9   ( 3.8 )
121 (8.7)
79 ( 10.5 )
42 ( 6.6 )
105 (23.1)
55 ( 26.3 )
50 ( 20.4 )
522 (20.6)
318 ( 21.9 )
204 (19.0 )
Low SEL
Middle / High SEL
38 /315 ( 10.8 )
1 / 112 ( 0.9 )
100 / 967 (10.3 )
21 / 427 ( 4.9 )
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with the questionnaires adapted from ISAAC (period-prevalence). However, in the 
Ghana 1 study the sensitivity was only 33% and in the Ghana 2 study even lower, 10% 
(see table 4 Chapter 5).  The use of ISAAC adapted questionnaires does not seem to be 
a reliable method to determine prevalence figures of eczema in an African setting. 
Factors related to translation of the questionnaires from the English language as well as 
cultural and educational differences in developing countries seem to play an important 
role.48;51;52 The conclusion that in Africa ISAAC adapted questionnaires are not a reliable 
method to determine prevalence figures has been confirmed in another recent study 
performed in South Africa.53
The repeated screening of large groups of children by a team of dermatologists will be 
too expensive and give (point) prevalences which are, due to the chronic character of 
eczema, too low. Since the ISAAC adapted questionnaires gave reliable figures about 
period-prevalence of eczema in Anglophone countries, the difficulties of the translation 
from the English language as well as the cultural and educational differences have to be 
reassessed and solved in order to make it an useful tool in an African setting.48
Characteristics of eczema among schoolchildren in Africa 
Besides the prevalences we were also interested in the allergic characteristics of African 
schoolchildren and the possible risk factors for developing eczema. The rising 
prevalence of eczema might be related to improved sanitation and reduction in 
childhood infections which is known as the hygiene hypothesis.54-56 Bacterial and viral 
infections lead to a maturation of the immune system and reduce the expression of the 
pro-allergic T-helper-2 (Th2) responses. According to this hypothesis an increasing gross 
national per-capita income, a higher socio-economic status, reduced crowding at 
home, eradication of endoparasites, vaccinations and the growing urbanization in 
Africa are all factors which can lead to a higher prevalence of eczema (Chapter 6).41;57-60 
In order to study the risk factors for eczema in an African setting we selected children 
with a moderate to severe eczema in three hospitals in Accra, Ghana and matched one 
to three controls for age and gender without any visible symptoms of eczema from the 
same school and class. Elevated total IgE levels were associated with eczema among the 
schoolchildren although also a high proportion of elevated total IgE levels was found in 
children without eczema. Elevated cockroach specific IgE levels appeared to be the 
main cause behind the association between elevated total IgE levels and eczema in our 
study. The association between any positive skin prick test (SPT) for house dust mite, cat, 
dog, grass, peanuts and eczema was less pronounced. The same pattern was seen in a 
study in Ethiopia where 60% of the children with clinical eczema didn’t show any 
positive SPT.50 There is evidence for a causal relationship between helminth infections 
and reduced SPT responsiveness to allergens.61 This protective effect of helminth 
infections on the development of eczema could not be found in our study because 
only very few children in this urban population had a helminthic infection at the time of 
Ethiopia (84%) much higher prevalences are found.6;34;35 We didn’t find any M. canis in 
Ghana and only 1.5% in Gabon which was conform other studies in Africa where 
anthropophilic infections are much more common than zoophilic infections. Only in 
recent studies from Nigeria (7.3%) and Tanzania (46.7%) M. canis had a high prevalence 
which is normally a pattern seen in the USA and Europe.6;26;27;36 However, also high 
prevalences of T. tonsurans can be found in the western world due to immigration 
patterns.26;27;29;37
Which species is causing tinea capitis is highly dependent on geography, time and 
social status. In our studies the most frequently seen were anthropophilic which are 
rapidly spreading in circumstances of overcrowding. Tinea capitis caused by 
anthropophilic species can be considered as a marker of poverty.
The prevalence of eczema among schoolchildren in Africa 
The prevalences of inflammatory skin diseases like acne vulgaris and eczema were 
considerably higher in the urban areas and in both Ghanaian studies especially in the 
schools with a middle/high SEL (table 3 Chapter 5). This is a pattern seen in industrialized 
countries.
Eczema is a growing problem in Africa, particularly amongst children.13;38-42 In the last 
decades the prevalence of eczema in the industrialized world has increased rapidly. 
Period prevalences between 15% and 30% have been found in Northern Europe, North 
America, Japan and Australasia.43-45 Most of these period prevalences were obtained by 
questionnaires adapted from the International Study of Asthma and Allergies in 
Childhood (ISAAC).46;47 The main advantages of the use  of questionnaires is that they are 
relatively easy and  cheap to distribute to children and their parents / care takers and 
they can be used to measure disease prevalences in larger populations.48 They measure 
period prevalences which are usually higher than the point- prevalences as determined 
by physical examination. Because eczema is a chronic relapsing disorder a period-prev-
alence may be the best method to determine its frequency. In our study (Chapter 5) we 
determined point-prevalences in all four studies by physical examination of all children 
by a dermatologist or a team of dermatologists (in total 4839 children), which is 
considered the Gold standard. The found prevalences were low (1.5% and 1.6% in both 
Ghanaian studies and 4.0% and 0.8% in the Gabon and Rwanda studies). These figures 
were in agreement with other studies in Africa though recent studies have shown an 
increase, especially among infants.7;38;49;50 In both Ghanaian studies we also measured by 
questionnaire the period-prevalences which were about twofold higher than the point-
prevalences (2.6% and 4.4%). These higher figures could be expected because of the 
chronic relapsing character of eczema. Comparing other period-prevalences in Africa, 
which in other sub-Saharan countries were generally more than 10%, our figures were 
low ( table 5 Chapter 5).   Ideally eczema among children, diagnosed at a certain point 
by physical examination by a dermatologist (point-prevalence) should also be detected 
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years. Female gender, increasing age and a high BMI were risk factors for inflammatory 
acne vulgaris (table 3 Chapter 7). The observed relation between the prevalence of 
acne and a higher BMI is one of the first reported in an African study. With the fast 
growing urbanization and westernization in developing countries, an increase of 
inflammatory skin diseases can be expected. 
the study. Maybe helminth infections in the past could have played a role.60 In the same 
study from Ethiopia no evidence was found that the risk of eczema was reduced in the 
presence of 1 or more parasite infections. They found even an increased risk of eczema 
in the presence of any parasite infection, especially caused by Trichuris.50 A non-signifi-
cant positive association between frequent bathing and eczema was observed in our 
study. Frequent bathing with water and soap is considered to be a healthy exercise in 
Ghana. Another non-significant association with the development of eczema was 
found with sleeping on a mattress, an association not found in an earlier African study. 
41 Sleeping on a mattress might be an indicator of a higher socio-economic status and 
can lead to higher exposure to house dust mite and cockroach antigens which all 
influence the occurrence of eczema.
Important factors in the development of eczema in individuals from European and 
Asian descent are mutations in the filaggrin gene (FLG), a key protein involved in 
maintaining skin barrier function and hydration.62 Only recently research to this has 
been carried out in Africa.63 It would be very interesting to look for mutations in the FLG 
in our study. Plans for this have been made.
Prevalence and risk factors of acne vulgaris in Africa
Acne vulgaris affects between 30% and 95% of the adolescents in the industrialized 
countries.64-66  The prevalence is considerably lower in developing countries.5;6;14 In our 
studies ( Chapter 7 ) the prevalences of acne vulgaris were 3.2% and 4.7% in both 
Ghanaian studies and 1.1% and 1.3% in Gabon and Rwanda. The prevalences in Gabon 
and Rwanda were low comparing with the both Ghanaian studies. One of the reasons 
might be that in both Ghanaian studies also urban private schools with a higher SEL 
were involved. In Chapter 7 we studied especially the Ghana study 2 to look at the 
difference between the prevalence rates among rural and urban schoolchildren and 
possible risk factors. There are several hospital-based studies about the prevalence of 
acne vulgaris in Africa, 17;67;68 but only a few community based studies that compared 
prevalences of acne among schoolchildren in rural and urban areas.5;69  In table 1 
(Chapter 7) the prevalence of acne vulgaris in several developing countries is reported. 
In the Ghana 2 study the schools were categorized as public (no school fees), private 
(middle to high school fees) and private rich (very high school fees) to reflect the 
average socioeconomic level of the children, respectively low, middle to high.  The 
prevalence of acne was less than 1% in the rural schools and varied between 1.3% in 
boys between 9 and 10 years old to 28.4% in girls between 13 and 14 years old in the 
urban schools.  One of the main reasons of this difference might be the significantly 
lower height and weight of the rural children. An association between overweight and 
acne has been described before.70;71  The observed association between a higher BMI 
(body mass index) and acne among the children who were attending the urban schools 
would fit in this hypothesis. In our study we only looked at children between 9 and 16 
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Summary and concluding remarks
Many skin diseases among schoolchildren in sub-Sahara Africa cause disturbing 
complaints like itch and pain and several of them are contagious. This high prevalence 
causes a major public health problem. Although in several studies and also in our 
studies skin diseases present in large numbers, they don’t get the attention they 
deserve. A high percentage of visits to hospitals or other health institutions are caused 
by skin diseases. Most of them can easily be prevented and treated. 
The studies presented in Chapter 2 focused on descriptive epidemiology to characterize 
and report the point-prevalence of skin diseases among schoolchildren in three African 
countries. We found high figures for the point-prevalence of infectious diseases like 
tinea capitis and pyoderma. The prevalence of the so called “typical” tropical diseases 
was very low. Most of the diseases are not difficult to diagnose and can easily be treated. 
Not many population based studies about the prevalence of skin diseases among 
schoolchildren in Africa have been published. The majority of studies are hospital or 
institution based. We have performed 4 studies in 3 different African countries which 
makes it quite unique. Most other studies present also high figures, especially of skin 
infections.
Eczema is a growing problem in sub-Sahara Africa but the point-prevalences among 
schoolchildren are still much lower than those found in the industrialized world. The 
point-prevalence of acne vulgaris was low in the rural areas and much higher in the 
urban schools with a higher socioeconomic level (SEL) (i.e. higher school fees).
In Chapters 3 and 4 the high prevalences of tinea capitis among schoolchildren in 
Ghana and Gabon were further studied and the causing species analyzed. The 
prevalences were higher in rural schools with a low SEL. The most prominent causing 
species were anthropophilic moulds which are mainly spread under circumstances of 
crowding. They can be seen as poverty markers. T. soudanense was not encountered in 
our study in Ghana, which was an exceptional observation because in other studies 
from West Africa it was the main causing species.
In Chapter 5 we focused especially on the prevalence of eczema. Most of the studies 
concerning the prevalence rate of eczema in Africa are hospital-based and therefore 
less reliable when estimating the prevalence of eczema on a national scale. The point-
prevalences in our study of eczema amongst schoolchildren, as measured by physical 
examination by a dermatologist, were low and comparable with other studies in Africa. 
There was not a significant difference between rural and urban areas however, as was 
anticipated. We analyzed the use of ISAAC (International Studies on Allergy and Asthma) 
based questionnaires to determine the period-prevalence of eczema. The sensitivity 
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In the concluding chapter (chapter 9), the descriptive epidemiological aspects as well 
as the analysis of the causing species in tinea capitis are discussed together with the 
study of risk factors of eczema and acne. The different studies are discussed in view of 
recent findings and publications by others. The impact of statistical and methodological 
biases of the study design on our findings is discussed.
Concluding remarks
Our study shows that skin diseases and conditions are common among schoolchildren 
in sub-Sahara Africa and about one-third or more of them are affected at any given 
time. 
The majority of skin diseases found was caused by infections and inflammation together 
and can be grouped into fewer than eight categories. This is important in designing 
training programs for medical teams involved in the delivery of health care services in 
sub-Sahara African countries where a big part of the population is less than 15 years of 
age. 
and the positive predictive values were very low in our hands, which suggest that this 
method might be less suitable and reliable to identify children with eczema in an 
African setting. Most probably these discrepancies are caused by factors related to 
translation of the questionnaires from the English language as well as cultural and 
educational differences in developing countries.
 
In Chapter 6 we were looking for risk factors of eczema among schoolchildren in Accra, 
Ghana. Elevated total IgE levels were associated with eczema among the schoolchildren, 
although also a high proportion of elevated total IgE levels were found in children 
without eczema. Elevated cockroach specific IgE levels appeared to be the main cause 
behind the association between elevated total IgE levels and eczema in our study. The 
association between any positive SPT (skin prick test) and eczema was less pronounced.
A positive association, though non-significant, between frequent bathing and eczema 
was observed. Another non-significant association with the development of eczema 
was found with sleeping on a mattress which might be an indicator of a higher 
socio-economic status and can lead to higher exposure to house dust mite and 
cockroach antigens which can all influence the occurrence of eczema.
Both the studies from Chapter 5 and 6 contribute to increasing our understanding of 
epidemiology and characteristics of eczema in sub-Sahara Africa.
Chapter 7 was based on analytic epidemiology where we searched for risk factors of 
acne vulgaris. Acne is a growing problem in Africa although the prevalence is still much 
lower than in industrialized countries. In our Ghana 2 study we observed a direct 
positive relation between an increasing body mass index (BMI) and the prevalence of 
acne. The relation found between a higher BMI and the prevalence of acne vulgaris, 
especially among children in urban areas is of importance because of the growing 
problem of obesity in Africa. Because of the “westernization” in urban areas in developing 
countries a steep increase of the prevalence of acne vulgaris in Africa can be expected.
This was one of the first observations of this kind described in Africa. 
In Chapter 8 the epidemiology, etiology and pathogenesis, clinical symptoms and the 
management and treatment of the most prevalent skin diseases among schoolchildren 
in Africa are described. Also some typical tropical diseases and skin conditions are 
mentioned. Although the prevalences in our studies of classical tropical diseases like 
leprosy or filarial lymph edema or a condition like albinism were low, the socio 
-economical impact of these diseases can be enormous. This list of skin diseases is far 
from complete and needs continuous improvements and additions. All skin diseases 
described will be freely accessible via the internet: www.africanskindiseases.org.
It is meant to be a practical guide for general practitioners, students and all others who 
are working with children in the medical field. 
Gutta cavat lapidem, non vi sed saepe cadendo.










De prevalentie van huidziekten onder schoolkinderen in sub-Sahara Afrika is erg hoog 
en vormt  een belangrijk maar vaak onderschat probleem voor de publieke gezond-
heidszorg. Diverse huidziekten veroorzaken klachten zoals pijn en jeuk en kunnen 
bijzonder besmettelijk zijn. Een hoog percentage van de bezoeken aan ziekenhuizen en 
klinieken wordt veroorzaakt door huidziekten waarvan de meeste gemakkelijk voorkomen 
en behandeld kunnen worden. 
In hoofdstuk 2 worden de puntprevalenties van huidziekten onder schoolkinderen in 
drie Afrikaanse landen (Gabon, Ghana en Rwanda) besproken. Opvallend zijn de 
buitengewoon hoge percentages van besmettelijke ziekten zoals tinea capitis en 
pyoderma terwijl de percentages van de zogenaamde klassieke tropische aandoeningen 
erg laag waren. Eczeem is een groeiend probleem in sub-Sahara Afrika hoewel de punt-
prevalenties onder kinderen nog steeds veel lager zijn dan die in de geindustrialiseerde 
landen. De gevonden punt-prevalentie van acne vulgaris was laag in de plattelands 
(rurale)  gebieden maar veel hoger in de stedelijke (urbane) gebieden, vooral op scholen 
met een hoger sociaal economisch niveau (hoger schoolgeld). 
Er zijn niet veel bevolkingsonderzoeken beschreven over de prevalentie van huidziekten 
onder schoolkinderen in Afrika. De meeste onderzoeken worden gedaan vanuit  zieken - 
huizen of andere instituten. Dat er vier onderzoeken verricht zijn in drie verschillende 
landen en met zulke grote aantallen kinderen, maakt deze studie bijzonder. 
In hoofdstukken 3 en 4  worden de hoge prevalenties van tinea capitis onder 
schoolkinderen in Ghana en Gabon beschreven. Gedurende  deze studies werd van 
klinisch verdachte kinderen materiaal afgenomen en in het mycologisch laboratorium 
op de poli Huidziekten van het Leids Universitair Medisch Centrum geanalyseerd. De 
gevonden prevalenties waren het hoogst op rurale scholen met een lager sociaal 
economisch niveau. De meest voorkomende verwekkers waren anthropophiele mycosen 
die vooral gezien worden op plaatsen waar mensen dicht op elkaar leven (grote klassen, 
gezinnen) in veelal armoedige omstandigheden. T. soudanense werd niet gevonden in 
de studie uit Ghana, hetgeen opmerkelijk is daar dit in de meeste studies uit West Afrika 
de grootste veroorzaker van tinea capitis betreft.
 
In hoofdstuk 5 wordt vooral de prevalentie van eczeem beschreven. De meeste preva-
lentiestudies in Afrika zijn vanuit ziekenhuizen of andere instituten verricht en daarom 
minder geschikt om een betrouwbare schatting te doen naar de prevalentie van 
eczeem op nationaal niveau. De puntprevalenties in onze studie, zoals bepaald na 
lichamelijk onderzoek door een dermatoloog (de “gouden” standaard), waren laag en 
vergelijkbaar met andere studies in Afrika. De verschillen in prevalentie tussen rurale en 
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studies zeer laag was, worden er toch enige hiervan gepresenteerd. De redenen hiervan 
zijn de grote sociale en economische  consequenties van deze ziekten. Dit laatste geldt 
ook voor een huidaandoening als albinisme.
Dit hoofdstuk is bedoeld als een praktische kinderdermatologische handleiding voor 
artsen, clinical assistants, verpleegkundigen, studenten en iedereen die werkzaam is 
in de gezondheidszorg in Afrika. Het is aanvullend op het boek: “ Common skindiseases 
in Africa. An illustrated guide” door Colette van Hees en Ben Naafs. De lijst met 
dermatologische aandoeningen is nog niet compleet en dient voordurend verbeterd, 
aangevuld en aangepast te worden. De informatie en klinische foto’s zullen vrij 
beschikbaar zijn op het internet via de website: www.africanskindiseases.org.
Hoofdstuk 9 geeft een samenvatting van de resultaten en bevindingen zoals beschreven 
in de voorgaande hoofdstukken. De verschillende studies worden vergeleken met recente 
bevindingen en publicaties verricht door anderen. Tevens worden methodologische en 
statistische tekortkomingen van de studies besproken.
Conclusies
Onze studies laten zien dat huidziekten en aandoeningen onder schoolkinderen veel in 
sub-Sahara Afrika voorkomen.Ongeveer een derde van de kinderen is op een gegeven 
moment aangedaan.
De meerderheid van de huidziekten werd gevormd door infectieuze en inflammatoire 
aandoeningen welke in minder dan acht categorieën samengevat kunnen worden. Dit 
is een belangrijk gegeven voor het maken van trainings- en behandelings programma’s 
voor diegenen die actief zijn in de gezondheidszorg in sub-Sahara Afrika, waar het 
grootste deel van de bevolking veelal jonger is dan 15 jaar. Er is een grote behoefte aan 
gestandaardizeerde adviezen over de behandeling van de belangrijkste huidaandoe-
ningen en aan speciale trainingen voor gezondheidszorgmedewerkers. 
urbane gebieden waren niet significant.  Het gebruik van op ISAAC (International 
Studies on Allergy and Asthma) gebaseerde  enquetes werd geanalyseerd, met name 
om de periode prevalentie van eczeem te bepalen. De sensitiviteit en de positief 
voorspellende waarden waren zeer laag. Deze verschillen worden vermoedelijk 
veroorzaakt door problemen met de vertaling van de enquetes uit het Engels en door 
cultuurverschillen. Dit maakt deze methode minder geschikt en betrouwbaar om de 
prevalentie van eczeem bij kinderen in Afrika te bepalen. 
In hoofdstuk 6  wordt nader ingegaan op de risicofactoren voor het ontwikkelen van 
eczeem in Accra, Ghana. In deze studie werd een verband gevonden tussen een 
verhoogd totaal IgE en eczeem onder schoolkinderen hoewel er ook bij diverse kinderen 
een verhoogd IgE werd gevonden, zonder dat er sprake was van eczeem. Een verhoogd 
specifiek IgE tegen kakkerlakken leek de hoofdoorzaak te zijn van de associatie tussen 
een verhoogd totaal IgE en eczeem in onze studie. De associatie tussen een positieve 
huidpriktest op kakkerlakken antigeen en eczeem was minder duidelijk.  
Een positieve associatie, hoewel niet significant, werd gevonden tussen veelvuldig 
wassen en het ontstaan van eczeem. Een andere, niet significante, associatie voor de 
ontwikkeling van eczeem werd gevonden met het slapen op een matras. Dit laatste kan 
wijzen op een hoger sociaal economische niveau en op een verhoging van blootstelling 
aan huisstofmijt en kakkerlakantigenen.Alle genoemde factoren kunnen het voorkomen 
en ontstaan van eczeem beinvloeden. 
Beide studies zoals beschreven in hoofdstuk 5 en 6 hebben geleid tot meer kennis over 
de epidemiologie en de oorzaken van eczeem in sub-Sahara Afrika.
In  hoofdstuk 7 worden de risicofactoren voor acne vulgaris nader geanalyseerd. Acne 
is in toenemende mate een probleem in Afrika hoewel de prevalentie een stuk lager is 
dan in geïndustrialiseerde landen. In onze tweede Ghanese studie zagen wij een direct 
positief verband tussen een verhoogde BMI (Body Mass Index) en de prevalentie van 
acne. De gevonden relatie tussen een hogere BMI en de prevalentie van acne vulgaris, 
speciaal bij kinderen in stedelijke gebieden, is door het toenemende probleem van 
obesitas in Afrika, belangrijk. Gezien de toenemend westerse leefstijl  in de stedelijke 
gebieden in ontwikkelingslanden kan een scherpe stijging van de prevalentie van acne 
in Afrika verwacht worden.
Deze studie vormt één van de eerste observaties die over de relatie tussen BMI en de 
prevalentie van acne in Afrika beschreven zijn.
In hoofdstuk 8 worden de epidemiologie, etiologie en pathogenese, klinische symptomen 
en de behandeling van veel voorkomende huidaandoeningen onder schoolkinderen 
beschreven. Tevens worden ook enige” typisch” tropische ziekten besproken. Hoewel 
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